Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - olfactory bulb [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - olfactory bulb [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
PGA3		ENSG00000229859	"Pepsinogen A3"	P0DJD8	11	61203307-61213098	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	924	"stomach 1: 89793.9"	"Cell type enriched"	"Detected in some"	526	"Gastric mucus-secreting cells: 3263.5"	"Cancer enriched"	"Detected in single"	498	"stomach cancer: 24.8"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.2"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.8;THP-1: 1.1"									"CAB026358, HPA046875"	Enhanced				"Secreted to digestive system"	NA	NA					"CAB026358: , HPA046875: AB_2679851"										"unprognostic (6.39e-2)"				"unprognostic (1.11e-1)"				41.6	10.1	0.6	0.2	0.3	0.2	18.4	0.8	1.0	8.5	0.0	78.0	1.3	3.8	0.0	97.1	4.5	0.1	7.7	3.2	0.1	5.2	16.3	6.3	0.0	0.1	0.0	0.6	5.4	13.1	0.0	13.6	0.5	0.1	5.5	0.1	0.9	6.8	0.8	4.4	5.6	5.7	0.4	0.0	6.4	89793.9	7.4	0.0	0.1	5.0	0.6	0.1	6.2	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.7	1.3	0.4	0.1	0.2	0.7	0.1	0.1	0.1	0.6	0.4	0.2	0.3	0.0	0.0	1.3	0.6	0.3	0.8	1.0	3.2	0.1	0.1	0.0	0.6	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	6.2	0.0	0.3	3263.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.1	0.0	3.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.1
GKN1	"AMP18, BRICD1, CA11"	ENSG00000169605	"Gastrokine 1"	Q9NS71	2	68974573-68980980	"Plasma proteins, Predicted secreted proteins"		Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1842	"stomach 1: 37772.3"	"Cell type enriched"	"Detected in some"	28	"Gastric mucus-secreting cells: 9780.9"	"Cancer enriched"	"Detected in some"	116	"stomach cancer: 255.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 6.5;HMC-1: 17.2;MOLT-4: 12.4;NTERA-2: 16.0;REH: 7.2;U-2 OS: 10.1;U-266/70: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047684	Enhanced				"Secreted to digestive system"	NA	NA		18000000			"HPA047684: AB_2680120"						"unprognostic (5.40e-2)"					"prognostic unfavorable (1.54e-4)"			"unprognostic (4.54e-1)"			"prognostic favorable (4.53e-4)"	1.6	1.8	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.4	0.0	1.3	0.0	0.3	0.0	3.6	0.4	0.0	0.6	0.0	0.0	1.8	0.8	3.5	0.0	0.0	0.0	0.0	0.4	4.8	0.0	0.3	20.5	0.0	0.7	0.3	0.0	0.4	0.1	1.0	0.5	0.4	0.0	0.0	10.5	37772.3	0.4	0.0	1.1	0.2	0.2	0.1	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	6.5	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.4	0.0	16.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	10.1	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	3.3	9780.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	346.5	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.5	0.0	0.0
LIPF	"HGL, HLAL"	ENSG00000182333	"Lipase F, gastric type"	P07098	10	88664441-88678814	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	142	"stomach 1: 37514.0"	"Cell type enriched"	"Detected in some"	444	"Gastric mucus-secreting cells: 1509.7"	"Cancer enriched"	"Detected in some"	75	"stomach cancer: 278.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 4.1;MOLT-4: 3.4;NTERA-2: 3.4;REH: 2.1;RPMI-8226: 1.8;THP-1: 6.8;U-2 OS: 2.2;U-266/70: 3.1"	"Region enriched"	"Detected in single"	77	"olfactory bulb: 7.6"					HPA045930	Enhanced				"Secreted to digestive system"	NA	NA					"HPA045930: AB_10959518"										"unprognostic (1.53e-1)"				"unprognostic (1.83e-1)"				3.6	2.9	0.1	0.0	0.0	0.0	4.6	0.1	0.0	3.1	0.0	8.7	264.5	1.9	0.0	118.8	5.5	0.0	2.2	0.0	0.1	11.5	5.0	7.3	0.0	0.2	0.2	0.0	2.2	4.5	0.0	7.3	0.5	0.1	6.8	0.0	0.0	2.6	0.0	1.6	1.7	1.9	0.0	0.1	2.6	37514.0	2.9	0.1	0.0	1.3	0.0	0.1	2.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	3.4	0.0	0.0	2.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	2.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1509.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
NR1I2	"BXR, ONR1, PAR2, PXR, SXR"	ENSG00000144852	"Nuclear receptor subfamily 1 group I member 2"	O75469	3	119780484-119818487	"FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 31.5;liver: 47.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 26.1;Hepatocytes: 32.2;Paneth cells: 13.8;Proximal enterocytes: 51.7;Undifferentiated cells: 9.0"	"Group enriched"	"Detected in some"	24	"colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	15	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	15	"NK-cells: 2.8"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029309, HPA055121, HPA073926"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643"	"unprognostic (6.76e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.51e-6)"	"unprognostic (4.86e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.12e-3)"	0.1	0.1	0.2	1.0	0.1	0.6	0.1	0.0	0.1	0.0	0.1	12.4	28.4	0.0	0.1	0.0	0.1	5.2	0.0	0.1	0.3	0.0	47.8	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	13.4	0.2	0.0	0.2	0.0	0.0	31.5	0.6	0.1	0.1	1.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.3	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.7	1.5	0.0	1.8	0.0	0.0	0.1	26.1	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.1	3.1	0.0	0.0	1.7	0.0	32.2	0.2	0.0	0.4	6.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	13.8	0.0	0.1	0.2	51.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.5	9.0	0.0
ATP4A	ATP6A	ENSG00000105675	"ATPase H+/K+ transporting subunit alpha"	P20648	19	35550031-35563658	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Transport"	Translocase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	83	"stomach 1: 848.7"	"Group enriched"	"Detected in some"	6	"Gastric mucus-secreting cells: 66.3;Late spermatids: 21.0"	"Cancer enriched"	"Detected in single"	21	"stomach cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039154, HPA076684"	Enhanced					NA	NA					"HPA039154: AB_10672772, HPA076684: "	"unprognostic (3.54e-2)"	"unprognostic (6.98e-3)"		"unprognostic (2.77e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-3)"		"unprognostic (4.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.2	0.0	0.1	0.0	0.0	10.2	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	848.7	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	66.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	21.0	0.6	1.2	0.0	0.0	0.6	0.1	0.0	0.0	0.1	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0
LGALS4	GAL4	ENSG00000171747	"Galectin 4"	P56470	19	38801671-38812945	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"intestine: 1127.6"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 4349.4;Intestinal goblet cells: 3767.6;Paneth cells: 3353.0;Proximal enterocytes: 4572.2;Undifferentiated cells: 2684.6"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 450.7;liver cancer: 133.6;pancreatic cancer: 213.7;stomach cancer: 190.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	205	"OE19: 987.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB025653, HPA031184, HPA031185, HPA031186"	Enhanced		Uncertain	"Plasma membrane"		NA	NA		200000	"Plasma membrane"		"CAB025653: , HPA031184: AB_2673776, HPA031185: AB_2673777, HPA031186: AB_2673778"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.69e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.71e-2)"	"prognostic favorable (3.21e-4)"	1.6	0.5	0.3	86.9	0.4	0.5	5.5	0.5	0.6	1.2	0.2	1127.6	819.5	3.2	0.2	1.5	2.4	138.4	0.9	0.3	0.3	3.0	80.1	1.2	1.2	0.3	0.3	0.3	1.7	31.8	0.0	0.8	0.2	0.3	2.3	941.8	0.2	1.1	2.3	1.6	1.4	697.8	55.7	0.2	4.0	136.4	1.0	0.3	0.3	1.8	0.2	0.4	11.3	1.5	0.4	0.0	0.4	0.1	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	1.3	0.1	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	2.2	0.0	987.1	0.0	0.1	0.0	2.5	0.1	4.8	0.2	1.4	0.1	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.2	1.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.4	1.7	3.2	6.5	0.7	10.3	1.1	3.0	0.6	3.4	1.1	3.6	3.0	1.3	770.7	1.0	0.0	0.0	0.8	0.9	4349.4	0.0	267.1	0.2	1.9	1.8	1.2	649.7	0.0	0.3	103.3	0.5	0.8	310.4	5.7	49.0	0.8	1.8	69.0	0.1	1.7	0.3	3767.6	0.0	1.9	0.3	0.0	0.0	1.2	0.0	1.0	3.0	0.8	1.0	0.0	0.7	492.7	3353.0	0.4	0.7	1.8	4572.2	9.3	0.4	2.3	0.0	3.9	1.1	0.3	0.9	0.9	2.7	0.5	11.1	1.1	2684.6	42.4
REG4	"GISP, REG-IV, RELP"	ENSG00000134193	"Regenerating family member 4"	Q9BYZ8	1	119794017-119811580	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 668.2"	"Cell type enriched"	"Detected in some"	7	"Intestinal goblet cells: 3458.1"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 180.6;pancreatic cancer: 215.1;stomach cancer: 162.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"naive CD8 T-cell: 24.6"	"Lineage enriched"	"Detected in single"	101	"T-cells: 24.6"	"Cell line enriched"	"Detected in some"	60	"OE19: 6164.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025867, HPA046555"	Enhanced				"Secreted to digestive system"	NA	NA		460000			"CAB025867: , HPA046555: AB_2679696"	"unprognostic (3.22e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.64e-2)"		"unprognostic (7.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.12e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.10e-1)"		"unprognostic (1.32e-3)"	0.7	0.0	0.2	34.7	0.1	0.3	0.0	0.1	0.2	0.4	0.1	238.3	266.8	0.5	0.0	1.5	0.0	0.5	0.0	0.2	0.1	0.7	0.3	0.0	1.6	0.2	0.1	0.1	0.0	134.8	0.0	0.0	0.0	0.2	2.6	317.4	0.0	2.3	0.2	0.0	0.0	668.2	8.6	0.1	0.2	19.2	2.4	0.2	0.4	0.0	0.0	0.8	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.3	2.3	0.1	6164.0	102.7	0.0	0.0	0.8	0.0	29.2	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	3.8	24.6	0.2	0.0	0.0	0.0	0.0	2.5	0.2	0.1	0.1	0.2	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	10.8	0.0	0.0	0.0	441.8	0.0	0.0	1.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3458.1	0.0	0.0	0.0	25.9	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	140.0	0.0	0.1	3.8	178.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	2.9	0.1	52.0	0.2
SPINK4	"MGC133107, PEC-60"	ENSG00000122711	"Serine peptidase inhibitor Kazal type 4"	O60575	9	33218365-33248567	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 991.0"	"Cell type enriched"	"Detected in some"	14	"Intestinal goblet cells: 8017.1"	"Group enriched"	"Detected in many"	20	"colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	12	"HMC-1: 175.7;OE19: 480.7"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Low region specificity"	"Detected in single"			HPA007286	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"	"Secreted to digestive system"	NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA007286: AB_1080083"	"unprognostic (3.49e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (8.85e-5)"	"unprognostic (3.09e-4)"		"unprognostic (1.49e-1)"		"unprognostic (1.00e-1)"		"unprognostic (9.66e-2)"	"unprognostic (2.43e-1)"			"unprognostic (1.24e-1)"	"unprognostic (3.25e-1)"		"unprognostic (2.42e-3)"	1.4	0.6	0.0	85.0	0.1	0.6	0.1	0.6	0.3	0.0	0.1	645.5	265.8	1.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.9	2.2	0.9	0.0	0.1	0.0	991.0	92.9	0.1	0.5	0.3	0.0	643.6	42.6	0.0	0.2	1.5	0.3	0.0	0.1	0.0	0.0	0.0	17.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.0	0.0	0.0	3.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	11.7	27.8	1.1	0.0	0.0	175.7	0.0	0.0	0.0	0.4	0.5	0.0	0.1	4.1	0.3	0.0	3.9	0.4	2.3	0.0	480.7	0.4	0.0	0.0	0.2	0.0	0.5	0.4	1.4	15.2	3.1	0.0	0.1	14.2	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.3	0.1	1.4	0.3	0.0	1.8	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.3	0.0	0.0	0.0	21.7	0.1	0.0	0.0	0.0	0.0	5.5	12.5	0.1	0.0	56.5	0.0	0.2	1.0	0.1	0.0	0.6	88.2	0.0	0.0	0.0	0.0	0.0	43.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8017.1	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.5	0.1	0.1	106.8	0.0	0.1	0.2	541.4	0.0	0.0	129.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.1	191.5	0.2
BNIP5	"C6orf222, DKFZp779B1540"	ENSG00000189325	"BCL2 interacting protein 5"	P0C671	6	36315761-36336888	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 24.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"colorectal cancer: 8.7;pancreatic cancer: 5.1;stomach cancer: 8.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;OE19: 2.3;REH: 1.0;U-937: 1.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA038407, HPA058189"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA038407: AB_10669644, HPA058189: AB_2683634"	"unprognostic (1.97e-5)"	"unprognostic (5.46e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"		"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.66e-4)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	24.9	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	0.0	5.8	0.0	0.0	0.0	0.0	0.2	23.7	0.1	0.0	0.0	4.2	1.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRNN	"C1orf10, SEP53"	ENSG00000143536	Cornulin	Q9UBG3	1	152409243-152414263	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 5389.2;vagina: 1705.5"	"Cell type enriched"	"Detected in some"	24	"Squamous epithelial cells: 79.9"	"Group enriched"	"Detected in many"	18	"cervical cancer: 19.3;head and neck cancer: 74.0;stomach cancer: 22.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA024343, CAB026182"	Enhanced					NA	NA		100000			"CAB026182: , HPA024343: AB_1847162"		"unprognostic (1.96e-2)"		"unprognostic (1.74e-6)"		"unprognostic (4.20e-2)"			"unprognostic (3.43e-1)"	"unprognostic (6.43e-3)"								1.0	0.9	0.1	0.0	0.1	0.0	0.7	0.0	0.2	413.5	0.0	0.6	0.0	0.8	0.0	5389.2	0.7	1.1	1.8	0.1	0.1	0.6	1.5	0.4	0.0	0.1	0.1	0.0	1.2	3.0	0.0	3.5	0.0	0.1	0.8	0.0	0.0	914.1	0.0	1.4	7.5	1.2	0.1	0.1	0.9	5.0	0.8	0.1	0.0	0.6	0.0	252.0	1.2	1705.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	79.9	0.0	0.0	0.0	0.0	0.0	0.0
VSIG1	"GPA34, MGC44287"	ENSG00000101842	"V-set and immunoglobulin domain containing 1"	Q86XK7	X	108044970-108079184	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"stomach 1: 195.3"	"Cell type enriched"	"Detected in some"	10	"Gastric mucus-secreting cells: 333.8"	"Group enriched"	"Detected in many"	17	"lung cancer: 8.7;pancreatic cancer: 17.7;stomach cancer: 31.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 12.0;T-reg: 12.9"	"Lineage enriched"	"Detected in many"	4	"T-cells: 12.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.5;HUVEC TERT2: 7.4;PC-3: 2.3;TIME: 1.7"	"Not detected"	"Not detected"							"HPA001445, HPA036310, HPA036311"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA001445: AB_10669749, HPA036310: AB_10670795, HPA036311: AB_10673350"	"unprognostic (4.33e-3)"	"unprognostic (4.60e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.80e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-7)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-3)"	0.0	0.1	0.3	1.3	0.4	0.5	0.1	0.2	0.3	0.0	0.3	0.2	1.3	0.1	0.3	0.2	0.0	8.5	0.0	0.2	0.2	0.1	0.1	1.0	1.9	0.1	0.1	0.2	0.0	0.2	0.0	2.6	0.3	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.4	0.5	0.0	0.1	0.8	195.3	48.1	0.2	0.8	0.1	0.0	1.6	9.0	0.1	0.2	0.1	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.6	0.0	1.1	0.0	7.4	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.2	0.6	2.3	0.2	0.0	0.0	0.3	0.6	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.7	0.1	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.1	1.0	0.0	3.8	2.8	8.1	3.6	0.0	1.3	12.0	5.8	0.3	0.1	0.1	0.1	12.9	2.6	0.3	0.4	0.2	0.3	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	25.6	11.0	1.0	2.4	0.6	0.9	0.7	0.0	0.9	0.2	0.1	0.5	1.5	0.7	0.0	0.0	0.0	0.1	0.4	0.0	2.9	6.1	1.1	0.1	1.0	0.0	0.0	4.1	4.6	0.0	0.6	333.8	0.2	2.5	0.0	0.0	0.0	0.1	0.0	1.4	0.3	0.0	0.0	0.4	10.8	0.6	0.7	0.0	0.0	0.3	0.1	1.0	0.0	0.1	32.9	0.0	0.0	1.0	0.6	0.0	0.0	0.9	0.8	0.0	1.1	0.2	1.0	0.6	0.0	0.0	0.1	4.5	0.2	0.1	3.8
PHGR1		ENSG00000233041	"Proline, histidine and glycine rich 1"	C9JFL3	15	40351033-40356434	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"intestine: 2339.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 19911.4;Intestinal goblet cells: 8220.0;Paneth cells: 9497.7;Proximal enterocytes: 51149.4"	"Group enriched"	"Detected in many"	16	"colorectal cancer: 248.3;stomach cancer: 94.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"OE19: 833.5"									HPA068787	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA068787: AB_2686035"	"prognostic favorable (2.05e-4)"		"unprognostic (1.73e-1)"				"unprognostic (5.18e-2)"				"unprognostic (1.18e-1)"	"unprognostic (2.80e-1)"		"unprognostic (1.20e-1)"			"unprognostic (1.27e-2)"	3.7	0.4	0.1	89.7	0.1	0.2	11.2	0.4	0.1	0.5	0.0	1489.2	888.9	1.2	0.0	2.0	3.6	0.3	0.3	0.1	0.2	1.9	1.0	0.2	1.2	0.1	0.1	0.0	0.5	1.9	0.0	0.5	0.0	0.2	2.5	374.1	0.0	0.3	3.1	0.4	2.5	2339.3	17.5	0.1	0.4	178.6	0.3	0.1	0.0	0.4	0.0	0.0	5.6	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.0	0.1	833.5	0.3	0.1	0.0	10.8	0.0	1.5	61.5	7.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	46.0	0.0	0.2	0.3	0.0	0.0	40.2	38.0	0.0	117.2	0.0	0.0	0.0	0.0	0.1	19911.4	0.0	2.5	0.1	0.0	0.0	0.2	1938.2	0.0	0.0	0.2	0.0	0.5	884.8	0.1	213.9	0.0	0.0	0.6	0.0	0.0	0.0	8220.0	20.3	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	9497.7	0.0	2.1	1.1	51149.4	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	32.6	0.0	4881.6	1.0
B3GNT6	B3Gn-T6	ENSG00000198488	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6"	Q6ZMB0	11	77034398-77041973	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 22.0;salivary gland: 6.5;stomach 1: 25.1"	"Group enriched"	"Detected in some"	20	"Gastric mucus-secreting cells: 23.0;Intestinal goblet cells: 60.8"	"Group enriched"	"Detected in some"	14	"colorectal cancer: 6.3;lung cancer: 3.9;pancreatic cancer: 5.1;prostate cancer: 5.0;stomach cancer: 4.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039805	Enhanced				"Intracellular and membrane"	NA	NA					"HPA039805: AB_2676690"		"unprognostic (1.71e-1)"	"prognostic favorable (2.31e-4)"	"unprognostic (4.79e-2)"	"unprognostic (5.42e-2)"	"unprognostic (7.64e-2)"		"unprognostic (1.95e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.77e-2)"		"unprognostic (2.19e-1)"		"unprognostic (9.30e-2)"	"unprognostic (1.71e-1)"	0.1	0.0	0.1	2.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	22.0	5.5	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	17.0	0.0	6.5	0.0	0.0	0.1	7.1	0.3	0.0	0.0	25.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.2	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.5	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.1	0.1	0.4	0.0	1.0	0.0	0.0	0.0	1.4	2.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.2	23.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	60.8	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.6	1.4	0.0	0.0	0.3	1.2	0.1	0.2	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.5	0.2
CDHR2	"FLJ20124, FLJ20383, PC-LKC, PCDH24, PCLKC"	ENSG00000074276	"Cadherin related family member 2"	Q9BYE9	5	176542511-176595974	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 278.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 167.0;Early spermatids: 182.4;Late spermatids: 680.0;Paneth cells: 215.0;Proximal enterocytes: 611.4"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 9.1;liver cancer: 5.7;pancreatic cancer: 11.7;renal cancer: 8.6;stomach cancer: 9.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"Hep G2: 22.2"	"Region enriched"	"Detected in single"	6	"hypothalamus: 2.1"	"Low region specificity"	"Detected in all"			"HPA012569, HPA017053"	Enhanced					NA	NA		8800000			"HPA012569: AB_1845298, HPA017053: AB_1845297"	"unprognostic (1.34e-2)"	"unprognostic (8.90e-4)"	"unprognostic (3.82e-2)"	"unprognostic (8.51e-2)"	"unprognostic (5.10e-4)"	"unprognostic (4.24e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (9.29e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.42e-1)"	0.0	0.1	1.0	4.5	0.6	0.2	0.0	0.2	0.7	0.0	0.0	23.4	278.3	0.1	0.0	0.1	0.6	5.1	0.0	1.4	0.4	10.2	30.5	0.0	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.3	0.0	0.2	0.0	12.7	0.3	0.0	0.0	0.0	0.1	240.3	1.1	0.0	0.1	12.5	4.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.2	0.5	0.0	0.2	0.0	0.1	0.0	1.3	0.0	0.0	0.3	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.2	0.7	1.4	0.4	0.0	0.0	0.7	0.2	0.0	0.6	0.2	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	8.6	0.0	1.8	0.0	0.0	0.3	167.0	0.0	4.0	182.4	3.2	0.1	0.2	33.6	0.0	3.9	1.0	0.0	0.0	55.0	0.1	0.0	0.0	0.0	15.3	0.0	0.0	4.2	42.7	0.0	0.6	0.0	680.0	1.5	0.5	0.0	1.0	0.0	1.6	0.0	1.5	0.5	15.3	215.0	2.2	0.1	0.0	611.4	13.7	0.7	0.3	0.0	0.0	0.1	3.8	2.0	0.0	0.0	0.1	0.7	3.5	19.8	0.0
OLFM4	"GC1, GW112, OlfD"	ENSG00000102837	"Olfactomedin 4"	Q6UX06	13	53028813-53052057	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1307.0;pancreas: 677.1"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 497.1;Exocrine glandular cells: 900.9;Intestinal goblet cells: 791.9;Pancreatic endocrine cells: 933.7;Paneth cells: 556.9;Undifferentiated cells: 2419.9;Urothelial cells: 1989.0"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.4;BJ hTERT+: 18.8;HaCaT: 26.4;OE19: 10.4;RPMI-8226: 6.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA077718	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"	"Secreted to digestive system"	Yes	NA		9300	"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA077718: AB_2732358"	"prognostic favorable (8.77e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.84e-3)"	1.9	0.1	0.3	197.1	0.6	127.1	6.8	0.2	0.5	4.2	0.2	455.9	1222.9	5.6	3.5	0.8	8.4	10.5	0.7	0.3	0.4	26.3	0.9	3.8	1.4	0.2	0.3	0.3	0.2	677.1	0.0	0.5	0.6	0.3	93.1	574.7	0.4	16.3	0.9	0.6	0.4	1307.0	53.0	0.2	18.2	16.2	0.3	0.2	4.2	0.4	2.2	0.2	128.1	288.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	5.4	2.4	18.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	26.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	10.4	0.0	0.0	0.8	6.2	0.2	0.0	1.1	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.6	0.9	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.2	0.5	0.3	0.4	0.2	0.3	0.3	0.3	0.2	0.2	0.3	0.2	0.0	0.0	0.3	3.8	0.1	168.5	0.3	0.0	0.0	9.8	2.5	0.5	0.0	11.9	139.8	0.0	0.0	0.0	98.7	1.9	497.1	0.2	13.5	0.5	1.4	92.3	0.8	1.0	900.9	0.0	1.5	0.0	17.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	791.9	2.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	10.3	4.0	0.0	0.0	0.2	933.7	556.9	0.0	0.4	209.4	300.6	0.0	0.5	0.2	0.0	2.1	9.2	0.0	0.1	0.0	0.0	0.0	3.1	0.2	2419.9	1989.0
ANXA13	ANX13	ENSG00000104537	"Annexin A13"	P27216	8	123680794-123737402	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 145.6;intestine: 296.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 180.1;Enteroendocrine cells: 44.9;Intestinal goblet cells: 161.1;Paneth cells: 58.1;Proximal enterocytes: 125.2;Undifferentiated cells: 38.5"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A549: 27.8;HDLM-2: 14.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018535, HPA019569, HPA019650, CAB025135"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856"	"unprognostic (6.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.79e-2)"	0.1	0.0	1.9	1.7	2.7	0.0	0.4	2.8	2.2	0.2	1.4	21.9	296.3	1.5	2.2	0.2	58.9	145.6	0.1	1.3	1.8	7.0	20.3	0.2	0.2	3.9	3.8	1.1	0.4	0.4	0.0	0.0	0.0	3.6	0.5	36.4	4.4	0.1	24.5	0.0	0.1	221.3	2.9	3.9	0.0	0.8	4.2	2.6	0.1	0.0	0.0	0.0	0.5	0.1	5.4	0.0	27.8	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	14.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.0	0.0	0.0	0.0	1.7	1.6	0.0	0.1	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.7	2.8	2.2	1.3	1.8	3.9	3.8	1.1	3.6	3.9	2.6	5.4	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.2	0.1	1.1	0.4	180.1	0.0	0.0	0.0	0.0	0.0	6.2	3.9	1.4	1.1	4.5	3.6	0.2	44.9	2.7	0.9	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.1	0.2	0.0	1.0	161.1	0.0	0.0	0.0	1.4	1.2	0.3	0.0	0.0	0.0	0.3	0.0	0.5	1.2	0.1	58.1	0.0	0.0	0.0	125.2	27.6	2.9	10.9	0.0	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.4	0.1	38.5	0.1
MYO1A	"DFNA48, MYHL"	ENSG00000166866	"Myosin IA"	Q9UBC5	12	57028517-57051198	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 333.0"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 174.5;Proximal enterocytes: 690.2"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8"	"Region enhanced"	"Detected in many"		"white matter: 7.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 43.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053490	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053490: AB_2682168"	"unprognostic (2.77e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.26e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.01e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.72e-2)"	0.2	0.2	0.1	5.2	0.5	0.1	0.1	0.8	0.6	0.0	0.5	68.9	333.0	0.4	0.0	0.2	0.1	4.2	0.0	0.0	0.2	0.1	0.1	0.2	0.3	2.4	1.5	0.0	0.0	0.2	0.0	0.1	0.2	1.7	0.1	66.4	0.1	0.0	0.2	0.1	0.1	312.3	3.0	4.6	0.1	16.4	1.0	0.4	0.4	0.0	0.0	0.1	0.0	0.1	7.3	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	8.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	1.5	0.1	43.3	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.8	0.6	0.0	0.2	2.4	1.5	0.0	1.7	4.6	0.4	7.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	1.9	4.3	0.1	0.0	0.0	0.0	0.0	174.5	0.0	0.1	0.7	0.3	0.0	0.1	24.7	0.0	0.1	0.0	0.0	0.1	26.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	85.4	0.0	0.3	1.0	1.2	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.3	66.8	0.0	0.1	0.0	690.2	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.4	0.1	0.0	0.4	0.0	102.3	0.1
ANKRD40CL	"C17orf73, FLJ20694, LINC00483"	ENSG00000167117	"ANKRD40 C-terminal like"	Q53H64	17	50761029-50767557	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	8	"intestine: 60.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"colorectal cancer: 3.3;pancreatic cancer: 0.8;stomach cancer: 2.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.1;HDLM-2: 6.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.98e-1)"		"unprognostic (1.96e-2)"	"unprognostic (2.02e-3)"			"unprognostic (2.76e-1)"	"unprognostic (4.52e-1)"		"unprognostic (1.95e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.67e-1)"		"unprognostic (1.05e-3)"	0.3	0.2	2.3	2.6	1.6	4.1	0.1	4.8	2.0	0.0	2.7	26.9	59.8	0.7	0.6	0.5	0.2	2.3	0.4	2.0	2.7	0.2	0.3	0.4	0.8	5.2	2.1	1.3	0.3	0.4	0.0		0.2	3.9	0.4	21.3	0.6	0.6	0.3	1.0	1.9	60.5	1.2	1.6	0.6	2.8	0.5	2.6	0.0	0.6	0.1	0.2	0.3		8.0	0.4	0.4	0.4	0.9	0.0	0.3	1.0	0.1	0.0	0.0	0.0	8.1	0.8	0.5	0.2	0.2	0.1	0.7	0.0	0.1	0.1	6.0	0.5	0.3	1.9	1.1	0.0	0.6	1.1	0.3	0.0	0.1	0.0	0.3	0.0	0.5	0.2	0.7	0.0	0.3	0.2	1.2	0.2	1.4	0.3	0.6	0.3	0.4	0.2	1.3	0.6	0.5	0.3	0.8	0.2	0.3	0.7	0.0	0.9	0.8	0.5	0.8	0.3	0.3	0.2	0.6	0.2	0.5	0.3	3.8	0.8	0.5	0.3	0.4	0.2	0.5	0.4	0.3	0.1	0.7	0.5	0.5	2.8	0.7	0.5	0.8	0.3	0.3	2.3	1.6	4.8	2.0	2.0	2.7	5.2	2.1	1.3	3.9	1.6	2.6	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP4B	ATP6B	ENSG00000186009	"ATPase H+/K+ transporting subunit beta"	P51164	13	113648804-113658198	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Hydrogen ion transport, Ion transport, Potassium transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	328	"stomach 1: 1105.7"	"Cell type enriched"	"Detected in some"	76	"Gastric mucus-secreting cells: 145.8"	"Cancer enriched"	"Detected in some"	12	"stomach cancer: 8.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045400, HPA052649"	Enhanced		Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA045400: AB_2679314, HPA052649: AB_2681900"	"unprognostic (9.92e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.66e-1)"	"unprognostic (4.86e-1)"			"unprognostic (6.43e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.22e-1)"	"unprognostic (6.50e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.78e-2)"		0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	2.9	0.2	0.0	0.0	0.0	0.4	3.3	0.0	0.1	0.2	0.0	0.4	0.1	0.4	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	1105.7	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.4	0.4	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	145.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1
BTNL8	"BTN9.2, FLJ21458"	ENSG00000113303	"Butyrophilin like 8"	Q6UX41	5	180899077-180950906	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"intestine: 120.1"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 79.6;Proximal enterocytes: 178.9"	"Group enriched"	"Detected in some"	12	"colorectal cancer: 2.6;liver cancer: 1.5;pancreatic cancer: 2.8;stomach cancer: 3.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	12	"neutrophil: 233.4"	"Lineage enriched"	"Detected in many"	221	"granulocytes: 233.4"	"Group enriched"	"Detected in some"	28	"CACO-2: 39.3;OE19: 56.2"									HPA039738	Enhanced					NA	NA					"HPA039738: AB_2676656"	"unprognostic (4.31e-1)"	"unprognostic (6.85e-6)"	"unprognostic (6.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.27e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.02e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.43e-1)"	"unprognostic (1.17e-2)"	1.1	0.3	0.2	2.1	0.2	7.3	0.5	0.2	0.4	0.0	0.2	26.9	120.1	0.1	0.0	0.2	1.4	7.0	0.3	0.2	0.6	0.6	0.6	2.6	0.3	0.4	0.3	0.1	0.1	1.7	0.2	0.2	0.2	0.3	0.1	26.0	0.0	0.1	0.0	0.3	0.0	87.2	0.6	0.2	3.1	7.2	5.5	0.3	0.2	1.1	0.5	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	39.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.4	56.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.0	0.0	1.6	0.0	0.2	0.4	0.0	0.1	1.0	20.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	233.4	0.0	0.5	0.0	0.4	0.3	0.2	0.2	0.2	0.4	0.2	0.6	0.4	0.3	0.1	0.3	0.2	0.3	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	8.6	0.1	0.0	0.0	0.0	0.0	79.6	0.0	0.2	0.3	0.0	0.0	0.6	3.6	0.0	0.3	2.6	0.0	0.2	12.2	0.0	0.0	0.0	11.7	0.1	0.8	0.0	0.1	29.6	0.0	4.5	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	26.3	0.0	0.0	0.0	178.9	0.1	0.8	0.0	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	15.6	0.1
HHLA2	"B7-H5, B7-H7, B7H7, B7y"	ENSG00000114455	"HERV-H LTR-associating 2"	Q9UM44	3	108296490-108378285	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 131.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 274.7;Paneth cells: 64.2;Proximal enterocytes: 186.8"	"Group enriched"	"Detected in many"	12	"colorectal cancer: 9.2;lung cancer: 5.0;pancreatic cancer: 5.1;renal cancer: 16.6;stomach cancer: 6.2"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.7;HDLM-2: 4.0;Karpas-707: 2.8"					"Low region specificity"	"Detected in all"			HPA055478	Enhanced					NA	NA					"HPA055478: AB_2682830"	"unprognostic (1.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.14e-5)"	"unprognostic (1.76e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.66e-2)"	0.4	0.2	0.6	5.7	0.5	1.2	0.2	0.8	1.3	0.0	0.0	88.7	87.6	0.3	0.8	0.5	3.7	29.5	0.2	0.7	0.5	7.7	0.1	5.8	0.6	0.7	0.4	0.3	0.1	3.0	0.1	0.2	0.1	0.8	0.2	83.8	1.2	0.2	0.3	0.5	0.3	131.0	2.1	0.2	0.3	9.4	3.3	0.4	0.4	0.2	0.0	0.3	0.0	0.0	0.8	0.2	0.3	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	1.7	0.2	0.1	0.1	0.0	0.1	0.2	0.6	0.0	0.0	4.0	0.1	0.1	1.4	0.2	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.8	0.0	0.2	0.4	1.5	0.5	0.2	0.3	0.3	0.1	0.8	0.0	0.1	0.7	0.7	0.7	0.0	0.1	0.5	0.1	0.2	0.1	0.1	0.7	0.2	0.2	1.3	0.7	0.3	0.0	0.4	0.1	0.5	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	1.8	0.1	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.2	0.6	0.5	0.8	1.3	0.7	0.5	0.7	0.4	0.3	0.8	0.2	0.4	0.8	0.0	0.0	2.0	0.7	0.4	0.0	0.1	0.7	0.0	0.0	0.7	0.3	0.2	27.1	1.6	0.0	0.0	0.0	0.0	274.7	0.0	8.5	3.3	3.2	0.0	0.3	1.8	0.0	1.3	37.6	0.1	0.3	2.6	0.1	2.5	0.0	0.0	0.0	0.1	0.0	0.5	12.5	2.0	0.0	0.7	4.2	0.3	0.3	0.0	0.0	1.1	0.0	0.0	0.5	0.9	35.7	64.2	0.0	0.0	0.1	186.8	20.4	19.4	0.0	0.0	0.1	0.1	0.7	0.3	0.0	0.0	0.1	0.5	0.0	17.7	0.1
PGA5		ENSG00000256713	"Pepsinogen A5"	P0DJD9	11	61241175-61251444	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	3701	"stomach 1: 40192.3"	"Cell type enriched"	"Detected in some"	77	"Exocrine glandular cells: 4383.1"	"Cancer enriched"	"Detected in some"	12	"stomach cancer: 15.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	29	"classical monocyte: 1.8;intermediate monocyte: 4.3;non-classical monocyte: 2.4"	"Lineage enriched"	"Detected in single"	44	"monocytes: 4.3"	"Cell line enriched"	"Detected in some"	19	"BJ hTERT+: 28.8"									HPA046875	Supported				"Secreted to digestive system"	NA	NA					"HPA046875: AB_2679851"				"unprognostic (1.36e-3)"	"unprognostic (2.98e-2)"		"unprognostic (5.83e-3)"			"unprognostic (2.11e-1)"	"unprognostic (4.22e-1)"		"unprognostic (4.36e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.10e-2)"		10.8	4.4	0.4	1.1	0.3	0.0	4.5	0.1	0.4	2.9	0.0	4.0	0.6	1.9	0.0	7.0	5.1	0.1	2.9	0.8	0.2	2.4	7.1	5.5	0.0	0.1	0.1	0.6	2.6	8.3	0.0	3.8	0.5	0.1	1.8	0.1	1.5	2.5	0.5	1.9	2.2	2.1	0.9	0.0	4.0	40192.3	2.3	0.0	0.2	3.1	0.2	0.1	2.4	2.5	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.3	0.4	0.3	0.1	0.4	0.8	0.2	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	4383.1	0.0	0.1	56.6	0.0	0.0	0.2	0.0	0.0	6.7	0.0	0.0	0.0	0.0	5.1	0.0	1.6	0.9	1.3	0.0	0.0	1.0	25.1	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TMPRSS11B	HATL5	ENSG00000185873	"Transmembrane serine protease 11B"	Q86T26	4	68226653-68245694	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 393.8;lymphoid tissue: 82.9;vagina: 119.2"	"Group enriched"	"Detected in some"	22	"Early spermatids: 10.4;Late spermatids: 14.5;Squamous epithelial cells: 8.2"	"Group enriched"	"Detected in some"	12	"cervical cancer: 2.6;head and neck cancer: 2.6;stomach cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"									NA	NA							"unprognostic (4.24e-2)"				"prognostic favorable (6.91e-4)"				"unprognostic (2.92e-1)"				"unprognostic (3.96e-1)"				0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.2	27.1	0.1	0.0	0.0	0.0	0.0	393.8	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.0	59.1	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.3	0.4	0.2	0.0	0.0	0.0	82.9	0.0	119.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.3	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	8.2	0.0	0.0	0.1	0.0	0.0	0.2
TMPRSS15	"ENTK, MGC133046, PRSS7"	ENSG00000154646	"Transmembrane serine protease 15"	P98073	21	18269116-18485879	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	523	"intestine: 988.7"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 28.0"	"Group enriched"	"Detected in some"	12	"liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"U-138 MG: 50.8;U-87 MG: 141.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"olfactory bulb: 5.0;spinal cord: 1.8"	"HPA015611, HPA034857, HPA072934"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214"					"unprognostic (9.26e-2)"	"unprognostic (4.14e-1)"		"unprognostic (3.52e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.70e-2)"		"unprognostic (6.35e-2)"	"unprognostic (5.92e-2)"			0.0	0.0	0.9	0.2	0.7	0.0	0.0	1.8	1.7	0.0	0.0	0.1	988.7	0.2	0.0	0.1	0.0	0.1	0.1	0.8	0.3	0.0	0.0	0.0	0.7	0.6	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.2	22.0	0.0	0.0	0.0	0.4	1.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.0	4.6	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	0.0	0.3	0.0	0.9	0.0	0.2	141.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.7	1.8	1.7	0.8	0.3	0.6	0.6	0.3	0.7	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	4.0	0.0
CBLIF	"GIF, IF, IFMH, INF, TCN3"	ENSG00000134812	"Cobalamin binding intrinsic factor"	P27352	11	59829273-59845499	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins"	"Cobalt transport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2569	"stomach 1: 1591.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	11	"stomach cancer: 10.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039908, HPA040774"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA039908: AB_10796335, HPA040774: AB_10795626"			"unprognostic (2.78e-4)"								"unprognostic (1.04e-1)"		"unprognostic (2.45e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.66e-1)"			0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1591.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLDN18	SFTPJ	ENSG00000066405	"Claudin 18"	P56856	3	137998735-138033655	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	50	"lung: 254.4;stomach 1: 731.4"	"Group enriched"	"Detected in some"	53	"Alveolar cells type 1: 1602.5;Alveolar cells type 2: 431.2;Gastric mucus-secreting cells: 1153.4;Pancreatic endocrine cells: 442.5"	"Group enriched"	"Detected in some"	11	"pancreatic cancer: 113.6;stomach cancer: 186.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"OE19: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013010, CAB013243, HPA018446"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.14e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.42e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.95e-1)"	0.3	0.3	1.0	0.4	0.6	0.1	0.2	1.0	0.4	0.3	1.9	0.5	1.6	0.2	0.5	0.6	0.5	3.4	9.8	0.3	0.5	0.2	0.1	254.4	0.0	0.7	0.7	0.1	0.5	0.8	0.0	0.5	0.3	0.6	0.2	0.2	0.7	0.3	0.4	0.1	1.1	0.9	0.1	1.1	0.5	731.4	1.3	0.4	0.1	0.1	0.0	0.7	0.2	0.3	0.3	0.1	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.5	15.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.3	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	1.0	0.4	0.3	0.5	0.7	0.7	0.1	0.6	1.1	0.4	0.3	0.0	1602.5	431.2	1.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	17.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.3	0.2	0.6	0.0	0.0	0.5	11.4	0.0	1.4	1153.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	2.0	0.0	1.9	0.0	0.1	0.0	0.0	0.2	442.5	0.0	0.0	1.3	0.0	0.0	0.1	0.7	1.3	0.0	0.9	0.1	15.3	11.9	0.0	0.0	0.0	1.3	0.0	0.0	0.1
MGAM2		ENSG00000257743	"Maltase-glucoamylase 2 (putative)"	Q2M2H8	7	142111749-142222324	"Enzymes, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 11.9;pancreas: 4.1;salivary gland: 5.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 27.4;Late spermatids: 18.2"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"OE19: 1.6;RH-30: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA055697	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA055697: AB_2682890"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-4)"	"unprognostic (7.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.33e-2)"	0.0	0.0	0.0	0.4	0.0	0.2	1.1	0.0	0.3	0.0	0.3	1.3	11.9	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.9	0.0	0.0	0.0	9.7	0.0	0.0	0.9	0.5	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	27.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
SULT1B1	ST1B2	ENSG00000173597	"Sulfotransferase family 1B member 1"	O43704	4	69721167-69787961	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 100.3;stomach 1: 45.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 298.2;Gastric mucus-secreting cells: 61.7;Paneth cells: 153.4;Proximal enterocytes: 234.3;Undifferentiated cells: 76.4"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 10.7;neutrophil: 32.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 32.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 110.9;OE19: 26.3;TIME: 36.2;U-2197: 31.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002107	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA002107: AB_2666542"	"unprognostic (9.58e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.46e-2)"	3.0	0.7	2.2	10.8	4.7	5.6	2.1	8.1	7.3	1.6	2.6	70.6	100.3	2.0	2.4	2.0	1.5	1.5	2.0	3.0	2.6	1.9	24.0	2.5	4.3	1.8	1.8	2.7	3.1	0.8	1.0	0.1	1.3	3.6	2.5	62.8	4.0	0.8	1.5	1.2	1.3	96.1	5.1	0.3	9.8	45.3	1.2	1.5	3.0	2.7	2.3	7.6	1.6	0.9	5.9	0.7	0.6	0.8	0.8	1.8	1.9	1.2	0.8	0.4	0.3	0.3	0.7	0.7	1.3	0.7	0.8	1.0	1.1	0.1	0.2	0.7	1.5	1.0	1.0	1.2	0.5	2.7	1.3	1.3	12.3	0.2	0.3	0.5	1.1	110.9	1.6	0.6	2.5	1.0	0.7	0.6	1.0	0.8	26.3	0.4	0.6	3.7	0.8	0.2	1.8	1.3	0.8	0.5	0.3	0.5	0.7	1.6	0.6	36.2	1.0	1.7	31.5	0.6	1.9	1.0	0.6	0.4	3.3	1.3	10.7	4.8	1.4	1.0	2.7	0.3	0.1	1.5	0.4	2.7	0.2	4.9	2.5	32.0	2.9	3.4	0.2	0.9	2.6	2.2	4.7	8.1	7.3	3.0	2.6	1.8	1.8	2.7	3.6	0.3	1.5	5.9	1.3	19.2	20.8	0.3	0.9	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	8.4	0.0	0.0	0.0	4.9	298.2	0.0	0.3	0.1	1.2	0.1	2.2	33.7	2.7	0.1	4.4	0.2	1.8	61.7	0.2	16.4	0.2	2.9	45.1	0.3	0.0	0.1	42.6	0.0	24.9	1.8	0.0	0.0	9.4	0.0	3.7	15.4	0.0	11.3	0.0	0.1	18.2	153.4	0.0	1.0	0.2	234.3	1.5	12.8	0.0	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.3	6.7	0.1	76.4	0.1
TFF2	SML1	ENSG00000160181	"Trefoil factor 2"	Q03403	21	42346357-42350997	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 6912.3"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 2057.4;Gastric mucus-secreting cells: 7217.7"	"Group enriched"	"Detected in many"	11	"pancreatic cancer: 320.9;stomach cancer: 244.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 35.4;Karpas-707: 20.0;OE19: 55.4;PC-3: 145.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025834, HPA036705"	Enhanced				"Secreted to digestive system"	NA	NA		890000			"CAB025834: , HPA036705: AB_2675263"	"unprognostic (3.95e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"			"prognostic unfavorable (1.99e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.55e-2)"		"unprognostic (1.27e-9)"	"unprognostic (1.99e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.26e-3)"	0.8	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.8	0.0	3.5	1437.5	0.1	0.0	3.4	1.2	106.4	0.1	0.0	0.0	0.2	4.1	1.1	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.2	1.0	0.0	0.1	4.2	0.0	2.9	0.0	0.1	0.1	0.5	0.2	0.0	2.7	6912.3	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	35.4	0.0	0.2	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	2.9	0.0	2.6	55.4	145.2	1.1	0.0	8.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.1	0.0	0.0	2.7	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.0	0.0	3.6	0.5	0.2	2057.4	0.0	0.0	0.0	0.0	0.0	3.4	0.0	104.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	93.8	0.2	1.3	7217.7	0.0	0.0	0.5	0.0	6.1	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	2.9	5.4	0.0	0.6	0.0	0.0	0.0	0.0	833.8	5.5	0.0	11.7	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.0	0.0	0.1	11.8
CA1	Car1	ENSG00000133742	"Carbonic anhydrase 1"	P00915	8	85327608-85379014	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	55	"bone marrow: 1813.7;intestine: 2128.9"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 11487.3"	"Group enriched"	"Detected in some"	10	"colorectal cancer: 3.4;stomach cancer: 0.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	987	"HEL: 1022.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006558, CAB025790"	Enhanced					NA	NA		4600000000			"CAB025790: , HPA006558: AB_1845989"	"unprognostic (1.44e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	1.2	0.4	0.7	0.5	0.3	1813.7	2.1	1.0	1.7	0.2	1.0	1032.7	0.2	1.6	0.1	0.7	2.2	0.3	1.4	0.2	2.1	1.9	6.8	6.0	0.2	0.4	0.6	0.2	0.4	0.3	0.1	1.9	20.8	0.5	0.4	2128.9	0.4	1.1	1.8	1.0	1.4	1.9	31.0	0.2	35.6	2.3	0.2	0.3	0.5	0.9	3.4	0.1	0.4	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1022.7	0.0	0.5	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.7	0.3	1.0	1.7	0.2	2.1	0.4	0.6	0.2	0.5	0.2	0.3	0.8	0.0	0.0	0.0	4.2	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	2565.3	0.0	0.0	0.5	0.1	0.0	0.5	45.8	11487.3	11.8	0.0	0.0	0.1	0.0	0.1	22.3	0.0	4.2	4.4	0.0	0.0	12.1	159.4	0.0	11.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.0	13.0	2.2	0.0	754.9	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.4	0.1	298.4	0.0
FEV	Pet-1	ENSG00000163497	"FEV transcription factor, ETS family member"	Q99581	2	218981087-218985184	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 21.6"	"Cell type enriched"	"Detected in some"	32	"Enteroendocrine cells: 744.9"	"Group enriched"	"Detected in some"	10	"pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4"	"Region enhanced"	"Detected in many"		"midbrain: 21.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HMC-1: 35.5;SH-SY5Y: 43.8"	"Region enhanced"	"Detected in single"		"midbrain: 1.9"	"Group enriched"	"Detected in some"	5	"midbrain: 4.8;pons: 2.7"	HPA067679		Supported	Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA067679: AB_2685884"			"unprognostic (4.58e-1)"		"unprognostic (1.60e-1)"					"unprognostic (7.21e-2)"	"prognostic favorable (4.85e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"			0.1	2.3	0.3	0.0	1.4	0.0	0.0	0.1	0.8	0.0	0.0	1.2	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	6.2	21.6	0.0	0.0	1.3	0.0	2.6	0.0	10.4	2.2	1.8	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	3.2	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.1	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.1	0.8	0.5	0.2	6.2	21.6	0.0	10.4	0.1	5.6	5.2	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	744.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.2	6.0	0.0	0.0	3.4	1.2	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.1
OR8K5		ENSG00000181752	"Olfactory receptor family 8 subfamily K member 5"	Q8NH50	11	56159394-56160317	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	10	"stomach cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFF1	"BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2"	ENSG00000160182	"Trefoil factor 1"	P04155	21	42362282-42366535	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"stomach 1: 8044.5"	"Group enriched"	"Detected in many"	9	"Gastric mucus-secreting cells: 12908.9;Pancreatic endocrine cells: 14603.3"	"Group enriched"	"Detected in many"	10	"breast cancer: 402.1;colorectal cancer: 268.3;pancreatic cancer: 805.7;stomach cancer: 744.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	42	"MCF7: 13512.4;OE19: 5337.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002170, HPA003425"	Enhanced				"Secreted to digestive system"	NA	NA		950000			"CAB002170: AB_563985, HPA003425: AB_1848260"	"prognostic favorable (5.00e-4)"	"unprognostic (8.81e-3)"	"unprognostic (9.82e-2)"	"prognostic favorable (5.67e-4)"		"unprognostic (2.42e-1)"	"unprognostic (1.72e-3)"	"unprognostic (8.14e-2)"		"unprognostic (2.45e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.62e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.07e-1)"	1.1	0.3	0.0	20.5	0.0	0.0	26.9	0.0	0.0	9.8	0.0	115.8	35.1	0.2	0.0	18.5	0.9	168.8	0.4	0.0	0.0	0.9	0.8	1.3	0.2	0.0	0.0	0.0	0.2	10.8	0.0	0.2	1.1	0.0	25.3	109.5	0.0	32.6	0.7	0.2	0.1	69.0	4.8	0.0	3.1	8044.5	0.1	0.0	0.2	5.3	0.0	0.2	30.9	2.2	0.0	0.0	42.7	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	16.2	5.7	0.0	1.1	0.0	1.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	13512.4	4.6	0.5	5.5	5337.9	223.4	1.7	0.0	0.2	0.0	1.4	0.3	0.2	0.0	5.0	0.0	1.3	5.0	0.1	0.0	0.0	3.5	0.1	0.0	3.6	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	18.7	0.0	6.1	5.9	0.0	0.0	432.7	197.2	0.0	564.7	12.1	35.0	0.0	0.1	3.1	601.9	0.0	245.7	0.0	1.8	0.2	3.5	430.2	0.0	0.0	821.8	3.1	5.1	12908.9	2.9	13.4	0.0	0.0	1.6	0.2	0.0	0.0	1395.6	111.9	0.0	0.0	0.0	0.0	9.2	0.0	0.0	10.3	0.0	0.0	0.0	0.0	14603.3	500.9	0.0	40.6	432.4	78.0	0.0	2.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.3	8.9	0.0	80.0	232.6
APOBEC1	"APOBEC-1, BEDP, CDAR1, HEPR"	ENSG00000111701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 1"	P41238	12	7649400-7665908	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"intestine: 29.3"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 153.8"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 6.2;pancreatic cancer: 6.1;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"CAPAN-2: 1.7;OE19: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA								"unprognostic (2.35e-1)"					"unprognostic (3.80e-4)"			"unprognostic (7.96e-3)"			"unprognostic (1.79e-1)"	"unprognostic (4.38e-1)"			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	28.2	0.0	0.0	0.0	153.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322138	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	173	"intestine: 554.6"	"Cell type enriched"	"Detected in some"	10	"Proximal enterocytes: 5965.8"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basophil: 1.6;neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;RPMI-8226: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		61000	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.2	0.1	0.1	3.2	0.1	0.9	0.0	0.7	0.3	0.0	0.4	28.5	293.6	0.3	0.1	0.1	0.2	0.1	0.6	0.1	0.1	0.3	0.1	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	35.6	0.3	0.0	0.0	0.1	0.4	554.6	1.9	0.0	0.1	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.3	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.2	0.0	0.2	0.1	0.0	0.0	1.6	0.4	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.2	4.2	0.4	0.1	0.3	0.3	0.0	0.1	0.1	0.7	0.3	0.1	0.1	0.1	0.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	1.8	0.0	0.0	0.0	242.0	0.0	0.0	0.0	1.4	0.1	0.1	1.2	0.0	0.0	0.2	0.1	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	570.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	383.1	0.0	0.0	0.0	5965.8	17.3	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	222.5	0.0
MUC21	"bCX31G15.2, C6orf205"	ENSG00000204544	"Mucin 21, cell surface associated"	Q5SSG8	6	30983718-30989903	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 701.9;vagina: 246.5"	"Group enriched"	"Detected in some"	5	"Club cells: 11.8;Squamous epithelial cells: 37.7;Urothelial cells: 32.0"	"Group enriched"	"Detected in many"	9	"cervical cancer: 6.8;head and neck cancer: 6.6;lung cancer: 13.9;stomach cancer: 7.0;thyroid cancer: 5.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA052028	Enhanced					NA	NA					"HPA052028: AB_2681700"	"unprognostic (2.27e-2)"	"unprognostic (4.85e-3)"		"unprognostic (5.24e-3)"		"unprognostic (1.68e-2)"		"unprognostic (2.68e-2)"		"unprognostic (2.98e-3)"	"unprognostic (1.32e-4)"			"unprognostic (1.05e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.81e-2)"	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	64.9	0.0	0.1	0.0	0.1	0.0	701.9	0.2	0.0	0.1	0.0	0.0	0.1	0.3	1.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.6	0.0	0.0	0.3	0.0	0.0	107.7	0.0	0.3	0.2	0.1	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.1	0.0	13.6	0.2	246.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	1.2	1.6	0.0	0.0	0.0	0.0	0.2	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	37.7	0.0	0.0	0.3	0.1	0.0	32.0
MUCL3	"bCX105N19.6, C6orf37, DPCR1, PBLT"	ENSG00000168631	"Mucin like 3"	Q3MIW9	6	30934523-30954221	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"stomach 1: 204.7"	"Cell type enriched"	"Detected in some"	20	"Pancreatic endocrine cells: 239.5"	"Group enriched"	"Detected in some"	9	"pancreatic cancer: 56.8;stomach cancer: 55.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014036	Enhanced					NA	NA					"HPA014036: AB_1847841"	"unprognostic (2.81e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.13e-4)"	"unprognostic (6.74e-2)"	"unprognostic (4.29e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.58e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.5	0.0	10.0	0.0	0.0	0.0	0.0	0.2	3.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	204.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	239.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ANKS4B	"FLJ38819, HARP"	ENSG00000175311	"Ankyrin repeat and sterile alpha motif domain containing 4B"	Q8N8V4	16	21233699-21253850	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 12.4;kidney: 5.9;liver: 13.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 63.4;Enteroendocrine cells: 25.1;Hepatocytes: 28.0;Intestinal goblet cells: 40.0;Paneth cells: 38.2;Proximal enterocytes: 113.0;Proximal tubular cells: 37.5;Undifferentiated cells: 24.7"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0"	"Region enhanced"	"Detected in single"		"cerebellum: 1.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;HDLM-2: 3.4;Hep G2: 8.2;OE19: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043523, HPA061125"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043523: AB_10966687, HPA061125: "	"unprognostic (1.35e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.75e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.77e-2)"		"unprognostic (4.34e-3)"	0.0	0.0	0.1	0.6	0.2	0.1	0.0	1.8	0.2	0.0	0.0	6.9	9.1	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	5.9	13.6	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.0	7.2	0.2	0.0	0.0	0.7	0.1	12.4	0.2	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	1.8	0.2	0.1	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.4	0.0	0.1	0.8	2.8	0.6	1.8	0.0	0.0	0.0	63.4	0.0	0.2	0.8	0.3	0.1	0.3	25.1	0.0	1.3	1.7	0.0	0.2	0.0	0.1	1.3	0.0	0.4	28.0	0.0	0.0	0.2	40.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.1	1.3	38.2	0.0	0.0	0.5	113.0	37.5	0.0	0.3	0.0	1.5	0.3	0.2	0.0	0.0	0.0	0.1	0.6	0.0	24.7	0.4
C17orf78	FLJ39647	ENSG00000278505	"Chromosome 17 open reading frame 78"	Q8N4C9	17	37375985-37392708	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	95	"intestine: 128.6"	"Cell type enriched"	"Detected in some"	18	"Proximal enterocytes: 223.7"	"Group enriched"	"Detected in some"	8	"colorectal cancer: 0.8;stomach cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.73e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-6)"	"unprognostic (1.94e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.85e-2)"	"unprognostic (3.19e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.1	128.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	7.3	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.4	0.0	7.5	0.0	0.0	0.0	223.7	0.3	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.0	0.0	0.1	12.1	0.0
GKN2	"blottin, BRICD1B, GDDR, PRO813, TFIZ1, VLTI465"	ENSG00000183607	"Gastrokine 2"	Q86XP6	2	68945232-68952893	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	57	"stomach 1: 4654.7"	"Cell type enriched"	"Detected in some"	22	"Gastric mucus-secreting cells: 2770.2"	"Cancer enriched"	"Detected in some"	8	"stomach cancer: 43.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.1;HaCaT: 1.1;HMC-1: 2.0;MOLT-4: 1.6;NTERA-2: 2.3;PC-3: 4.5;U-2 OS: 1.6;U-266/70: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057765	Enhanced				"Secreted to digestive system"	NA	NA					"HPA057765: AB_2683520"								"unprognostic (1.81e-1)"			"unprognostic (1.44e-4)"			"unprognostic (2.22e-1)"				0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.9	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.2	0.1	81.5	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.6	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.5	4654.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	2.3	0.0	4.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.2	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.4	109.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.9	2770.2	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	121.2	0.0	0.0	10.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0
CASP5	ICE(rel)III	ENSG00000137757	"Caspase 5"	P51878	11	104994235-105023168	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 4.5;intestine: 16.9;lymphoid tissue: 14.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 31.4;Paneth cells: 18.7;Proximal enterocytes: 17.2;Undifferentiated cells: 7.3"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 3.9;stomach cancer: 1.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"intermediate monocyte: 18.1;neutrophil: 13.0;non-classical monocyte: 41.2"	"Group enriched"	"Detected in many"	15	"granulocytes: 13.0;monocytes: 41.2"	"Cell line enriched"	"Detected in single"	6	"HHSteC: 3.7"															NA	NA						"unprognostic (4.30e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.38e-3)"	"unprognostic (7.39e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.82e-9)"	"unprognostic (7.30e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-1)"	0.7	0.1	0.5	14.8	0.5	0.2	0.1	0.5	4.5	0.2	1.2	15.8	10.0	0.1	0.2	0.1	0.2	0.4	0.1	1.1	0.9	0.1	0.2	1.6	0.9	0.8	0.5	0.3	0.1	0.0	0.0	0.1	0.9	1.5	0.1	13.0	0.0	0.1	0.1	0.0	0.0	16.9	1.8	0.7	2.7	0.1	0.3	1.2	0.1	0.1	0.4	0.3	2.2	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.7	0.0	0.0	0.1	0.4	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	18.1	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.1	13.0	0.0	41.2	0.5	0.0	1.4	0.5	0.5	0.5	4.5	1.1	0.9	0.8	0.5	0.3	1.5	0.7	1.2	1.7	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	2.3	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	5.3	0.0	4.7	0.4	0.7	0.0	4.8	0.0	1.9	2.4	0.0	0.0	0.0	0.1	0.1	18.7	0.0	0.0	0.0	17.2	0.0	0.8	0.0	0.0	0.2	0.1	0.5	0.7	0.0	0.0	0.0	0.3	0.0	7.3	0.1
ELANE	"ELA2, HLE, HNE, NE"	ENSG00000197561	"Elastase, neutrophil expressed"	P08246	19	851014-856247	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	91	"bone marrow: 3927.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 8.7;Fibroblasts: 16.2;Langerhans cells: 11.1;Leydig cells: 6.2;Melanocytes: 7.2;Suprabasal keratinocytes: 7.4"	"Group enriched"	"Detected in some"	7	"pancreatic cancer: 3.5;stomach cancer: 3.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"classical monocyte: 4.0;neutrophil: 12.1"	"Group enriched"	"Detected in many"	9	"granulocytes: 12.1;monocytes: 4.0"	"Cell line enriched"	"Detected in some"	91	"THP-1: 3105.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015409, HPA066836, HPA073774"	Enhanced				"Secreted to blood"	NA	NA		370000			"CAB015409: AB_831596, HPA066836: AB_2685733, HPA073774: "	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.80e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.19e-10)"	"unprognostic (6.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.75e-3)"	3.3	1.0	0.2	0.1	0.3	3927.4	3.4	0.1	0.8	0.4	0.1	1.9	0.4	1.0	0.0	1.1	1.5	0.1	3.8	0.2	0.1	0.7	3.4	19.6	0.6	0.1	0.2	0.2	0.5	0.5	0.0	1.2	0.8	0.2	2.9	0.0	0.0	2.4	0.1	1.5	5.4	1.8	0.1	0.1	43.0	1.5	0.4	0.2	6.4	3.1	0.0	0.0	2.2	1.0	0.2	2.0	0.1	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3105.0	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.8	0.0	34.0	0.0	0.0	4.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	27.2	0.2	0.3	0.1	0.8	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.2	0.9	0.0	0.0	0.0	0.3	8.7	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	0.0	4.2	0.1	0.0	1.3	16.2	0.0	0.1	0.0	0.0	0.7	0.9	0.2	0.0	0.1	0.0	0.0	3.4	11.1	0.0	6.2	1.1	7.2	0.0	0.9	0.0	1.0	0.0	0.1	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.2	0.0	0.0	7.4	0.0	0.7	0.2	0.0	0.0
ONECUT2	OC-2	ENSG00000119547	"One cut homeobox 2"	O95948	18	57435374-57491298	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.1;gallbladder: 10.2;intestine: 10.2;liver: 8.5;retina: 5.5"	"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 964.0"	"Group enriched"	"Detected in many"	7	"liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 7.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.3;HeLa: 14.1;RT4: 6.7;SCLC-21H: 10.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"basal ganglia: 8.7;cerebellum: 4.7;cerebral cortex: 5.6;hippocampal formation: 3.2;hypothalamus: 2.5"	HPA057058	Enhanced		Supported	"Nucleoplasm,Actin filaments"		NA	NA			Nucleoplasm	"Actin filaments"	"HPA057058: AB_2683323"	"unprognostic (3.02e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.06e-3)"	"unprognostic (3.79e-5)"	"unprognostic (1.13e-2)"	"unprognostic (4.48e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.56e-3)"	"unprognostic (8.66e-3)"	"unprognostic (1.16e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.21e-1)"	0.0	0.1	0.2	0.0	7.1	0.0	0.0	0.6	1.9	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	10.2	0.0	0.3	4.2	0.0	8.5	0.0	0.0	2.2	0.3	0.1	0.0	2.4	0.8	0.8	0.0	2.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	1.0	1.2	3.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	1.4	0.0	3.4	0.0	0.1	20.3	3.1	0.7	14.1	3.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	2.3	4.0	0.7	0.0	0.5	1.9	0.0	0.1	1.6	0.7	0.0	1.2	0.0	1.6	6.7	10.1	1.7	0.1	0.0	0.2	0.1	0.5	0.7	0.0	1.0	1.3	0.2	0.2	0.3	3.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.1	0.6	1.9	0.3	4.2	2.2	0.3	0.1	2.0	0.0	1.0	0.3	0.3	0.0	0.0	2.3	0.0	0.1	0.2	0.0	0.0	4.5	0.4	1.1	2.8	184.5	0.0	7.3	14.6	0.0	0.0	2.0	0.0	79.7	4.9	0.2	0.1	0.5	8.9	0.0	38.7	8.8	0.1	0.3	0.0	0.3	0.0	0.5	5.3	47.0	1.0	964.0	1.8	0.6	0.0	1.3	0.0	3.2	0.3	0.1	0.0	1.0	0.0	3.0	0.0	3.5	1.0	38.7	3.3	0.0	0.0	0.4	0.1	0.1	0.0	5.6	0.0	0.9	0.7	1.9	2.0	0.0	0.1	0.0	0.1	0.2	0.5	0.0
ONECUT3		ENSG00000205922	"One cut homeobox 3"	O60422	19	1753506-1780988	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 2.2;stomach 1: 4.4"	"Group enriched"	"Detected in some"	28	"Cardiomyocytes: 89.7;Horizontal cells: 312.9"	"Group enriched"	"Detected in some"	7	"pancreatic cancer: 3.5;stomach cancer: 3.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HaCaT: 8.1;OE19: 10.9;PC-3: 18.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059936			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059936: AB_2684172"	"unprognostic (9.43e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.08e-10)"	"unprognostic (1.18e-1)"	"unprognostic (9.86e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.21e-2)"	0.0	0.0	0.5	0.1	0.2	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.7	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.2	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.1	4.4	0.9	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	10.9	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.2	0.2	1.1	0.7	0.4	0.1	0.5	0.2	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	1.0	0.2	0.5	89.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.9	0.2	0.4	2.9	0.0	0.0	0.1	0.2	0.0	1.3	7.1	0.8	0.0	0.0	0.0	0.1	0.1	312.9	0.1	1.3	0.0	0.0	0.8	1.5	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	6.4	0.0	0.4	0.0	0.4	0.2	0.0	0.0	2.6	0.0	0.4	2.1	3.2	2.9	0.0	0.3	0.0	0.2	0.0	0.2	0.5
PRSS3	"PRSS4, TRY3, TRY4"	ENSG00000010438	"Serine protease 3"	P35030	9	33750679-33799231	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	268	"pancreas: 31377.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1022.9;Exocrine glandular cells: 2040.4;Pancreatic endocrine cells: 478.8;Paneth cells: 969.9;Proximal enterocytes: 1127.1"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	104	"basophil: 158.7"	"Lineage enriched"	"Detected in many"	104	"granulocytes: 158.7"	"Group enriched"	"Detected in many"	5	"OE19: 316.6;PC-3: 852.5"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		700000000	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.94e-2)"	"unprognostic (7.75e-4)"	"unprognostic (5.46e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-1)"	2.9	4.6	22.2	7.2	27.1	0.6	1.7	25.6	35.7	14.8	16.9	87.8	93.4	0.4	0.0	117.2	0.3	23.0	6.3	26.6	24.7	3.6	12.5	0.6	0.7	24.4	25.1	25.8	13.0	31377.8	0.0	0.8	1.7	25.8	1.1	78.5	0.3	21.0	0.3	0.5	72.0	106.3	3.1	19.1	0.7	23.0	5.2	24.2	0.8	0.4	0.0	15.3	4.2	57.3	24.5	12.0	13.7	0.7	0.0	0.2	5.9	0.1	33.6	7.7	4.1	1.6	34.3	3.0	0.0	0.2	14.9	0.2	15.0	0.0	31.7	10.1	0.4	0.2	0.0	1.1	0.0	2.7	0.0	0.0	0.2	0.0	10.8	110.2	0.3	68.8	0.2	0.0	0.0	0.0	0.2	0.7	0.4	0.2	316.6	852.5	0.0	0.0	0.0	0.0	1.7	0.3	81.2	0.2	0.0	0.0	0.5	0.0	0.0	78.3	0.0	0.0	12.8	0.0	0.0	0.0	0.1	18.1	0.0	0.1	158.7	0.0	0.0	0.2	1.5	1.2	0.0	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.3	22.2	27.1	25.6	35.7	26.6	24.7	24.4	25.1	25.8	25.8	19.1	24.2	24.5	0.1	0.0	0.0	0.7	1.9	57.1	0.6	1.3	0.0	0.2	0.1	2.8	1.0	47.1	1.2	1.8	0.0	0.0	0.1	1022.9	3.9	43.2	31.4	0.0	0.0	3.2	192.6	0.0	32.8	2040.4	0.0	0.8	39.3	0.0	8.9	0.0	0.7	4.2	0.0	0.0	4.7	146.4	0.0	0.3	12.1	79.7	1.5	1.2	7.2	3.7	5.7	0.0	0.0	3.5	1.2	478.8	969.9	0.7	0.3	12.1	1127.1	14.7	0.1	0.2	0.0	0.0	1.7	0.5	0.9	1.1	134.1	0.1	2.1	0.0	329.0	56.2
SLC7A9	CSNU3	ENSG00000021488	"Solute carrier family 7 member 9"	P82251	19	32830509-32869767	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 125.6;kidney: 68.8"	"Cell type enriched"	"Detected in some"	7	"Proximal enterocytes: 772.0"	"Group enriched"	"Detected in some"	7	"liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"BEWO: 3.4;CACO-2: 8.2;Hep G2: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042591	Enhanced					NA	NA					"HPA042591: AB_10962500"	"unprognostic (4.12e-2)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.69e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (5.10e-5)"	0.2	0.1	0.8	0.1	0.8	0.0	0.3	0.8	0.9	0.6	0.6	0.7	79.0	0.4	1.5	0.2	0.5	0.2	0.1	0.7	0.8	68.8	17.4	0.2	0.1	0.7	0.7	0.7	0.6	0.3	0.0	0.7	0.1	0.9	1.0	0.2	1.0	0.2	0.2	0.0	0.2	125.6	0.2	0.7	0.3	0.2	0.4	0.7	0.2	0.8	0.0	0.0	0.3	0.5	0.9	0.0	0.1	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	0.9	0.7	0.8	0.7	0.7	0.7	0.9	0.7	0.7	0.9	0.1	0.0	0.0	2.3	0.5	0.0	0.1	0.0	0.0	1.3	0.2	0.6	0.4	0.0	0.0	5.5	4.2	0.2	0.1	0.0	1.9	0.1	1.6	0.3	0.2	0.1	0.0	0.0	3.1	7.2	8.8	0.2	0.0	0.2	0.0	0.4	0.0	12.2	0.2	0.0	3.0	18.2	0.0	0.0	0.0	0.1	0.6	0.5	0.0	2.8	0.0	0.2	0.0	0.0	1.7	0.6	27.5	0.0	0.0	0.0	772.0	97.8	1.8	1.2	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.1	11.7	0.0
TRAJ31		ENSG00000211858	"T cell receptor alpha joining 31"	A0A075B700	14	22510968-22511024	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 7.3;lymphoid tissue: 15.8;retina: 17.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	7	"stomach cancer: 2.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 147.2;memory CD8 T-cell: 73.7;naive CD4 T-cell: 121.4;naive CD8 T-cell: 84.3;T-reg: 170.1"	"Lineage enriched"	"Detected in many"	103	"T-cells: 170.1"	"Group enriched"	"Detected in some"	11	"JURKAT: 1.1;U-266/84: 1.0"															NA	NA																			"unprognostic (6.41e-2)"				0.0	0.0	0.7	6.3	2.5	1.8	2.2	3.4	7.3	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	1.1	15.8	2.0	1.5	0.0	0.0	0.0	0.0	0.0	0.6	1.7	1.2	3.7	17.5	0.0	0.0	0.0	0.0	1.8	1.4	1.2	4.8	0.0	0.0	1.3	7.2	0.0	0.0	7.8	1.6	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.6	24.7	0.0	147.2	73.7	0.9	0.0	121.4	84.3	1.6	0.4	0.6	0.0	170.1	35.6	0.7	2.5	3.4	7.3	0.4	1.7	2.0	1.5	0.0	1.7	1.2	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USH1C	"AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C"	ENSG00000006611	"USH1 protein network component harmonin"	Q9Y6N9	11	17493895-17544416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Hearing"		"Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 98.7;kidney: 54.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 190.0;Muller glia cells: 163.6;Paneth cells: 203.0;Proximal enterocytes: 430.7;Proximal tubular cells: 190.3;Undifferentiated cells: 115.7"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 60.6;HeLa: 21.8;OE19: 57.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB013690, HPA027398, HPA027492, HPA028033"	Enhanced		Enhanced	Cytosol		No	NA			Cytosol		"CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782"	"unprognostic (3.60e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.22e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.65e-2)"	"prognostic favorable (9.41e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	0.4	0.3	3.2	5.9	7.3	0.0	0.2	3.4	4.2	0.1	1.8	52.0	98.7	0.1	0.3	0.0	2.9	26.1	0.0	8.9	6.7	54.5	0.6	0.1	0.1	6.4	6.3	1.5	0.0	3.9	0.0	6.7	0.0	7.3	0.0	48.8	19.2	0.0	0.3	0.0	0.0	97.3	2.1	4.1	0.0	26.9	0.2	4.5	0.1	1.1	0.0	0.0	0.6	0.1	8.9	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	60.6	8.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	21.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	7.3	3.4	4.2	8.9	6.7	6.4	6.3	1.5	7.3	4.1	4.5	8.9	0.0	0.0	0.0	18.3	1.6	0.0	0.1	0.0	0.0	0.7	0.0	1.3	0.6	52.9	0.7	5.5	2.1	0.0	0.0	190.0	21.5	20.5	1.0	1.7	0.0	0.4	64.0	0.0	0.6	27.5	0.0	0.3	53.5	0.0	4.5	0.0	0.0	0.0	0.0	1.7	0.2	92.9	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	163.6	0.0	0.5	36.4	56.0	203.0	0.0	0.2	0.0	430.7	190.3	1.0	4.9	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.8	0.1	115.7	0.1
A4GNT	alpha4GnT	ENSG00000118017	Alpha-1,4-N-acetylglucosaminyltransferase	Q9UNA3	3	138123713-138132390	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"stomach 1: 23.8"	"Group enriched"	"Detected in some"	25	"Cholangiocytes: 4.3;Gastric mucus-secreting cells: 16.3"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 2.5;stomach cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA008017	Enhanced				"Intracellular and membrane"	NA	NA					"HPA008017: AB_1078073"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-1)"			"unprognostic (2.14e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.48e-3)"	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.1	2.7	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.8	0.1	0.2	0.0	0.2	0.3	0.0	0.1	3.3	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.2	23.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AQP2		ENSG00000167580	"Aquaporin 2"	P41181	12	49950737-49958878	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Diabetes insipidus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	92	"kidney: 390.4;seminal vesicle: 214.4"	"Cell type enriched"	"Detected in some"	440	"Collecting duct cells: 4143.6"	"Group enriched"	"Detected in some"	6	"renal cancer: 1.7;stomach cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.4;HEL: 1.1;HMC-1: 2.2;OE19: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046834	Enhanced					NA	NA					"HPA046834: AB_2679830"	"unprognostic (2.10e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.60e-2)"			"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.38e-3)"	"unprognostic (5.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.11e-1)"		0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.2	0.7	0.0	0.0	390.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.4	214.4	0.0	0.2	0.0	0.0	0.0	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4143.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.1	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0
C6orf58	LEG1	ENSG00000184530	"Chromosome 6 open reading frame 58"	Q6P5S2	6	127519455-127591820	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 618.3;salivary gland: 2275.9"	"Group enriched"	"Detected in some"	12	"Early spermatids: 14.3;Gastric mucus-secreting cells: 41.3"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 17.1;stomach cancer: 14.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.0;RPMI-8226: 2.8;WM-115: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036263, HPA041449"	Enhanced				"Secreted to digestive system"	NA	NA		30000			"HPA036263: AB_10673349, HPA041449: AB_2677486"	"unprognostic (1.49e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.62e-4)"	"unprognostic (2.10e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.99e-3)"	0.1	0.6	0.0	0.0	0.4	0.0	0.3	0.0	0.3	0.1	0.0	0.1	618.3	0.0	0.0	16.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	2275.9	0.0	0.2	0.0	0.2	0.1	0.0	0.3	270.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.2	2.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	2.8	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	14.3	0.1	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.2	41.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	2.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.8	0.7	0.0	0.1	0.3	0.0	0.2	0.0	0.3
CDH17	"cadherin, HPT-1"	ENSG00000079112	"Cadherin 17"	Q12864	8	94127162-94217303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"intestine: 317.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 569.4;Enteroendocrine cells: 108.4;Intestinal goblet cells: 183.7;Paneth cells: 408.6;Proximal enterocytes: 336.9;Undifferentiated cells: 241.6"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 156.4;stomach cancer: 54.9"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 16.0"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 16.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 98.8;OE19: 430.1;U-266/70: 157.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023614, HPA023616, CAB025143, HPA026556"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA		7500000	"Cell Junctions"	Nucleoplasm	"CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897"	"unprognostic (2.08e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.46e-2)"	0.9	0.2	0.7	29.1	0.5	2.7	0.5	0.9	0.8	0.1	1.6	263.3	317.1	1.4	0.8	1.7	0.3	3.1	0.6	0.5	0.2	0.8	0.3	0.2	1.5	0.4	0.3	0.5	0.5	1.7	0.0	0.0	0.2	0.4	1.2	249.0	0.5	0.9	1.6	0.5	0.6	272.9	9.4	0.2	5.5	2.6	0.6	0.2	0.3	0.7	0.1	1.8	0.8	0.1	1.2	0.2	18.5	0.2	0.4	0.0	0.4	1.6	0.2	0.3	0.2	0.3	98.8	3.5	0.3	0.3	0.0	0.1	1.0	0.3	0.3	0.3	0.2	1.1	0.1	0.8	0.6	0.3	0.2	4.3	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.4	1.5	0.1	0.7	0.5	1.3	0.3	430.1	0.5	0.3	0.0	2.8	0.3	0.2	1.3	1.2	0.4	0.4	0.5	0.4	0.7	0.9	0.0	0.6	0.7	1.2	0.5	157.2	0.3	0.2	0.3	0.3	0.6	2.9	0.9	1.4	0.2	0.8	0.1	0.3	0.2	0.1	0.5	0.8	0.2	0.3	16.0	0.7	0.5	0.4	0.2	0.2	0.7	0.5	0.9	0.8	0.5	0.2	0.4	0.3	0.5	0.4	0.2	0.2	1.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	569.4	0.0	0.3	1.0	0.0	0.0	0.0	108.4	0.0	0.5	0.0	0.0	0.1	2.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	183.7	0.0	0.0	0.5	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	408.6	0.0	0.2	0.0	336.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	2.1	0.0	241.6	0.1
CHST5	"FLJ22167, I-GLCNAC-6-ST"	ENSG00000135702	"Carbohydrate sulfotransferase 5"	Q9GZS9	16	75528535-75535247	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 85.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 5.2;Intestinal goblet cells: 3.7;Paneth cells: 8.1;Proximal enterocytes: 11.6;Undifferentiated cells: 2.6"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.4;stomach cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 1.5"									"HPA043804, HPA068029"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA043804: AB_10960563, HPA068029: "	"unprognostic (6.82e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.46e-2)"		"unprognostic (6.76e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.09e-2)"	"unprognostic (9.03e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.42e-2)"	0.1	0.2	3.0	1.3	1.9	0.6	0.4	2.0	2.3	0.3	1.8	46.5	85.8	0.4	0.3	0.2	1.1	0.2	0.3	2.4	1.0	0.2	0.1	0.3	0.3	1.7	1.6	2.2	0.5	0.1	0.4	0.7	0.2	1.3	0.3	55.8	1.5	0.1	0.4	7.7	0.2	76.3	1.0	1.9	0.4	4.8	0.7	1.2	0.3	0.3	0.8	0.1	0.2	0.1	1.7	0.1	0.3	0.4	0.5	0.1	0.3	0.2	0.0	0.1	0.2	0.1	0.2	0.6	0.4	0.2	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.5	0.0	0.2	0.6	0.1	0.2	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.4	0.0	0.9	0.2	1.3	0.3	0.0	1.5	0.2	0.1	0.9	0.5	0.1	0.7	1.2	0.6	0.4	0.0	0.0	0.3	0.1	0.0	0.5	0.3	0.9	0.1	0.2	0.7	0.0	0.3	0.1	0.3	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.4	0.1	0.2	0.2	0.1	0.0	3.0	1.9	2.0	2.3	2.4	1.0	1.7	1.6	2.2	1.3	1.9	1.2	1.7	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.3	0.0	0.0	2.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	2.0	0.6	0.0	8.1	0.0	0.0	0.0	11.6	0.0	1.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0
EPS8L3	"FLJ21522, MGC16817"	ENSG00000198758	"EPS8 like 3"	Q8TE67	1	109750080-109764027	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"gallbladder: 36.0;intestine: 143.3;stomach 1: 51.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 254.4;Gastric mucus-secreting cells: 80.5;Intestinal goblet cells: 103.4;Late spermatids: 144.6;Paneth cells: 257.8;Proximal enterocytes: 285.3;Undifferentiated cells: 112.6"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 52.5;pancreatic cancer: 29.7;stomach cancer: 26.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 15.6;CAPAN-2: 14.4;Hep G2: 36.2;OE19: 67.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030998	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA030998: AB_2673691"	"unprognostic (1.73e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (5.55e-3)"		"unprognostic (3.71e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (5.87e-3)"	"unprognostic (3.89e-1)"		"prognostic favorable (1.82e-4)"	0.0	0.0	0.1	10.9	0.0	0.0	0.2	0.0	0.0	1.3	0.0	73.2	143.1	0.2	0.9	0.1	0.1	36.0	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	77.9	0.0	0.0	0.2	0.0	0.0	143.3	2.9	0.0	0.0	51.2	2.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	15.6	14.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	67.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	14.3	0.3	0.0	0.0	0.0	0.0	254.4	0.0	11.6	28.0	0.7	0.1	0.3	51.4	0.0	0.0	23.9	0.0	0.0	80.5	1.0	4.5	0.0	0.0	0.2	0.0	0.0	0.0	103.4	0.0	0.0	0.0	144.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.5	257.8	0.4	0.3	0.0	285.3	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.4	0.6	112.6	1.8
FER1L6	C8ORFK23	ENSG00000214814	"Fer-1 like family member 6"	Q2WGJ9	8	123851987-124120061	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 10.9;stomach 1: 43.5"	"Group enriched"	"Detected in some"	9	"Early spermatids: 15.8;Gastric mucus-secreting cells: 39.3;Intestinal goblet cells: 10.4;Late spermatids: 30.5;Pancreatic endocrine cells: 10.8"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 4.2;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;ASC TERT1: 1.8;BJ hTERT+: 1.2;PC-3: 1.7;U-87 MG: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054117	Enhanced					NA	NA					"HPA054117: AB_2682387"	"unprognostic (1.90e-1)"	"unprognostic (3.08e-3)"	"unprognostic (2.06e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.23e-6)"	"unprognostic (7.09e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.39e-2)"	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.1	0.3	0.0	5.1	2.9	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	3.2	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.9	0.0	0.0	0.0	0.1	0.0	4.6	0.1	0.0	0.0	43.5	2.5	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.1	0.0	0.2	1.0	0.0	0.0	1.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.5	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.3	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.7	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.0	0.4	15.8	0.3	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	39.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.4	0.0	0.0	0.0	30.5	0.9	0.0	0.0	1.9	0.0	0.0	0.0	1.0	1.0	10.8	2.2	0.0	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.8
GAL3ST2	GP3ST	ENSG00000154252	"Galactose-3-O-sulfotransferase 2"	Q9H3Q3	2	241776822-241804287	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"intestine: 9.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Oligodendrocyte precursor cells: 1.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 6.7;ovarian cancer: 4.9;stomach cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 3.7;HMC-1: 10.5"	"Not detected"	"Not detected"							HPA071809	Enhanced				"Intracellular and membrane"	NA	NA					"HPA071809: AB_2686450"	"unprognostic (5.22e-3)"	"unprognostic (6.52e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.04e-3)"	"unprognostic (3.04e-4)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.87e-11)"	"unprognostic (4.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.49e-1)"	0.2	0.3	0.5	0.8	0.2	0.2	0.0	0.0	0.4	0.3	0.0	9.5	0.0	0.1	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.1	3.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	3.7	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.4	0.1	0.0	0.7	0.0	0.0	0.5	0.1	0.2	0.7	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0
GAST	GAS	ENSG00000184502	Gastrin	P01350	17	41712331-41715969	"Cancer-related genes, FDA approved drug targets, Predicted secreted proteins"		Hormone	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	167	"stomach 1: 9634.4"	"Cell type enriched"	"Detected in some"	5	"Glandular and luminal cells: 103.7"	"Group enriched"	"Detected in many"	6	"pancreatic cancer: 38.8;stomach cancer: 23.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 34.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB000038	Enhanced				"Secreted to digestive system"	NA	NA		87000			"CAB000038: "		"unprognostic (1.27e-1)"	"unprognostic (4.27e-3)"		"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"		"unprognostic (2.75e-2)"		"unprognostic (5.68e-2)"	"unprognostic (2.11e-1)"			"unprognostic (2.85e-1)"	"unprognostic (3.17e-1)"		"unprognostic (9.07e-2)"	0.0	0.0	1.0	0.0	0.5	0.0	0.7	0.3	0.9	0.2	0.3	0.0	57.8	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.1	0.0	3.7	0.0	0.7	0.7	0.4	0.0	0.0	0.0	0.1	4.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	9.4	9634.4	0.3	1.9	4.3	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	5.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	34.8	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	0.9	0.4	1.8	0.7	0.7	0.4	0.7	0.7	1.9	0.9	0.8	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.3	0.9	0.4	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.1	2.2	13.5	18.7	0.7	0.0	0.0	0.0	0.0	0.1	1.0	0.5	103.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.8	0.2	0.2	0.0	0.0	8.8	1.0	0.0	0.0	0.4
KCNE2	"LQT6, MiRP1"	ENSG00000159197	"Potassium voltage-gated channel subfamily E regulatory subunit 2"	Q9Y6J6	21	34364006-34371381	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"stomach 1: 318.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 35.0;Gastric mucus-secreting cells: 109.1;Late spermatids: 20.1"	"Cancer enriched"	"Detected in some"	6	"stomach cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.6;SCLC-21H: 1.9"	"Region enhanced"	"Detected in many"		"pons and medulla: 29.0"					"HPA029706, HPA051553"	Enhanced					NA	NA					"HPA029706: AB_2673159, HPA051553: AB_2681532"	"unprognostic (5.29e-4)"	"unprognostic (3.13e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.65e-5)"	"unprognostic (7.45e-2)"	"unprognostic (7.33e-3)"	"unprognostic (5.77e-3)"	"unprognostic (6.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.81e-2)"	0.5	0.4	1.0	0.3	1.1	0.1	0.4	0.8	1.3	0.5	1.1	0.9	7.1	0.3	0.8	0.4	0.4	0.5	0.4	1.0	1.1	1.0	1.3	0.5	0.1	1.0	1.1	1.0	0.5	0.7	0.0	0.5	0.3	1.1	0.5	0.3	0.4	0.3	0.3	0.8	0.3	0.2	0.0	1.0	0.2	318.8	4.2	1.2	0.0	1.0	0.3	0.0	0.6	0.3	1.0	0.3	0.1	0.8	1.5	0.0	0.0	1.0	0.3	0.2	0.0	0.0	0.3	0.4	0.3	0.5	0.0	0.2	0.0	0.1	0.0	0.4	0.4	0.4	0.3	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.1	1.6	0.1	0.6	0.0	0.3	1.1	1.1	0.6	0.2	0.2	0.4	0.1	0.1	1.9	0.1	0.5	0.2	0.5	0.9	0.5	0.4	0.0	0.4	0.2	0.2	0.1	1.6	0.9	0.3	0.1	0.8	0.4	0.0	0.3	0.5	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.1	1.0	1.1	0.8	1.3	1.0	1.1	1.0	1.1	1.0	1.1	1.0	1.2	1.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	35.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.3	109.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.3	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.0
KRT20	"CK20, K20, MGC35423"	ENSG00000171431	"Keratin 20"	P35900	17	40875889-40885242	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 652.3"	"Group enriched"	"Detected in some"	6	"Distal enterocytes: 1328.5;Intestinal goblet cells: 421.7;Paneth cells: 1606.6;Proximal enterocytes: 1107.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 159.5;stomach cancer: 52.7;urothelial cancer: 99.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000032, HPA024309, HPA024684, HPA027236"	Enhanced		Supported	Cytosol		NA	NA		30000000	Cytosol		"CAB000032: AB_2133718, HPA024309: AB_1852220, HPA024684: AB_1852222, HPA027236: AB_1852224"	"unprognostic (3.49e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.66e-3)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (2.63e-2)"			"unprognostic (4.87e-3)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.71e-2)"	"unprognostic (6.30e-2)"		"unprognostic (7.27e-2)"	1.3	0.0	0.0	50.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	603.3	298.6	2.1	0.0	0.3	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	484.6	0.0	0.0	1.2	0.0	0.1	652.3	27.3	0.0	0.0	126.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.4	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1328.5	0.0	0.1	0.0	0.0	0.0	0.0	43.9	0.0	0.1	0.0	0.0	0.0	115.7	0.1	13.4	0.0	0.0	0.0	0.1	0.0	0.0	421.7	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1606.6	0.0	0.6	1.9	1107.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.6	0.0	160.4	1.4
STYXL2	DUSP27	ENSG00000198842	"Serine/threonine/tyrosine interacting like 2"	Q5VZP5	1	167094075-167129165	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	43	"heart muscle: 64.2;skeletal muscle: 115.7;tongue: 54.5"	"Cell type enriched"	"Detected in some"	7	"Cardiomyocytes: 143.6"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 12.8;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RH-30: 14.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA012912			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012912: AB_2668767"	"unprognostic (1.26e-2)"		"unprognostic (1.74e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.1	0.1	64.2	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.7	0.0	0.9	1.7	0.0	115.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	54.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	3.6	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
TEX49	LINC00935	ENSG00000257987	"Testis expressed 49"	A0A1B0GTD5	12	48727435-48765790	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 21.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"stomach cancer: 0.6;testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA066635			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA066635: "											"unprognostic (2.63e-2)"			"unprognostic (6.32e-3)"	"unprognostic (8.28e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TM4SF20	"FLJ22800, TCCE518"	ENSG00000168955	"Transmembrane 4 L six family member 20"	Q53R12	2	227362038-227381995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"intestine: 269.0"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 703.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.6;RPMI-8226: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051838, HPA063184, HPA065531"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506"	"unprognostic (4.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"		"unprognostic (4.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.04e-3)"		0.1	0.1	0.1	0.3	0.2	0.2	0.0	1.2	0.4	0.0	0.3	3.1	269.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.1	3.9	0.3	0.0	0.0	0.0	0.3	145.7	1.6	0.0	0.1	0.5	3.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.1	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	1.2	0.4	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	48.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	21.4	0.0	0.0	0.0	77.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.5	0.0	157.9	0.7	0.0	0.0	703.0	0.0	0.0	0.3	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	18.8	0.0
VIP		ENSG00000146469	"Vasoactive intestinal peptide"	P01282	6	152750797-152759765	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 72.9;lymphoid tissue: 156.9"	"Group enriched"	"Detected in some"	5	"Inhibitory neurons: 80.6;Melanocytes: 28.4"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 3.7;pancreatic cancer: 4.3;stomach cancer: 2.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 2.7;TIME: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017324, CAB018649, HPA072701, CAB079780"	Supported	Supported	Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	122000		"Endoplasmic reticulum"		"CAB018649: AB_2304501, CAB079780: , HPA017324: AB_1858754, HPA072701: AB_2686550"	"unprognostic (9.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.47e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.90e-2)"	2.0	12.3	6.5	156.9	8.8	0.1	1.9	5.7	11.0	1.5	5.6	72.9	16.7	1.2	0.4	4.3	1.5	3.7	3.1	7.8	25.3	2.0	1.1	3.4	0.4	7.7	17.9	7.3	0.8	8.3	0.3	0.8	0.6	7.3	2.7	62.0	1.0	0.5	0.5	1.4	0.3	46.1	42.0	5.6	9.8	22.4	1.0	10.9	0.1	2.4	1.7	0.1	1.6	9.4	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.8	5.7	11.0	7.8	25.3	7.7	17.9	7.3	7.3	5.6	10.9	6.8	2.5	0.0	0.0	3.3	0.2	0.4	0.0	0.0	0.0	1.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	80.6	0.0	0.0	0.3	0.0	6.5	0.0	0.0	28.4	4.7	0.0	0.0	0.0	2.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AGMAT	FLJ23384	ENSG00000116771	Agmatinase	Q9BSE5	1	15571699-15585051	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Putrescine biosynthesis, Spermidine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 135.1;liver: 62.6;skeletal muscle: 34.5"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 306.8"	"Group enriched"	"Detected in all"	5	"colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.1;T-cells: 8.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 36.7;Hep G2: 92.6;RPMI-8226: 22.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA026443, HPA028321"	Enhanced					NA	NA		240000			"HPA026443: AB_1844644, HPA028321: AB_10600779"	"unprognostic (2.27e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-2)"	0.4	1.1	1.3	3.2	1.2	1.0	0.3	1.4	1.5	0.5	0.9	9.3	18.0	0.5	0.3	0.5	0.3	0.5	0.1	1.0	0.9	135.1	62.6	0.2	4.0	0.8	0.7	1.5	0.1	0.6	2.2	0.3	0.2	1.1	0.5	6.9	0.4	4.6	0.1	34.5	0.4	13.5	0.7	0.4	1.6	1.8	0.8	0.8	2.2	0.5	6.2	4.2	0.8	0.1	1.5	7.7	6.3	0.5	0.3	0.1	0.8	0.2	1.3	1.4	0.8	0.5	36.7	5.1	0.1	0.2	0.9	0.2	0.2	0.0	0.0	0.9	7.6	0.1	5.2	5.1	92.6	0.9	4.0	0.2	0.9	0.4	2.4	0.0	0.6	0.7	0.1	0.1	10.3	1.9	8.6	0.2	4.0	8.1	6.5	3.7	0.1	0.0	22.3	0.2	2.2	1.5	1.1	10.9	0.4	1.3	0.4	1.5	8.2	1.1	0.3	0.3	2.1	0.1	0.3	6.1	5.0	0.4	0.1	0.2	1.2	0.3	0.2	2.1	0.3	2.6	4.1	4.5	2.4	0.2	2.7	8.4	5.0	1.4	0.5	0.2	0.4	6.4	2.0	1.3	1.2	1.4	1.5	1.0	0.9	0.8	0.7	1.5	1.1	0.4	0.8	1.5	0.2	0.0	0.0	1.0	5.9	0.3	1.7	0.5	0.0	1.3	0.5	0.9	0.6	2.8	0.3	3.7	0.0	0.9	0.5	7.4	31.3	1.1	9.4	1.2	1.1	0.6	1.2	2.1	1.9	0.9	0.8	0.7	5.1	2.1	0.0	1.4	1.8	42.5	1.1	3.3	2.2	9.6	2.0	2.9	0.8	4.2	0.3	2.0	1.8	3.7	1.9	1.0	5.2	0.5	0.4	2.3	6.0	0.0	2.0	1.7	27.0	306.8	1.4	2.4	0.0	4.7	0.5	1.6	3.5	1.2	0.6	0.8	5.0	3.4	18.9	3.0
ANXA10	ANX14	ENSG00000109511	"Annexin A10"	Q9UJ72	4	168092537-168187736	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"stomach 1: 490.8"	"Group enriched"	"Detected in some"	5	"Exocrine glandular cells: 172.6;Gastric mucus-secreting cells: 667.7;Pancreatic endocrine cells: 315.0"	"Group enriched"	"Detected in many"	5	"pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"OE19: 284.8;PC-3: 125.5;RT4: 172.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005469, HPA074650"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Nucleoplasm, Nucleoli"	Vesicles	"HPA005469: AB_1844849, HPA074650: "	"unprognostic (2.29e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.29e-2)"	"prognostic favorable (3.64e-6)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-1)"	"unprognostic (8.61e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-3)"	"unprognostic (8.41e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.89e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	19.8	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	490.8	0.9	0.1	0.0	0.0	0.0	0.0	90.4	0.1	0.1	0.0	4.6	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.6	0.5	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.4	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.4	0.1	9.7	0.0	4.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	284.8	125.5	0.0	0.6	0.0	0.0	172.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.3	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.5	0.0	1.5	0.0	0.5	15.5	0.0	0.4	0.1	0.0	0.2	7.2	3.2	0.0	2.1	0.0	0.0	0.1	0.0	21.1	11.0	0.1	0.1	0.3	0.0	2.7	0.2	172.6	0.0	0.4	667.7	0.1	0.0	0.0	1.8	72.6	0.0	0.0	0.2	0.5	0.0	2.8	0.0	0.8	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.5	0.0	315.0	1.1	0.0	1.4	0.6	0.0	0.2	0.3	0.6	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.1	14.7
AOC1	"ABP, ABP1, DAO"	ENSG00000002726	"Amine oxidase copper containing 1"	P19801	7	150824627-150861504	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"intestine: 229.1;kidney: 137.8;placenta: 500.8"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 272.2;Distal enterocytes: 517.5;Paneth cells: 532.1;Proximal enterocytes: 957.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	12	"eosinophil: 31.2"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 31.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 20.5;HaCaT: 6.2;NB-4: 6.4;RPMI-8226: 7.7;THP-1: 27.1"					"Low region specificity"	"Detected in many"			"HPA031032, HPA031033"	Approved				"Secreted in other tissues"	NA	NA		2500000			"HPA031032: AB_10670150, HPA031033: AB_10669670"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (9.07e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (5.32e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	0.7	0.1	0.4	13.1	0.2	1.9	0.2	0.3	0.3	7.2	0.5	143.5	185.7	2.1	1.9	3.3	0.1	1.8	0.7	0.3	0.7	137.8	5.8	0.6	1.3	0.3	0.4	0.0	0.3	1.4	0.0	0.0	500.8	0.3	6.1	95.0	0.1	0.7	1.0	0.1	1.3	229.1	3.5	0.5	0.5	18.2	2.1	0.4	2.1	0.2	0.0	3.9	0.8	0.4	0.5	0.0	0.1	0.1	0.4	0.0	0.0	1.0	0.2	0.0	0.0	0.0	3.2	20.5	0.0	2.7	0.0	1.7	6.2	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.3	0.1	6.4	0.2	1.9	0.0	0.0	0.0	7.7	0.3	0.2	2.2	2.5	0.1	0.9	0.0	0.3	0.8	27.1	0.6	0.2	0.1	0.6	0.0	0.2	0.1	0.1	0.2	1.0	0.1	0.2	0.1	31.2	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.3	0.3	0.3	0.7	0.3	0.4	0.0	0.3	0.5	0.4	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.8	272.2	0.0	2.1	0.0	517.5	15.6	0.0	7.1	1.9	0.5	0.4	43.3	0.0	0.1	3.3	63.4	0.5	13.7	4.8	5.7	0.0	0.0	0.0	2.8	0.0	0.1	129.7	2.0	0.0	1.7	18.4	0.0	1.0	0.0	0.0	66.2	0.0	0.0	0.0	0.0	3.7	532.1	0.0	0.0	0.7	957.9	145.2	0.2	0.0	0.0	0.0	0.3	3.7	1.3	0.0	0.1	3.4	0.9	0.0	117.9	0.3
ARL14	"ARF7, FLJ22595"	ENSG00000179674	"ADP ribosylation factor like GTPase 14"	Q8N4G2	3	160677160-160678448	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 130.2;intestine: 51.7;stomach 1: 77.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 588.3;Gastric mucus-secreting cells: 377.7;Intestinal goblet cells: 154.6;Paneth cells: 519.2;Proximal enterocytes: 174.5"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 6.6;pancreatic cancer: 26.0;stomach cancer: 14.3;urothelial cancer: 8.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	15	"memory B-cell: 1.8"	"Lineage enriched"	"Detected in single"	18	"B-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"A-431: 9.7;CAPAN-2: 36.2;HaCaT: 9.0;OE19: 25.3;RT4: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.65e-1)"	"unprognostic (7.26e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.70e-3)"		"unprognostic (6.36e-2)"	"unprognostic (2.47e-3)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (2.30e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (4.74e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-2)"	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	43.3	51.7	0.1	0.0	1.0	0.1	130.2	0.0	0.0	0.0	0.4	1.4	0.0	0.2	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.1	36.4	0.0	0.1	0.0	0.0	0.2	34.4	2.8	0.0	0.1	77.9	0.0	0.0	0.3	0.6	0.0	3.3	24.0	0.3	0.0	9.7	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	36.2	0.0	0.8	0.0	4.2	9.0	0.0	0.9	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	25.3	2.0	0.0	0.0	0.3	2.9	17.7	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.0	1.9	4.5	2.6	0.0	0.0	0.2	0.1	0.0	18.6	1.2	0.0	0.0	0.0	0.0	588.3	0.0	12.6	0.0	5.6	0.4	0.1	89.1	0.0	0.0	41.4	0.1	0.5	377.7	10.7	8.9	0.0	0.0	0.0	0.0	0.0	0.0	154.6	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.3	519.2	0.0	1.0	1.2	174.5	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.9	0.0	1.4	0.0	112.0	25.9
ASCL2	"ASH2, bHLHa45, HASH2"	ENSG00000183734	"Achaete-scute family bHLH transcription factor 2"	Q99929	11	2268498-2270588	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 7.0;salivary gland: 8.1;skin 1: 6.7"	"Cell type enriched"	"Detected in many"	9	"Extravillous trophoblasts: 1042.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 76.1;stomach cancer: 23.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 7.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"BEWO: 25.1;NB-4: 8.1;OE19: 14.2;SCLC-21H: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.71e-3)"	"prognostic favorable (5.11e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.22e-2)"	"prognostic favorable (4.73e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.45e-6)"	"unprognostic (8.86e-3)"	"unprognostic (5.48e-2)"	"unprognostic (6.12e-4)"	"unprognostic (1.07e-3)"	0.3	0.2	1.0	1.3	0.9	0.9	0.7	0.6	0.9	1.7	0.5	3.9	7.0	2.2	0.5	1.7	0.4	0.1	0.1	0.9	0.5	1.3	0.8	0.6	0.7	1.2	2.1	0.7	0.1	0.7	0.1	0.1	5.5	1.0	2.4	2.5	0.0	8.1	1.6	0.2	6.7	5.6	0.1	1.3	2.4	2.1	0.8	1.8	0.5	0.5	0.0	0.6	1.5	1.9	2.0	0.0	0.0	0.4	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	2.7	0.0	8.1	0.6	14.2	0.0	0.0	0.0	0.0	0.0	0.6	20.5	0.1	0.0	0.5	0.0	0.0	2.5	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.9	1.2	7.9	2.2	1.7	0.1	0.0	0.5	1.3	0.8	0.0	0.1	1.3	0.9	0.0	1.4	0.0	0.0	0.4	1.0	0.9	0.6	0.9	0.9	0.5	1.2	2.1	0.7	1.0	1.3	1.8	2.0	1.2	0.0	0.0	0.0	1.4	13.6	14.1	3.3	23.3	0.0	7.2	3.3	0.9	1.5	0.7	20.2	0.0	18.7	29.2	14.4	7.9	0.2	0.1	1.4	4.7	2.6	78.2	4.4	0.0	0.0	1042.9	1.5	10.2	3.5	0.0	0.0	23.2	0.5	31.1	0.0	0.0	31.4	2.0	22.0	7.0	0.2	1.8	14.3	1.8	3.7	22.6	0.0	110.2	0.0	0.0	0.0	3.6	1.5	1.3	6.5	9.1	0.4	1.0	0.1	0.0	0.1	0.3	0.3	13.7	9.1	4.7	23.3	8.9	0.1	112.1	9.4
CCK		ENSG00000187094	Cholecystokinin	P06307	3	42257825-42266185	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 274.4;choroid plexus: 110.8;intestine: 116.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.1;Excitatory neurons: 154.8;Fibroblasts: 42.5;Inhibitory neurons: 157.7;Melanocytes: 40.9;Oligodendrocytes: 40.9;Prostatic glandular cells: 63.8"	"Group enriched"	"Detected in many"	5	"glioma: 4.0;pancreatic cancer: 1.8;prostate cancer: 3.5;stomach cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"OE19: 236.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 74.4"	"HPA045039, HPA069515"	Enhanced	Supported			"Secreted to blood"	NA	NA	43700000				"HPA045039: , HPA069515: AB_2732135"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"		"unprognostic (2.39e-3)"		"unprognostic (1.97e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.77e-2)"		"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.10e-2)"	0.1	0.9	153.7	0.5	200.3	0.0	0.2	104.1	274.4	0.0	110.8	3.5	116.7	0.0	0.0	0.3	0.5	0.0	0.1	174.6	133.7	0.2	0.4	3.4	0.0	135.3	117.3	198.7	0.1	0.4	0.0	18.5	1.2	136.9	19.7	0.1	4.5	0.2	0.2	0.2	0.3	17.1	0.2	110.5	0.0	2.2	2.4	126.0	0.2	0.1	0.0	0.0	0.1	0.1	167.4	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	9.7	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	236.5	0.1	0.0	0.0	1.1	25.0	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	153.7	200.3	104.1	274.4	174.6	133.7	135.3	117.3	198.7	136.9	110.5	126.0	167.4	0.4	0.0	0.0	40.1	0.2	5.7	1.3	0.3	0.6	6.8	1.3	1.9	0.3	0.0	0.2	5.5	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	2.5	0.0	0.0	154.8	0.4	0.1	42.5	5.1	0.4	0.0	0.0	1.4	0.0	0.1	0.0	157.7	11.4	2.0	0.3	3.0	0.3	0.0	0.6	40.9	34.7	0.0	36.7	0.0	34.7	40.9	0.7	0.0	0.0	0.0	63.8	0.6	0.1	0.0	3.5	0.0	0.8	6.4	0.1	1.7	0.0	1.3	10.5	0.0	0.0	0.5	8.7
CIDEC	"CIDE-3, FLJ20871, Fsp27"	ENSG00000187288	"Cell death inducing DFFA like effector c"	Q96AQ7	3	9866711-9880255	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 738.8;breast: 497.0"	"Cell type enriched"	"Detected in some"	7	"Proximal enterocytes: 219.4"	"Group enriched"	"Detected in many"	5	"breast cancer: 4.5;colorectal cancer: 1.4;liver cancer: 2.4;pancreatic cancer: 4.6;stomach cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC diff: 1683.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018837, HPA020553"	Uncertain					NA	NA					"HPA018837: AB_1846767, HPA020553: AB_1846769"	"unprognostic (1.83e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.26e-5)"	"unprognostic (9.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.48e-3)"	"unprognostic (8.14e-2)"	"unprognostic (5.37e-5)"	"unprognostic (9.47e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.46e-3)"	"unprognostic (2.94e-2)"	738.8	5.6	0.2	1.1	0.3	0.0	497.0	0.1	0.4	0.9	0.0	11.6	69.6	4.7	0.3	0.7	2.2	5.0	7.0	0.1	0.2	2.1	10.1	0.2	1.2	0.2	0.1	0.0	0.4	7.4	0.1	0.2	0.0	0.1	2.3	3.9	0.0	16.3	3.8	6.2	15.5	90.6	1.6	0.1	0.2	7.5	0.9	0.1	1.5	3.9	11.7	0.0	13.4	4.9	0.3	0.0	0.2	0.0	0.0	1683.2	376.0	1.2	0.1	0.0	0.0	0.0	7.5	9.1	0.0	0.2	0.6	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	19.1	2.8	0.0	0.0	228.9	0.4	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.3	0.0	0.6	1.6	0.0	0.0	1.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.1	0.4	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.3	2.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	2.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	30.0	1.9	0.0	0.5	0.2	0.1	0.1	3.5	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.1	8.4	0.0	0.0	0.4	1.0	2.5	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	14.5	0.4	0.0	0.4	219.4	1.1	0.0	0.0	0.0	0.5	0.6	0.6	0.4	0.0	0.0	0.0	0.2	0.1	3.8	0.3
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 92.2;gallbladder: 102.5;kidney: 166.7;seminal vesicle: 90.9"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 77.5;Exocrine glandular cells: 49.1;Hepatocytes: 25.9;Pancreatic endocrine cells: 30.9;Proximal enterocytes: 32.9;Proximal tubular cells: 153.1"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in many"	6	"hippocampal formation: 8.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 296.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.5;hippocampal formation: 9.5;pons and medulla: 10.3;thalamus: 8.9"	"Region enhanced"	"Detected in some"		"medulla oblongata: 1.7"	"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB002609: , HPA051548: AB_2681530"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (9.76e-2)"	0.7	3.0	0.2	2.2	0.1	0.1	0.6	1.5	1.2	0.0	92.2	2.1	21.1	0.1	34.0	0.1	0.3	102.5	0.0	8.8	0.0	166.7	44.6	1.4	0.0	0.2	1.2	0.1	0.0	13.3	0.0	0.2	0.0	0.3	1.2	4.6	0.7	0.1	90.9	0.2	0.3	24.7	0.2	0.1	0.0	7.8	0.0	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.2	27.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	296.4	0.2	0.0	0.0	0.1	46.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.5	1.2	8.8	0.0	0.2	1.2	0.1	0.3	0.1	1.1	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	14.3	0.0	1.8	0.0	0.0	0.0	0.3	15.6	77.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	49.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.9	0.0	0.0	0.3	2.7	0.0	0.8	0.0	1.4	0.0	0.7	0.0	0.0	1.6	1.6	0.0	1.0	0.2	30.9	3.6	0.0	0.0	0.0	32.9	153.1	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	14.2	0.0
CYP2W1	"FLJ20359, MGC34287"	ENSG00000073067	"Cytochrome P450 family 2 subfamily W member 1"	Q8TAV3	7	983181-989640	"Predicted intracellular proteins"	"Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 19.2;intestine: 6.2;skin 1: 9.2"	"Cell type enriched"	"Detected in some"	7	"Enteroendocrine cells: 98.5"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 25.3;stomach cancer: 15.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 13.5;Hep G2: 49.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (7.09e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.72e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.85e-4)"	0.1	19.2	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.0	0.9	6.2	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.3	1.0	0.1	2.1	0.5	0.2	0.3	0.2	0.0	9.2	1.0	0.0	0.0	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.3	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.2	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	2.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.6	4.3	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	4.0	2.3	1.5	0.0	0.6	0.0	0.0	0.5	0.0	2.6	0.0	0.0	1.1	0.0	3.7	0.0	0.1	0.1	0.1	0.0	0.3	98.5	0.0	0.0	0.9	0.6	10.2	0.0	0.1	0.0	0.3	0.0	0.0	1.1	0.0	0.0	13.6	0.0	0.0	0.9	0.0	1.8	0.3	0.0	0.0	0.1	10.5	0.0	0.0	0.0	0.1	3.3	0.0	0.1	1.2	1.1	0.0	3.3	0.6	0.0	0.8	0.3	0.2	0.1	0.0	4.4	1.9	0.2	4.4	11.4	3.7
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565405	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 167.2;kidney: 317.9;retina: 177.1"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 410.3;Proximal enterocytes: 391.5;Proximal tubular cells: 429.5;Rod photoreceptor cells: 498.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.5;liver cancer: 13.4;pancreatic cancer: 6.4;renal cancer: 18.7;stomach cancer: 9.9"	"Region enhanced"	"Detected in many"		"midbrain: 28.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 54.5;Hep G2: 49.3;OE19: 83.6;SCLC-21H: 130.9;SH-SY5Y: 135.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"midbrain: 74.5;pons: 29.4"	HPA017742	Enhanced		Approved	"Actin filaments"		NA	NA		120000	"Actin filaments"		"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.5	49.3	0.4	2.3	0.6	0.0	1.0	0.0	1.3	0.0	0.2	36.9	156.2	0.0	9.2	0.1	0.0	0.2	0.0	0.1	1.9	317.9	55.1	2.1	0.1	6.2	28.5	0.0	0.8	15.9	0.0	0.0	0.0	15.4	0.6	37.8	177.1	0.0	0.0	0.0	0.0	167.2	1.7	0.0	0.1	18.3	1.5	9.6	0.0	0.2	0.0	0.0	0.0	0.1	6.4	0.0	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	11.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	83.6	0.0	0.0	0.0	0.7	1.3	0.0	130.9	135.9	0.0	4.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	1.3	0.1	1.9	6.2	28.5	0.0	15.4	0.0	9.6	6.4	0.0	0.0	12.2	0.0	2.5	0.0	0.0	0.0	0.0	89.3	0.1	0.1	0.4	2.8	0.6	3.7	41.7	0.0	0.0	34.4	25.4	0.1	6.6	0.1	0.0	1.8	410.3	0.0	0.3	0.9	0.1	0.1	0.0	0.4	0.0	0.0	1.1	67.2	0.1	3.3	0.4	67.8	0.0	1.3	0.0	5.4	0.0	2.5	0.0	0.0	0.0	45.1	0.0	0.0	0.1	0.2	31.8	0.0	0.0	0.3	391.5	429.5	0.0	498.9	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.1	1.3	0.1	88.7	0.2
EIF3CL		ENSG00000205609	"Eukaryotic translation initiation factor 3 subunit C like"	B5ME19	16	28379579-28403841	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 44.0;Cardiomyocytes: 35.1;Club cells: 37.9;Respiratory ciliated cells: 38.2"	"Group enriched"	"Detected in some"	5	"glioma: 0.8;ovarian cancer: 0.5;stomach cancer: 0.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA047097, HPA049495, HPA050112"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA047097: AB_2679930, HPA049495: AB_2680793, HPA050112: AB_2681020"	"unprognostic (1.22e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.75e-5)"	"unprognostic (6.56e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.59e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.58e-2)"	40.3	35.7	21.9	1.0	19.0	6.3	41.6	19.5	33.8	35.8	15.5	35.8	1.3	29.6	3.5	44.7	34.1	1.9	45.4	21.1	18.9	43.2	40.2	31.0	1.6	20.4	19.1	19.5	50.9	73.5	4.0	32.4	2.5	22.7	35.9	2.3	5.5	38.9	3.4	99.4	52.5	30.5	2.0	17.6	32.3	43.4	30.9	19.5	1.8	41.0	6.9	3.0	38.1	36.1	22.1	3.0	6.9	6.6	5.5	9.1	5.2	4.3	3.8	4.6	9.5	8.2	7.7	3.5	4.1	6.8	5.8	7.6	5.5	11.0	10.9	14.1	1.9	6.5	4.7	12.7	15.3	2.7	6.9	8.3	5.7	7.3	5.7	6.0	5.7	3.6	6.8	7.6	7.8	3.6	9.4	8.2	17.3	15.1	5.7	4.0	10.9	8.0	7.4	8.1	5.1	13.1	8.5	3.2	6.4	6.0	1.8	16.4	6.8	5.2	4.2	7.9	5.2	7.6	4.2	3.8	7.2	7.3	7.2	7.7	2.9	1.3	0.7	1.1	1.8	1.3	0.9	1.4	1.2	1.7	0.9	1.2	1.6	0.1	1.1	2.3	0.8	1.2	1.3	21.9	19.0	19.5	33.8	21.1	18.9	20.4	19.1	19.5	22.7	17.6	19.5	22.1	0.1	22.4	44.0	0.7	2.2	1.3	2.0	0.3	1.8	0.0	0.5	0.6	35.1	0.0	37.9	0.0	0.0	0.8	0.0	0.4	0.0	0.5	0.1	0.2	0.2	4.9	0.0	8.4	0.5	1.2	0.6	10.5	3.1	0.1	10.1	0.0	1.8	0.2	0.5	0.0	0.6	0.7	0.0	1.3	2.3	0.7	0.3	5.2	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.1	1.7	0.4	5.2	1.1	0.9	1.7	38.2	0.0	0.0	0.5	7.4	0.3	0.6	2.5	1.6	0.8	2.6	0.1	0.7	1.0
FOXA3	HNF3G	ENSG00000170608	"Forkhead box A3"	P55318	19	45863989-45873797	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"intestine: 17.7;liver: 65.1;pancreas: 48.6;stomach 1: 37.2"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 83.3;Gastric mucus-secreting cells: 152.9;Intestinal goblet cells: 230.1;Paneth cells: 74.7;Undifferentiated cells: 46.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 19.9;liver cancer: 26.4;pancreatic cancer: 20.7;stomach cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.5;Hep G2: 29.1;K-562: 23.5;OE19: 101.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB015154, HPA054034"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB015154: AB_647545, HPA054034: AB_2682349"	"unprognostic (2.88e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.11e-1)"	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.1	1.5	0.0	17.7	10.7	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.0	1.5	65.1	0.3	0.1	0.0	0.0	0.0	0.0	48.6	1.1	0.0	0.0	0.0	0.5	17.3	0.0	2.1	0.4	0.0	0.0	13.0	0.7	0.0	0.0	37.2	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.6	4.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	12.5	1.1	0.2	0.0	29.1	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.7	23.5	0.0	0.0	0.3	0.1	0.0	11.2	101.2	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	2.5	0.3	0.9	0.3	1.3	0.7	0.0	0.0	2.6	1.5	0.5	15.7	2.5	1.8	0.0	0.0	0.6	40.2	0.0	12.5	0.2	0.1	0.1	0.9	83.3	10.7	0.1	24.5	0.0	0.5	152.9	0.4	4.5	0.1	1.4	29.9	0.0	0.0	0.1	230.1	0.0	2.2	0.7	0.5	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.5	0.1	26.0	74.7	0.0	0.6	6.6	17.8	0.4	0.3	0.0	0.0	0.0	1.1	2.7	5.6	0.2	0.3	0.0	0.4	0.1	46.2	1.7
GUCY2C	"GUC2C, STAR"	ENSG00000070019	"Guanylate cyclase 2C"	P25092	12	14612632-14696599	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 68.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 34.4;Enteroendocrine cells: 176.7;Intestinal goblet cells: 56.0;Paneth cells: 97.9;Proximal enterocytes: 81.5;Undifferentiated cells: 47.6"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.9;stomach cancer: 9.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.4;CACO-2: 1.1;CAPAN-2: 1.7;SiHa: 1.6"	"Region enhanced"	"Detected in some"		"midbrain: 1.8"	"Low region specificity"	"Detected in all"			"HPA037655, HPA073759"	Uncertain		Uncertain	Vesicles		NA	NA			Vesicles		"HPA037655: AB_10672388, HPA073759: "	"unprognostic (1.08e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.67e-3)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (9.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.35e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.98e-1)"	0.5	0.2	0.3	3.4	0.3	0.5	0.0	0.3	0.1	0.0	2.5	37.5	68.8	0.3	0.0	1.9	0.0	0.9	2.2	0.2	0.6	0.4	0.3	0.2	0.4	0.3	0.3	0.0	0.0	2.3	0.0	0.0	0.2	0.3	0.3	41.8	0.1	0.6	0.0	0.7	0.9	67.0	1.4	0.6	0.2	1.9	0.4	0.3	0.0	0.5	0.0	0.3	0.5	0.2	0.5	0.4	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	1.6	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.3	1.1	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.2	0.3	0.3	0.3	0.1	0.2	0.6	0.3	0.3	0.0	0.3	0.6	0.3	0.5	0.0	0.0	0.0	1.3	6.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.0	0.0	0.1	0.1	0.0	0.0	176.7	0.0	1.4	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	56.0	0.0	0.3	0.3	0.2	0.0	0.3	0.0	1.0	0.3	0.0	0.0	1.0	0.2	0.4	97.9	0.0	0.1	0.0	81.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	47.6	0.0
HEPACAM2	FLJ38683	ENSG00000188175	"HEPACAM family member 2"	A8MVW5	7	93188534-93226469	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 97.1"	"Group enriched"	"Detected in some"	11	"Enteroendocrine cells: 218.2;Intestinal goblet cells: 387.5;Ionocytes: 349.9;Paneth cells: 318.1"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 8.4;pancreatic cancer: 10.7;renal cancer: 10.6;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	36	"SCLC-21H: 172.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA012381			Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	NA		210000	"Vesicles, Mitotic spindle"	Nucleoplasm	"HPA012381: AB_1853037"	"unprognostic (2.01e-3)"	"unprognostic (6.05e-2)"	"prognostic favorable (9.73e-5)"	"unprognostic (1.33e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (8.40e-3)"	"unprognostic (7.61e-2)"	"unprognostic (8.68e-2)"	"unprognostic (5.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.34e-2)"	0.1	0.1	0.1	2.3	0.0	2.6	9.0	0.0	0.1	0.0	0.0	64.9	30.3	0.0	0.5	0.1	0.0	0.2	0.1	0.0	0.0	15.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	4.4	0.4	7.3	0.2	0.1	0.8	97.1	0.0	2.6	1.4	0.0	0.0	48.4	1.5	0.1	0.1	10.2	3.2	0.1	0.1	0.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	172.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.7	0.4	0.3	1.1	0.7	0.0	0.0	15.1	6.6	0.2	0.0	0.9	5.5	0.0	0.0	0.0	17.2	9.8	0.1	2.5	0.0	0.0	0.1	218.2	18.7	0.5	0.0	0.0	0.1	27.5	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.6	387.5	349.9	0.0	0.0	2.4	0.0	0.0	7.2	1.0	0.0	0.0	0.0	0.0	2.2	0.0	318.1	0.0	0.1	0.9	11.5	0.0	0.3	0.0	0.0	0.0	0.1	5.6	1.2	0.0	0.1	0.1	0.1	0.0	19.7	0.3
HNF4G	NR2A2	ENSG00000164749	"Hepatocyte nuclear factor 4 gamma"	Q14541	8	75407914-75566834	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 115.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.8;Distal enterocytes: 51.0;Intestinal goblet cells: 32.3;Paneth cells: 54.3;Proximal enterocytes: 165.3;Undifferentiated cells: 36.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 8.5;liver cancer: 2.8;pancreatic cancer: 4.0;renal cancer: 4.6;stomach cancer: 10.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.3;CAPAN-2: 16.1;Karpas-707: 4.5;OE19: 10.0;PC-3: 4.8;THP-1: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005438, HPA010610"	Enhanced		Enhanced	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			Nucleoplasm	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA005438: AB_1850822, HPA010610: AB_2668318"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-2)"	0.2	0.0	0.4	2.5	0.4	0.0	1.0	0.3	0.3	2.3	0.1	20.8	101.4	0.4	1.2	0.3	1.0	12.3	0.0	0.3	0.3	17.5	13.0	0.2	0.1	0.5	0.4	0.2	0.0	5.6	0.0	0.0	0.1	0.3	0.6	19.8	0.0	0.4	0.4	0.0	0.0	115.6	0.9	0.4	0.1	8.2	3.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.4	1.1	4.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	16.1	0.0	2.2	0.0	1.8	0.0	2.0	0.0	0.0	0.0	1.8	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.3	10.0	4.8	0.0	0.0	0.3	2.7	0.1	0.3	1.6	0.3	0.1	0.0	0.2	0.2	5.5	0.0	0.3	0.1	0.1	0.0	1.1	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.3	0.3	0.3	0.5	0.4	0.2	0.3	0.4	0.3	0.4	0.0	0.0	1.1	39.8	0.5	0.0	0.6	0.4	2.2	0.0	1.3	0.5	0.2	17.2	1.5	3.7	0.0	0.0	0.0	51.0	5.9	3.2	3.1	3.6	0.2	0.0	16.3	0.0	0.5	4.3	0.0	0.1	8.2	3.2	0.0	0.0	0.0	10.7	0.0	0.0	0.6	32.3	2.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.2	0.6	5.6	54.3	0.0	0.0	1.6	165.3	18.5	8.1	0.0	0.0	0.1	0.4	4.8	0.0	0.4	0.0	0.0	0.2	0.0	36.9	2.9
IGLL1	"14.1, CD179B, IGL5, IGLL, IGVPB"	ENSG00000128322	"Immunoglobulin lambda like polypeptide 1"	P15814	22	23573125-23580302	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 70.5;testis: 25.4"	"Group enriched"	"Detected in some"	6	"Early spermatids: 78.0;Late spermatids: 140.7;Melanocytes: 119.2"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 0.5;lung cancer: 0.5;stomach cancer: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"memory B-cell: 12.0;naive B-cell: 14.8"	"Lineage enriched"	"Detected in many"	11	"B-cells: 14.8"	"Cell line enriched"	"Detected in some"	32	"REH: 787.7"									"HPA051134, HPA071406"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		48000000000	"Endoplasmic reticulum"		"HPA051134: AB_2681356, HPA071406: AB_2686393"	"unprognostic (6.21e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.91e-6)"		"unprognostic (1.08e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.17e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.2	0.3	0.2	70.5	0.0	0.3	0.4	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.1	1.4	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.4	0.2	25.4	0.2	10.2	0.0	0.0	1.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	24.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	14.3	2.6	0.0	0.0	0.0	787.7	0.3	17.3	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.1	6.2	0.0	0.0	0.3	0.3	0.0	0.6	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.8	0.2	0.2	0.3	0.4	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.4	0.0	0.0	0.0	0.8	0.3	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.9	0.0	78.0	0.2	0.3	0.3	0.0	10.5	0.3	0.0	0.4	0.6	0.0	0.5	0.0	0.2	0.7	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	140.7	1.2	0.4	119.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.3	0.0	6.2	0.0	0.0	0.0	1.5	0.3	17.1	0.6	0.0	0.3	0.0	17.9	0.1	0.0	0.2
ISL1	"Isl-1, ISLET1"	ENSG00000016082	"ISL LIM homeobox 1"	P61371	5	51383448-51394730	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 23.1;seminal vesicle: 19.4;vagina: 16.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 207.5;Cytotrophoblasts: 34.4;Enteroendocrine cells: 91.6;Horizontal cells: 43.7;Syncytiotrophoblasts: 34.2"	"Group enriched"	"Detected in some"	5	"cervical cancer: 1.1;pancreatic cancer: 4.1;prostate cancer: 2.1;stomach cancer: 1.6;testis cancer: 1.4"	"Group enriched"	"Detected in many"	4	"hypothalamus: 7.8;thalamus: 3.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"SH-SY5Y: 297.1"	"Group enriched"	"Detected in many"	8	"basal ganglia: 13.8;hypothalamus: 15.0;thalamus: 6.0"	"Group enriched"	"Detected in some"	9	"basal ganglia: 5.8;hypothalamus: 5.4"	"HPA048613, HPA057416"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Mitochondria"		NA	NA			Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA048613: , HPA057416: AB_2683431"	"unprognostic (4.97e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.41e-3)"		"unprognostic (5.52e-2)"		"unprognostic (6.79e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.77e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (9.11e-3)"	"unprognostic (4.39e-3)"	1.3	1.4	0.8	0.0	1.3	0.0	0.1	0.0	1.4	4.7	0.0	1.1	2.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.7	0.3	0.5	0.0	4.8	0.0	2.2	7.9	1.2	12.1	2.4	23.1	1.2	19.4	0.0	1.1	0.7	0.1	0.1	0.0	10.1	1.6	3.6	4.3	0.3	0.0	0.4	0.7	16.0	0.2	0.0	0.0	0.0	3.4	0.0	0.0	0.2	3.0	3.8	0.0	0.0	0.3	2.7	0.0	2.5	0.0	0.0	2.2	4.6	3.4	0.0	0.0	7.1	0.0	12.6	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.9	3.2	0.0	3.0	0.0	0.0	0.0	19.1	297.1	0.0	0.0	0.0	11.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.0	1.4	0.0	7.8	0.7	0.3	0.5	1.2	0.1	3.6	0.2	0.0	0.0	0.0	0.0	0.1	1.5	5.1	11.8	0.0	207.5	0.0	0.0	0.2	0.0	2.8	0.0	4.2	34.4	0.0	0.5	0.0	0.1	17.3	0.0	0.0	1.7	91.6	0.0	0.0	0.0	10.9	6.1	11.7	0.0	0.0	0.0	0.0	0.0	2.7	43.7	0.0	1.9	8.2	0.0	0.4	3.2	0.3	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	1.1	0.0	0.0	0.8	11.8	0.0	0.0	4.0	2.5	7.3	0.0	1.0	34.2	0.0	0.0	0.2	5.6
KIF26A	"DKFZP434N178, KIAA1236"	ENSG00000066735	"Kinesin family member 26A"	Q9ULI4	14	104138723-104180894	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.4;Endothelial cells: 11.9;Enteroendocrine cells: 7.7;Hepatic stellate cells: 13.9;Horizontal cells: 18.5;Spermatogonia: 8.1"	"Group enriched"	"Detected in many"	5	"stomach cancer: 3.8;testis cancer: 14.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 30.6;MCF7: 24.9;NTERA-2: 20.8;REH: 18.8;SCLC-21H: 19.2;SH-SY5Y: 39.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046882, HPA060346"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA046882: AB_2679856, HPA060346: AB_2684259"	"unprognostic (3.01e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.24e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (7.78e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.68e-3)"	4.5	2.3	2.1	0.7	1.3	2.0	4.7	0.5	1.5	4.0	3.0	2.6	0.4	2.4	0.2	1.5	2.6	0.4	4.6	0.8	1.4	1.9	0.7	2.2	0.3	1.0	1.1	0.8	4.1	5.7	0.3	2.9	1.8	1.2	0.9	0.4	0.1	1.0	0.8	3.0	2.6	1.9	0.4	0.7	4.2	1.8	2.9	1.8	0.2	1.5	1.0	0.1	2.0	2.1	1.1	0.0	1.7	1.0	3.9	0.0	0.0	6.7	0.3	0.0	0.0	0.0	3.1	0.0	0.0	5.3	0.0	0.7	2.5	3.1	0.0	0.0	0.0	4.9	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	6.7	0.0	0.0	0.0	24.9	0.0	0.0	20.8	0.2	2.0	18.8	7.9	2.0	0.0	0.0	19.2	39.3	4.4	0.6	0.0	2.5	0.4	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.3	0.5	1.5	0.8	1.4	1.0	1.1	0.8	1.2	0.7	1.8	1.1	22.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.3	0.1	3.2	0.0	0.0	1.8	0.0	1.0	0.0	1.3	1.9	0.7	0.4	0.2	4.4	11.9	7.7	4.8	0.5	0.2	0.8	2.1	0.0	0.2	0.0	0.4	13.9	0.2	2.6	18.5	0.7	2.6	0.0	0.3	1.1	0.1	0.0	0.1	1.8	3.7	0.0	0.2	0.0	0.0	0.1	0.2	1.0	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.7	0.7	0.2	8.1	1.2	1.7	0.4	0.1	0.3	2.8	0.0
KRT4	"CK4, CYK4, K4"	ENSG00000170477	"Keratin 4"	P19013	12	52806549-52814116	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"esophagus: 19918.5"	"Cell type enriched"	"Detected in some"	18	"Squamous epithelial cells: 5828.7"	"Group enriched"	"Detected in many"	5	"cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"HaCaT: 734.9;SK-BR-3: 361.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002154, HPA034881"	Enhanced		Supported	"Intermediate filaments"		NA	NA		600000000	"Intermediate filaments"		"CAB002154: AB_563803, HPA034881: AB_2674370"	"unprognostic (4.04e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (8.52e-3)"		"unprognostic (1.20e-1)"		"unprognostic (2.64e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.85e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.58e-11)"	"unprognostic (1.64e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (6.26e-4)"	1.3	1.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	246.0	0.0	1.0	0.0	1.2	0.0	19918.5	9.6	3.2	7.2	0.0	0.0	0.9	2.6	17.5	0.0	0.0	0.0	0.0	1.8	2.8	0.0	8.9	0.0	0.0	4.4	0.0	0.0	2140.9	0.0	2.6	3.2	1.7	0.9	0.0	1.6	8.7	0.8	0.0	2.0	1.0	0.1	1430.5	4.4	1048.7	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.8	0.0	0.1	0.0	734.9	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.5	1.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	1.4	0.0	0.2	0.0	15.5	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	1.0	361.6	0.0	0.0	2.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	1.0	0.9	0.5	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	3.3	0.0	0.0	0.0	6.5	36.9	23.3	0.0	0.5	2.9	0.5	0.0	308.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.2	2.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.5	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.9	6.9	0.0	0.1	53.7	0.0	0.0	0.0	5.3	0.0	0.1	5828.7	0.0	0.0	2.0	0.0	0.0	54.4
MOGAT3	"DC7, DGAT2L2, MGAT3"	ENSG00000106384	"Monoacylglycerol O-acyltransferase 3"	Q86VF5	7	101195007-101201038	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 24.6;liver: 19.0"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 81.9;Paneth cells: 56.3;Proximal enterocytes: 88.9;Undifferentiated cells: 26.3"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 11.0;liver cancer: 11.1;stomach cancer: 3.2"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"CACO-2: 2.9;Hep G2: 10.7"									HPA011940	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA011940: AB_1854057"		"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.14e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.20e-1)"	"unprognostic (9.54e-3)"		"unprognostic (9.36e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-1)"		"unprognostic (2.59e-2)"	0.1	0.1	0.5	1.7	0.5	0.9	0.1	1.3	0.8	0.0	0.4	9.1	24.6	0.2	0.2	0.2	0.1	0.2	0.1	0.5	0.2	1.2	19.0	0.1	0.2	0.3	0.2	0.7	0.0	0.2	0.0	0.0	0.1	0.7	0.1	7.3	0.4	0.1	0.1	0.5	0.4	24.0	0.8	0.2	0.2	0.2	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.0	1.2	0.4	0.1	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	2.9	0.8	0.1	0.4	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.4	10.7	0.1	0.2	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.0	0.1	0.2	0.3	0.1	0.3	0.4	0.1	0.0	0.3	0.4	0.4	0.1	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.6	0.6	0.1	0.6	0.3	0.2	0.1	0.0	0.6	0.3	0.8	0.8	0.2	0.3	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.4	0.2	0.3	1.6	0.5	0.2	0.3	0.1	0.1	0.5	0.5	1.3	0.8	0.5	0.2	0.3	0.2	0.7	0.7	0.2	0.3	1.2	0.3	0.0	0.5	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	81.9	0.0	0.1	0.0	0.1	0.2	0.1	1.8	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	1.1	7.4	0.0	0.0	0.0	14.7	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.3	0.0	0.0	0.2	88.9	5.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.1	0.1	0.5	0.1	26.3	0.4
MUC3A	MUC3	ENSG00000169894	"Mucin 3A, cell surface associated"	Q02505	7	100949534-100968347	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 14.0;intestine: 42.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 220.6;Intestinal goblet cells: 114.2;Paneth cells: 157.1;Proximal enterocytes: 360.1;Undifferentiated cells: 129.5"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 16.4;pancreatic cancer: 14.0;stomach cancer: 29.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.3;CAPAN-2: 2.4;MCF7: 1.6;OE19: 3.7"	"Region enriched"	"Detected in many"	7	"cerebellum: 16.5"					"HPA010871, HPA047868"	Uncertain		Uncertain	"Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cell Junctions"		"HPA010871: AB_1854201, HPA047868: "	"unprognostic (1.12e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.50e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.51e-2)"	0.9	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.4	0.0	0.0	9.5	42.1	0.0	0.0	0.0	0.0	14.0	2.0	0.0	0.6	0.1	8.7	0.2	0.3	0.1	0.1	0.0	0.0	0.6	0.8	0.0	0.0	0.7	3.1	12.0	0.0	0.1	0.0	5.0	0.1	33.8	0.8	0.0	0.1	2.7	0.1	0.1	10.0	0.8	0.5	0.3	0.4	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	7.3	2.4	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.6	0.0	0.0	1.0	3.7	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.1	0.1	0.0	0.7	0.0	0.1	0.2	1.9	0.0	0.0	0.0	0.2	0.0	27.2	0.0	0.0	0.0	1.0	0.4	2.1	28.6	0.0	1.8	0.0	0.7	0.0	220.6	0.0	18.8	0.8	0.0	0.1	0.8	10.3	0.0	0.1	28.8	1.1	0.4	15.8	0.0	0.0	0.0	0.4	5.3	0.3	0.0	0.0	114.2	0.0	0.8	0.0	0.4	0.3	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.1	28.9	157.1	0.0	0.0	65.7	360.1	0.3	0.0	0.0	0.0	0.4	6.4	0.8	6.8	0.0	0.1	0.3	0.4	0.0	129.5	21.3
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181308-135219173	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 35.5;breast: 20.3;intestine: 26.8;lymphoid tissue: 66.7"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 47.8;Erythroid cells: 83.2;granulocytes: 26.0;Intestinal goblet cells: 32.7;Ionocytes: 26.4;Respiratory ciliated cells: 37.2;Undifferentiated cells: 52.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.7;colorectal cancer: 16.4;stomach cancer: 5.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 4.6;eosinophil: 5.4;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 219.8;MOLT-4: 403.1;NB-4: 208.5;REH: 244.9;THP-1: 343.8;U-937: 186.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favorable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.2	0.5	1.7	5.3	1.6	35.5	20.3	0.1	0.6	1.6	0.4	25.5	11.0	1.0	0.1	3.1	8.5	1.0	0.1	0.3	0.4	0.1	0.4	2.0	6.3	0.8	0.8	0.3	0.0	0.3	3.7	0.0	0.4	0.7	1.5	26.8	0.3	0.6	0.9	0.1	3.0	9.5	1.4	0.3	1.2	2.1	0.7	0.4	66.7	0.1	0.0	7.1	1.2	1.3	0.2	1.8	0.3	1.9	3.0	0.0	0.1	0.3	1.0	0.6	1.1	1.1	0.3	1.4	10.9	0.4	0.3	0.4	0.9	5.6	0.0	0.7	18.0	2.5	138.8	1.0	0.5	0.1	219.8	105.1	0.0	0.1	0.6	0.0	0.5	0.3	133.4	114.6	20.1	1.1	11.6	403.1	208.5	1.5	19.2	1.7	244.9	5.9	33.2	0.3	1.5	10.5	6.9	0.5	10.4	0.6	0.5	7.9	343.8	0.4	0.3	1.6	7.9	2.4	27.7	7.7	66.0	0.1	186.1	2.3	4.6	0.7	5.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.4	0.2	1.7	1.6	0.1	0.6	0.3	0.4	0.8	0.8	0.3	0.7	0.3	0.4	0.2	0.2	0.0	1.3	0.0	2.3	2.7	1.3	1.3	0.6	0.9	47.8	12.6	0.4	2.8	7.1	0.0	0.0	1.4	9.1	18.1	0.0	0.0	0.1	24.3	0.3	0.3	17.6	83.2	0.6	0.8	0.4	0.5	4.6	2.2	26.0	0.4	0.0	0.0	1.1	0.0	2.7	32.7	26.4	1.2	1.7	0.2	0.0	2.1	8.8	0.0	2.8	0.9	0.0	0.0	0.2	0.1	10.2	0.0	4.6	2.1	2.3	0.0	37.2	0.0	0.0	0.6	0.9	0.0	1.8	10.2	7.0	0.3	3.6	0.1	52.0	2.2
MYH11	"SMHC, SMMHC"	ENSG00000133392	"Myosin heavy chain 11"	P35749	16	15703135-15857028	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Aortic aneurysm, Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 2272.9;seminal vesicle: 1681.4;urinary bladder: 2065.2"	"Group enriched"	"Detected in many"	8	"Peritubular cells: 1669.7;Sertoli cells: 624.5;Smooth muscle cells: 964.6"	"Group enriched"	"Detected in many"	5	"prostate cancer: 173.2;stomach cancer: 125.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;RPMI-8226: 1.4;U-698: 7.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"midbrain: 39.8"	"CAB002302, HPA014539, HPA015310"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		23000000	"Plasma membrane, Cytosol"		"CAB002302: AB_563902, HPA014539: AB_1234906, HPA015310: AB_1854261"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.21e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (1.10e-5)"	"unprognostic (1.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.45e-3)"	134.5	39.0	5.0	110.1	11.4	0.2	79.1	5.1	14.7	352.1	28.4	2272.9	96.2	1083.7	221.6	766.8	611.4	252.8	52.9	4.8	5.8	20.8	9.3	109.9	9.5	12.3	8.0	3.9	145.2	10.8	2.9	11.7	68.7	6.3	769.4	295.8	0.4	84.0	1681.4	41.5	55.4	491.6	1062.7	5.5	46.4	839.5	61.4	6.0	3.0	46.4	34.9	5.4	2065.2	316.9	6.8	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.9	0.0	0.2	0.2	7.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	5.0	11.4	5.1	14.7	4.8	5.8	12.3	8.0	3.9	6.3	5.5	6.0	6.8	7.6	0.0	1.8	0.0	4.4	13.3	2.1	1.7	5.7	2.7	5.3	122.3	40.5	0.0	1.9	0.0	8.4	0.3	3.4	0.4	0.0	0.2	50.2	4.7	19.5	12.8	1.2	0.8	0.8	0.4	0.3	22.2	0.0	3.4	0.0	27.3	6.4	0.1	1.1	0.0	5.2	0.5	0.0	2.2	17.3	46.2	42.9	2.8	12.4	15.9	3.7	0.3	3.1	1.5	10.7	0.4	0.2	1669.7	2.4	5.6	0.1	0.2	2.5	1.9	624.5	4.3	964.6	3.1	8.8	3.5	18.6	0.0	5.7	34.7	0.4	2.6
NPC1L1	SLC65A2	ENSG00000015520	"NPC1 like intracellular cholesterol transporter 1"	Q9UHC9	7	44512535-44541330	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 54.7;liver: 48.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 12.3;Hepatocytes: 44.7"	"Group enriched"	"Detected in many"	5	"liver cancer: 8.5;pancreatic cancer: 7.8;stomach cancer: 4.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 6.8;Hep G2: 17.9;SCLC-21H: 14.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB070127, CAB070128"	Enhanced					NA	NA					"CAB070127: AB_10002744, CAB070128: AB_10000815"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.59e-2)"	"unprognostic (8.08e-10)"	"unprognostic (1.64e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.83e-2)"	0.5	0.1	0.7	0.0	0.4	0.0	0.4	0.8	1.2	0.5	0.2	1.1	54.7	0.4	0.0	0.4	0.5	5.9	0.1	0.8	0.3	0.9	48.5	0.2	0.0	1.2	0.3	0.3	0.6	0.6	0.0	0.0	0.0	1.4	0.4	0.1	0.0	0.1	0.1	0.1	0.2	50.9	0.1	0.6	0.0	1.5	1.1	0.4	0.0	0.0	0.0	0.0	0.5	0.5	1.1	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	14.3	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.8	1.2	0.8	0.3	1.2	0.3	0.3	1.4	0.6	0.4	1.1	0.2	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.7	0.8	0.8	5.7	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.3	12.3	0.3	0.1	0.2	1.8	2.7	0.3	0.5	0.0	0.2	0.0	0.5	0.0	0.0	1.4	44.7	0.0	0.0	0.1	0.3	0.0	1.0	0.3	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.2	3.4	1.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.3	0.1	0.3	0.7	0.2	0.1
NPSR1	"GPR154, GPRA, PGR14"	ENSG00000187258	"Neuropeptide S receptor 1"	Q6W5P4	7	34658218-34878332	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.1;Early spermatids: 4.4;Excitatory neurons: 3.8;Inhibitory neurons: 2.2;Late spermatids: 2.1;Oligodendrocyte precursor cells: 1.0"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 2.3;pancreatic cancer: 2.0;stomach cancer: 2.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 6.2"							NA	NA							"unprognostic (3.56e-1)"	"unprognostic (9.34e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.00e-2)"		"unprognostic (9.35e-2)"			"unprognostic (6.34e-3)"			"unprognostic (2.85e-1)"	"unprognostic (1.36e-2)"		"unprognostic (2.08e-2)"	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.7	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.3	0.4	1.5	0.7	1.3	0.1	0.3	0.1	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0
PSAPL1		ENSG00000178597	"Prosaposin like 1"	Q6NUJ1	4	7430285-7434930	"Predicted secreted proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"skin 1: 93.8;stomach 1: 38.9"	"Cell type enriched"	"Detected in some"	13	"Gastric mucus-secreting cells: 41.8"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 0.7;melanoma: 2.5;pancreatic cancer: 2.0;stomach cancer: 3.0;urothelial cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 16.6;OE19: 32.2;RPMI-8226: 24.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038013, HPA038482"	Approved		Enhanced	Cytosol	"Secreted - unknown location"	NA	NA		31000	Cytosol		"HPA038013: AB_10673652, HPA038482: AB_2676037"		"unprognostic (2.64e-2)"				"unprognostic (2.40e-1)"		"unprognostic (9.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.52e-1)"		"unprognostic (2.08e-2)"	"unprognostic (2.75e-1)"		"unprognostic (2.63e-3)"	0.2	0.0	0.0	0.0	0.2	0.0	5.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	93.8	0.0	0.0	0.0	0.0	38.9	3.5	0.1	0.2	0.0	0.0	3.1	0.0	0.2	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.1	0.0	0.6	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.2	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0
SLC35D3	FRCL1	ENSG00000182747	"Solute carrier family 35 member D3"	Q5M8T2	6	136922301-136925660	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 3.4"	"Cell type enriched"	"Detected in single"	9	"Ionocytes: 8.2"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 3.3;stomach cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 15.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 29.6;olfactory bulb: 8.5"	"Region enriched"	"Detected in many"	6	"basal ganglia: 20.1"	"HPA030431, HPA067497"	Uncertain		Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA030431: AB_10601716, HPA067497: AB_2685854"	"unprognostic (6.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-2)"		"unprognostic (2.48e-1)"		"unprognostic (9.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.03e-1)"	0.0	0.9	0.3	0.0	2.2	0.2	0.0	0.0	1.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.0	1.1	2.0	0.2	0.0	0.4	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	15.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.2	0.0	1.2	0.0	3.2	1.1	2.0	0.2	1.7	0.1	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.1
SMIM24	"C19orf77, HSPC323"	ENSG00000095932	"Small integral membrane protein 24"	O75264	19	3473986-3480525	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"epididymis: 1594.7;intestine: 760.7;kidney: 852.8"	"Group enriched"	"Detected in many"	12	"Proximal enterocytes: 4096.4;Proximal tubular cells: 1884.8"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.7;pancreatic cancer: 37.4;renal cancer: 78.4;stomach cancer: 52.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 154.9;HEL: 74.0;Hep G2: 117.7;MOLT-4: 113.8;OE19: 185.0;REH: 61.5;U-937: 87.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA045046, HPA056027"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA045046: AB_10964444, HPA056027: AB_2683012"	"unprognostic (2.18e-4)"	"unprognostic (4.63e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.13e-10)"	"unprognostic (1.68e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.11e-2)"	0.2	0.0	4.7	2.7	5.2	92.1	0.8	4.6	6.9	0.6	6.0	30.5	760.7	0.8	1594.7	0.4	2.9	82.8	0.1	5.1	4.7	852.8	36.1	0.4	1.6	5.0	5.1	4.7	0.3	8.1	0.2	3.5	0.1	5.0	1.0	24.7	92.4	0.3	2.3	0.3	1.2	633.4	0.8	4.6	1.2	151.5	2.9	5.0	50.9	0.2	0.1	2.0	0.2	0.2	5.1	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.1	0.0	0.3	0.0	154.9	0.5	0.2	7.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	74.0	1.0	117.7	0.0	6.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	10.7	1.5	0.1	0.1	0.0	113.8	15.8	0.0	185.0	0.3	61.5	0.1	4.3	1.6	0.1	1.4	2.3	0.1	0.1	1.6	0.4	0.0	1.9	0.0	0.0	0.4	1.2	0.1	0.0	0.0	6.5	0.0	87.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.3	0.4	1.0	0.0	5.9	0.0	1.5	1.6	0.8	4.7	5.2	4.6	6.9	5.1	4.7	5.0	5.1	4.7	5.0	4.6	5.0	5.1	0.1	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.0	14.1	0.1	0.8	0.2	188.8	0.0	58.8	27.1	0.0	0.5	35.1	238.7	4.0	5.1	7.7	0.8	0.3	139.0	22.3	0.7	12.4	0.2	0.3	205.4	13.0	1.3	0.2	0.4	36.3	0.1	0.0	0.1	136.6	0.0	0.6	0.0	15.0	0.3	11.6	0.0	0.0	0.7	4.1	0.0	0.0	0.2	12.4	178.9	0.0	1.7	0.3	4096.4	1884.8	0.0	34.9	0.0	0.2	0.3	0.6	0.7	0.0	0.0	0.0	7.4	0.0	141.3	0.2
SYNPO2	MYOPODIN	ENSG00000172403	"Synaptopodin 2"	Q9UMS6	4	118850688-119061247	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 999.7;tongue: 497.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 135.4;Endometrial stromal cells: 130.0;Excitatory neurons: 149.6;Peritubular cells: 101.5;Sertoli cells: 131.5;Skeletal myocytes: 93.4;Smooth muscle cells: 206.1"	"Group enriched"	"Detected in all"	5	"prostate cancer: 25.7;stomach cancer: 27.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 57.8;LHCN-M2: 18.5;SH-SY5Y: 83.2"	"Region enriched"	"Detected in all"	4	"thalamus: 27.1"	"Low region specificity"	"Detected in all"			"HPA030665, CAB037231, HPA049707, HPA068563"	Enhanced		Enhanced	"Vesicles,Actin filaments"		NA	NA			"Vesicles, Actin filaments"		"CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.71e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.91e-4)"	51.6	10.9	6.8	47.8	5.9	0.3	36.2	5.9	8.8	54.7	8.5	253.5	34.6	138.2	33.6	199.0	90.2	50.4	66.8	11.0	36.5	8.8	7.1	16.3	10.6	7.8	4.8	1.4	39.3	3.9	3.6	7.5	21.0	6.0	182.1	58.5	1.2	16.1	270.0	999.7	14.5	76.1	246.6	10.5	10.3	127.3	6.7	6.7	14.4	16.1	497.9	6.6	228.4	54.5	11.7	0.2	4.2	0.2	0.0	10.5	3.5	0.7	13.4	14.1	0.4	0.5	0.0	0.7	1.5	0.1	57.8	0.9	0.2	0.4	0.3	0.7	5.9	0.1	0.8	1.3	0.0	2.4	0.1	0.2	14.5	0.3	4.0	0.2	3.7	0.2	0.2	0.0	0.7	18.5	0.3	0.7	7.2	1.4	0.0	0.0	0.5	1.5	0.4	0.2	0.3	0.4	83.2	0.4	0.3	0.1	3.3	0.0	7.0	0.4	0.6	0.1	0.2	0.1	0.1	0.3	0.1	1.1	0.6	0.2	0.8	0.1	0.5	0.2	0.0	0.4	0.3	0.4	0.2	0.0	0.4	0.4	0.3	0.2	0.3	0.1	0.0	0.5	0.1	6.8	5.9	5.9	8.8	11.0	36.5	7.8	4.8	1.4	6.0	10.5	6.7	11.7	25.5	3.2	1.1	42.7	1.1	13.5	17.9	3.7	46.1	2.5	6.3	30.7	135.4	0.0	0.3	1.8	0.0	1.4	0.5	0.1	0.0	0.1	2.2	6.9	130.0	11.3	0.0	1.7	149.6	1.8	0.5	41.5	0.5	10.6	0.0	16.1	13.9	0.4	1.4	0.0	31.5	0.2	0.0	0.9	11.4	7.0	27.1	3.8	5.4	76.8	12.9	0.0	0.0	6.0	3.0	0.2	0.4	101.5	0.8	24.9	0.1	0.3	2.5	0.5	131.5	93.4	206.1	1.3	0.5	5.3	8.1	0.8	2.6	33.4	0.2	4.0
SYT13	KIAA1427	ENSG00000019505	"Synaptotagmin 13"	Q7L8C5	11	45240302-45286341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.2;gallbladder: 21.0;pituitary gland: 16.9"	"Cell type enriched"	"Detected in many"	7	"Enteroendocrine cells: 336.8"	"Group enriched"	"Detected in many"	5	"breast cancer: 13.5;colorectal cancer: 7.4;pancreatic cancer: 19.9;renal cancer: 16.9;stomach cancer: 11.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 19.1;NTERA-2: 8.8;RPTEC TERT1: 56.8;SCLC-21H: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046224, HPA056602"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA046224: AB_10961288, HPA056602: AB_2683185"	"unprognostic (4.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (7.79e-5)"	"unprognostic (1.00e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.70e-2)"	"unprognostic (5.13e-2)"	0.1	4.7	4.9	1.5	12.5	0.0	0.2	1.5	30.7	0.0	0.0	12.4	12.7	0.2	0.0	0.0	0.2	21.0	5.2	15.7	14.0	9.0	0.3	0.5	0.0	6.8	8.3	17.3	0.0	7.1	0.4	16.9	0.0	12.2	1.9	12.7	11.4	1.9	0.0	0.1	0.2	12.9	0.8	0.0	0.1	11.1	1.7	9.0	0.3	1.6	0.1	0.0	0.0	0.0	31.2	0.0	19.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	1.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	8.8	0.0	0.2	0.0	0.0	0.0	56.8	0.0	15.0	0.7	0.0	0.0	0.1	0.7	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	12.5	1.5	30.7	15.7	14.0	6.8	8.3	17.3	12.2	0.0	9.0	31.2	0.0	0.0	0.0	4.6	0.1	0.0	0.2	0.0	0.0	3.3	0.1	0.3	15.3	17.2	0.0	3.7	25.0	0.0	0.0	10.2	5.9	1.2	3.1	0.4	0.2	0.1	336.8	0.0	41.6	0.6	0.0	1.7	3.6	2.0	0.0	2.5	0.0	0.0	0.0	1.7	43.8	37.3	4.1	0.0	0.0	9.7	0.3	0.0	0.0	5.6	0.0	0.7	0.0	1.5	3.5	8.2	14.3	0.0	0.0	2.3	13.9	0.5	0.0	2.7	0.0	0.0	0.2	2.0	0.2	0.0	0.0	0.0	0.0	0.0	32.8	0.2
TRIM31	"C6orf13, HCG1, HCGI, RNF"	ENSG00000204616	"Tripartite motif containing 31"	Q9BZY9	6	30102897-30113090	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 12.2;stomach 1: 6.0;urinary bladder: 8.6"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 409.1;Paneth cells: 404.9;Proximal enterocytes: 193.3;Urothelial cells: 227.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 6.7;colorectal cancer: 25.8;pancreatic cancer: 11.4;stomach cancer: 19.8;urothelial cancer: 12.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	726	"RT4: 294.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074175	Enhanced					NA	NA					"HPA074175: "	"unprognostic (1.37e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	12.2	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.3	12.2	0.1	0.0	0.0	6.0	3.3	0.0	0.0	0.0	0.0	0.0	8.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	294.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.6	0.1	12.3	2.5	0.0	0.0	0.4	0.3	5.7	4.3	3.0	0.0	0.0	0.0	0.2	409.1	0.0	2.7	0.2	25.7	0.2	0.4	5.4	2.7	0.0	1.7	0.0	0.3	73.9	1.1	4.5	0.0	0.0	0.0	0.1	0.0	0.0	52.3	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	404.9	0.0	0.2	2.7	193.3	0.6	14.2	0.0	0.0	0.2	0.5	1.8	0.2	0.0	0.0	0.0	0.8	0.0	25.6	227.9
UTS2R	GPR14	ENSG00000181408	"Urotensin 2 receptor"	Q9UKP6	17	82371400-82375586	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.6;testis: 3.2;thyroid gland: 1.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"stomach cancer: 0.7;testis cancer: 2.2;thyroid cancer: 1.1"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.2;U-266/70: 15.2;U-266/84: 2.7"															NA	NA						"unprognostic (1.55e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.26e-2)"		"unprognostic (2.30e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.73e-2)"		"unprognostic (1.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.84e-2)"		0.0	0.0	0.2	0.1	0.5	0.0	0.1	0.0	1.6	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.1	3.2	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	1.8	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	15.2	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	1.6	0.1	0.0	0.2	0.0	0.3	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BCL2L14	"BCL-G, BCLG"	ENSG00000121380	"BCL2 like 14"	Q9BZR8	12	12049844-12211084	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 15.7;stomach 1: 9.4;testis: 31.6"	"Group enriched"	"Detected in many"	6	"Early spermatids: 385.6;Late spermatids: 863.1"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 5.2;pancreatic cancer: 1.8;stomach cancer: 3.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.1;NTERA-2: 1.6;OE19: 2.0;RT4: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040665, HPA059846"	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA040665: AB_10964282, HPA059846: "	"unprognostic (3.65e-4)"	"unprognostic (4.95e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.70e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.59e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.79e-6)"	"unprognostic (3.83e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.73e-8)"	0.0	0.0	0.1	2.6	0.0	0.1	0.5	0.0	0.3	0.3	0.0	10.8	13.8	0.1	0.1	0.2	0.1	1.2	0.0	0.2	0.0	0.1	0.5	0.4	1.3	0.1	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.2	1.1	15.7	0.0	0.9	0.0	0.0	0.0	13.0	0.4	0.0	0.7	9.4	31.6	0.0	1.2	0.0	0.0	0.8	1.5	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.4	0.0	2.3	1.6	0.2	0.4	2.9	3.2	0.0	0.3	2.5	1.3	0.7	2.8	4.5	1.8	0.0	0.1	0.2	30.1	0.0	0.3	385.6	1.2	0.2	0.7	6.7	0.0	2.1	7.5	0.0	0.5	28.5	0.8	0.0	0.1	0.0	0.3	0.2	0.0	1.4	45.0	2.0	0.3	3.8	863.1	5.6	0.9	0.0	0.0	3.8	0.1	0.0	1.5	1.1	2.6	22.9	3.8	0.5	4.0	95.0	0.0	5.0	1.0	6.6	1.2	0.6	6.5	2.8	0.0	0.4	0.1	0.6	0.1	30.6	9.4
BPIFA2	"bA49G10.1, C20orf70, PSP, SPLUNC2"	ENSG00000131050	"BPI fold containing family A member 2"	Q96DR5	20	33161768-33181412	"Predicted secreted proteins"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1618	"salivary gland: 6917.3"	"Cell type enriched"	"Detected in some"	4	"Ionocytes: 649.0"	"Group enriched"	"Detected in some"	4	"lung cancer: 2.6;pancreatic cancer: 2.9;stomach cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.0;RT4: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044006	Enhanced				"Secreted to digestive system"	NA	NA					"HPA044006: AB_10963580"							"unprognostic (9.10e-3)"	"unprognostic (1.22e-1)"		"unprognostic (1.95e-1)"	"unprognostic (3.56e-2)"		"unprognostic (3.03e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.14e-4)"	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.8	4.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6917.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	49.3	0.0	0.0	0.0	0.0	0.2	0.0	145.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	649.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	17.3	0.0	0.0	0.0	8.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5
CCL25	"Ckb15, SCYA25, TECK"	ENSG00000131142	"C-C motif chemokine ligand 25"	O15444	19	8052318-8062660	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	1031	"intestine: 586.3;lymphoid tissue: 778.4"	"Cell type enhanced"	"Detected in some"		"Intestinal goblet cells: 149.1;Proximal enterocytes: 774.7;Undifferentiated cells: 399.3"	"Group enriched"	"Detected in many"	4	"liver cancer: 25.4;stomach cancer: 33.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 3.5"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;HEL: 2.1;NB-4: 2.6;REH: 6.1;RPMI-8226: 1.8;SH-SY5Y: 1.9"									HPA055883	Approved				"Secreted to blood"	NA	NA	183000000				"HPA055883: AB_2682955"	"unprognostic (9.22e-3)"	"unprognostic (3.13e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-4)"	"unprognostic (6.43e-2)"	"unprognostic (3.86e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.2	0.5	0.0	0.1	0.8	517.0	0.3	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.3	0.0	1.4	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	586.3	0.0	0.1	0.5	0.5	0.6	0.2	778.4	0.2	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.6	0.1	0.0	0.3	6.1	0.0	1.8	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.5	0.2	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.2	0.2	1.6	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	149.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	57.6	0.0	1.5	0.0	774.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	399.3	0.0
CEACAM6	"CD66c, NCA"	ENSG00000086548	"CEA cell adhesion molecule 6"	P40199	19	41750977-41772211	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 183.1;esophagus: 196.8;intestine: 222.5;lung: 289.2;salivary gland: 179.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 942.3;Club cells: 322.1;Distal enterocytes: 640.1;Paneth cells: 391.1;Urothelial cells: 182.3"	"Group enriched"	"Detected in many"	4	"cervical cancer: 139.4;colorectal cancer: 500.8;lung cancer: 344.1;pancreatic cancer: 437.5;stomach cancer: 231.8"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	11	"OE19: 1799.0"									"CAB008370, HPA011041"	Enhanced					NA	NA		86000000			"CAB008370: AB_592067, HPA011041: AB_1078481"	"unprognostic (1.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-4)"	"unprognostic (4.08e-1)"	"unprognostic (8.71e-3)"	"unprognostic (2.85e-1)"	"unprognostic (7.68e-2)"	2.1	0.4	0.3	30.0	1.0	183.1	2.7	0.5	0.6	19.2	0.0	196.9	33.3	0.6	1.8	196.8	8.3	131.3	0.2	0.2	0.0	0.3	0.7	289.2	0.3	0.3	0.1	0.1	0.4	5.3	0.1	0.3	0.5	0.2	2.4	222.5	0.0	179.1	1.4	0.1	6.2	24.6	6.7	0.0	2.4	15.7	0.4	0.2	2.2	0.3	0.0	32.7	9.7	79.7	0.5	0.1	162.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	5.5	4.6	0.0	0.2	0.0	0.5	19.4	0.0	0.0	0.1	0.3	0.2	0.0	0.5	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.1	11.2	0.1	0.2	0.2	1799.0	4.5	0.1	0.0	0.1	1.0	0.7	1.8	0.1	0.0	4.2	0.0	0.2	0.6	1.9	0.4	0.2	0.3	0.5	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.5	0.1	0.0	3.1	0.3	1.0	0.5	0.6	0.2	0.0	0.3	0.1	0.1	0.2	0.0	0.2	0.5	0.0	942.3	84.5	0.0	2.3	0.0	4.9	17.9	0.0	0.0	3.5	2.0	0.2	75.8	322.1	0.0	0.0	0.0	0.0	640.1	0.0	77.0	0.2	0.4	0.1	1.3	5.4	0.0	0.1	16.3	0.0	1.3	1.5	0.8	7.0	0.0	0.4	0.3	0.0	0.0	0.1	102.3	14.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	156.7	391.1	0.0	0.0	24.2	5.7	0.0	71.8	0.0	0.0	0.0	9.9	0.0	0.1	15.6	0.0	0.0	1.2	0.0	31.7	182.3
CHIA	"AMCase, CHIT2, TSA1902"	ENSG00000134216	"Chitinase acidic"	Q9BZP6	1	111290851-111320566	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Carbohydrate metabolism, Chitin degradation, Immunity, Inflammatory response, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"stomach 1: 330.2"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 2: 34.6"	"Group enriched"	"Detected in some"	4	"lung cancer: 1.8;stomach cancer: 2.0;thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"ASC diff: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059193	Approved				"Intracellular and membrane"	NA	NA					"HPA059193: AB_2683942"				"unprognostic (8.00e-2)"	"unprognostic (7.08e-2)"			"unprognostic (2.02e-2)"					"unprognostic (4.99e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"		0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.6	0.5	1.6	0.3	0.0	0.0	0.1	0.2	0.1	0.2	10.7	0.3	0.1	0.1	0.1	0.1	0.2	2.0	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.0	330.2	0.5	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	34.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0
CXCL5	"ENA-78, SCYB5"	ENSG00000163735	"C-X-C motif chemokine ligand 5"	P42830	4	73995642-73998677	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 36.2;salivary gland: 50.6"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 64.6;Ductal cells: 94.0;Macrophages: 222.6;Pancreatic endocrine cells: 245.4"	"Group enriched"	"Detected in many"	4	"pancreatic cancer: 56.2;stomach cancer: 74.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 191.9;EFO-21: 157.0;HSkMC: 111.4;hTEC/SVTERT24-B: 81.6;RPTEC TERT1: 603.6"									HPA065474	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	1110000	1600000	Vesicles		"HPA065474: AB_2685494"	"unprognostic (5.56e-3)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (3.72e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.30e-2)"	2.1	0.2	1.4	36.2	0.9	1.2	3.2	0.8	7.9	7.8	0.5	0.7	0.8	0.2	0.0	0.1	0.2	4.8	0.5	0.8	2.3	0.1	1.3	10.1	6.4	1.3	2.0	0.6	0.0	0.5	0.0	0.1	0.2	3.2	1.3	0.3	0.0	50.6	0.6	0.1	0.0	2.1	0.2	1.1	2.2	8.6	0.4	4.9	0.6	0.0	0.2	0.6	8.4	0.0	1.3	0.1	191.9	0.7	0.0	0.3	6.9	0.0	3.5	2.9	1.5	3.0	0.6	1.6	0.0	157.0	0.1	34.0	0.4	0.0	0.0	17.6	0.2	0.0	0.0	0.0	0.0	15.1	0.0	0.0	111.4	0.0	81.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	603.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.0	1.0	0.0	0.1	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.0	1.4	0.9	0.8	7.9	0.8	2.3	1.3	2.0	0.6	3.2	1.1	4.9	1.3	0.2	3.2	0.0	0.0	0.0	0.9	0.7	64.6	0.0	0.0	8.0	4.4	1.2	15.7	33.2	0.0	0.0	0.0	0.1	1.3	0.0	94.0	0.7	0.7	0.1	1.8	0.0	0.0	0.3	1.4	0.1	3.6	15.3	1.2	0.0	0.0	0.7	0.0	0.5	0.0	0.3	0.7	4.1	0.3	30.4	0.3	0.0	222.6	0.0	1.0	2.1	0.0	0.0	0.0	0.1	245.4	0.0	0.0	0.3	3.1	0.0	0.1	4.3	0.0	0.0	0.6	4.0	0.1	0.6	0.0	0.3	0.0	0.3	0.0	1.1	2.0
GABRP		ENSG00000094755	"Gamma-aminobutyric acid type A receptor subunit pi"	O00591	5	170763350-170814047	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 153.9;esophagus: 173.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 169.0;Breast myoepithelial cells: 113.2;Club cells: 83.1;Endometrial ciliated cells: 146.0;Glandular and luminal cells: 464.0;Urothelial cells: 146.6"	"Group enriched"	"Detected in many"	4	"breast cancer: 35.4;cervical cancer: 49.3;endometrial cancer: 16.8;pancreatic cancer: 41.9;stomach cancer: 25.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 11.8;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"A-431: 215.1;EFO-21: 236.8;HeLa: 166.8;PC-3: 331.3;SuSa: 418.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB014883	Uncertain					NA	NA					"CAB014883: "	"unprognostic (3.98e-3)"	"prognostic favorable (3.37e-4)"	"unprognostic (8.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.72e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.92e-3)"	"unprognostic (6.52e-3)"	4.5	3.6	13.5	7.3	13.5	10.0	153.9	21.1	19.6	8.7	5.4	4.3	15.5	49.1	19.2	173.1	13.0	27.5	5.4	12.5	12.4	6.1	7.2	14.8	5.7	13.2	9.6	5.5	3.9	24.0	2.0	2.0	9.1	15.5	12.8	5.0	42.5	36.0	16.8	13.8	19.1	16.3	2.7	3.3	7.4	27.6	8.3	14.1	4.7	6.2	2.7	42.6	5.4	29.7	22.3	215.1	9.9	10.1	7.0	0.7	4.3	23.8	3.8	1.5	0.5	0.6	38.1	23.6	3.3	236.8	1.1	2.3	75.7	6.4	0.5	0.6	3.5	7.6	14.1	166.8	5.7	0.8	5.1	11.2	1.6	3.0	2.8	1.8	8.0	1.4	13.4	57.6	26.5	0.4	6.7	9.5	4.7	84.5	3.7	331.3	13.7	6.6	8.2	13.8	11.6	8.2	4.0	76.5	3.9	2.2	418.8	4.2	2.4	8.8	19.1	69.3	15.7	15.7	10.0	6.7	6.3	2.6	13.9	2.9	11.8	1.9	6.1	0.4	1.5	1.1	0.3	0.4	0.3	0.6	0.7	0.5	0.5	4.5	0.2	5.7	0.9	0.6	2.3	13.5	13.5	21.1	19.6	12.5	12.4	13.2	9.6	5.5	15.5	3.3	14.1	22.3	1.1	3.2	0.6	0.0	0.9	0.0	14.9	44.4	0.0	0.0	169.0	113.2	0.7	51.5	83.1	1.8	0.0	5.2	2.3	0.0	0.0	10.4	0.0	146.0	48.8	3.8	0.0	0.0	0.3	13.8	0.6	2.4	2.0	464.0	0.0	0.0	0.0	0.1	2.3	0.0	0.2	0.3	12.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.6	0.1	0.0	0.0	24.2	0.1	0.1	34.0	0.0	0.0	0.2	5.9	0.0	0.0	4.5	0.0	5.7	2.7	0.0	0.6	146.6
GCNT3	"C2/4GnT, C2GnT-M, C2GnT2"	ENSG00000140297	"Glucosaminyl (N-acetyl) transferase 3, mucin type"	O95395	15	59594875-59640239	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 76.1;intestine: 144.2;salivary gland: 56.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 104.8;Distal enterocytes: 360.1;Ductal cells: 92.6;Glandular and luminal cells: 75.6;Paneth cells: 163.2;Proximal enterocytes: 85.5"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 16.4;pancreatic cancer: 29.8;stomach cancer: 20.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 147.4;EFO-21: 24.6;Hep G2: 30.3;OE19: 75.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011154	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA011154: AB_1078961"	"unprognostic (5.09e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.92e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (3.99e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (6.49e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.43e-1)"	0.2	0.7	0.3	12.0	0.2	0.5	0.4	0.6	0.4	19.4	0.2	144.2	98.4	2.0	0.0	16.0	4.2	76.1	0.1	0.2	0.1	6.2	0.4	0.7	0.9	0.2	0.2	0.1	0.1	2.1	1.0	0.1	0.1	0.3	1.2	124.4	0.1	56.3	0.3	0.2	0.3	124.3	4.7	0.1	0.1	26.1	4.4	0.2	1.3	2.1	0.0	10.7	9.2	30.2	0.4	0.1	147.4	0.0	0.2	0.0	1.0	0.2	0.1	7.7	0.0	0.0	6.3	6.0	0.6	24.6	0.0	9.5	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.5	30.3	0.0	0.2	0.2	0.3	3.5	0.7	0.0	0.1	0.0	0.2	0.0	0.4	1.4	0.6	0.1	0.2	0.2	75.9	0.3	0.4	0.0	0.6	10.2	1.2	0.2	0.2	0.0	0.2	0.4	0.1	0.1	0.0	0.1	0.2	0.4	7.3	0.1	0.2	0.5	0.8	8.9	0.3	0.1	0.9	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.7	0.2	0.1	0.3	0.1	0.0	0.3	0.2	0.6	0.4	0.2	0.1	0.2	0.2	0.1	0.3	0.1	0.2	0.4	0.0	0.0	2.2	0.0	1.0	0.0	18.3	8.9	0.0	0.0	0.5	0.0	0.7	11.5	40.5	104.8	0.0	0.0	0.1	360.1	0.0	92.6	9.8	23.3	8.6	0.3	7.8	0.0	0.0	14.9	0.0	0.2	27.5	75.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	26.9	8.2	0.6	0.0	19.2	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	58.4	163.2	0.0	0.1	8.0	85.5	4.4	9.8	0.0	6.6	0.6	1.5	3.0	0.3	1.4	0.0	0.0	0.8	0.0	48.5	52.4
GPR35		ENSG00000178623	"G protein-coupled receptor 35"	Q9HC97	2	240605430-240631259	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 82.8;granulocytes: 38.1;Intestinal goblet cells: 32.2;Langerhans cells: 35.7;Paneth cells: 38.6;Proximal enterocytes: 99.3;Undifferentiated cells: 31.1"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 20.7;pancreatic cancer: 6.9;stomach cancer: 9.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"classical monocyte: 36.3;eosinophil: 40.1;intermediate monocyte: 51.7;myeloid DC: 32.5;non-classical monocyte: 14.5"	"Group enriched"	"Detected in many"	16	"dendritic cells: 32.5;granulocytes: 40.1;monocytes: 51.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 20.7;CAPAN-2: 51.2;HDLM-2: 17.6;Hep G2: 33.6;HMC-1: 31.5;NB-4: 16.4;OE19: 38.7;U-937: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.05e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (2.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (2.59e-5)"	"unprognostic (7.03e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-3)"	1.9	0.8	5.4	4.3	4.1	4.5	2.4	3.7	5.8	4.3	2.3	18.8	41.4	3.8	1.2	2.5	7.4	5.9	2.6	4.7	4.1	5.0	1.6	3.4	1.7	4.7	4.2	3.6	5.4	1.8	0.2	6.7	0.5	5.4	4.6	16.7	2.0	1.6	1.0	7.0	2.6	38.5	1.9	3.7	10.4	15.9	5.5	4.8	1.8	3.0	0.3	1.0	3.0	2.7	5.7	0.1	0.5	0.3	1.1	0.9	0.0	0.4	0.1	0.3	0.1	0.3	20.7	51.2	0.3	0.2	0.2	0.7	0.5	0.0	0.0	0.1	17.6	0.7	8.7	0.5	33.6	0.4	0.4	31.5	0.2	0.1	0.6	0.3	0.4	0.1	1.3	0.3	2.9	0.0	0.7	0.4	16.4	0.8	38.7	0.2	1.9	0.1	0.5	0.2	0.2	2.0	0.8	0.0	0.1	0.4	0.5	0.2	5.9	0.7	0.2	0.2	1.4	0.1	3.5	1.6	0.2	0.1	18.2	0.4	0.1	36.3	40.1	1.5	51.7	2.6	0.0	0.8	0.8	32.5	0.1	0.5	1.2	0.4	0.8	14.5	0.6	0.3	13.6	5.4	4.1	3.7	5.8	4.7	4.1	4.7	4.2	3.6	5.4	3.7	4.8	5.7	0.6	0.0	4.4	7.8	1.6	2.0	0.1	0.2	0.0	1.4	0.4	0.4	1.2	2.8	0.3	1.8	0.0	0.1	5.1	82.8	0.0	0.9	0.1	3.1	0.6	0.4	6.7	0.0	1.9	3.3	0.0	0.3	25.0	3.1	38.1	0.8	0.4	0.3	10.7	1.7	2.1	32.2	0.0	8.5	35.7	0.0	0.3	22.3	0.0	1.9	9.7	0.2	1.0	0.5	1.5	14.1	38.6	1.2	1.2	0.0	99.3	3.7	0.9	2.5	0.0	0.2	0.9	1.2	0.6	0.1	1.1	0.3	8.0	0.1	31.1	0.3
HBA1	HBA-T3	ENSG00000206172	"Hemoglobin subunit alpha 1"	P69905	16	176680-177522	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 24541.9"	"Cell type enriched"	"Detected in many"	51	"Erythroid cells: 224916.4"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 2.6;glioma: 6.3;ovarian cancer: 2.6;stomach cancer: 2.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 142.6;plasmacytoid DC: 101.1"	"Group enriched"	"Detected in all"	5	"dendritic cells: 101.1;granulocytes: 142.6"	"Group enriched"	"Detected in some"	36	"HEL: 3355.8;K-562: 2416.8"									"CAB032534, HPA043780"	Enhanced					NA	NA		14000000000			"CAB032534: AB_2294993, HPA043780: AB_2678667"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.87e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.56e-2)"	563.6	184.5	89.5	82.7	213.9	24541.9	319.3	152.8	802.0	157.9	2244.8	128.0	10.7	41.8	2.4	246.9	353.9	60.6	1410.3	51.0	108.5	1386.9	1109.3	2221.0	5.0	164.5	327.4	35.4	161.1	101.4	5.2	469.4	2009.5	282.8	171.6	11.6	3.1	139.4	44.1	235.9	193.3	85.8	7.1	198.0	5572.2	137.1	105.6	283.2	20.9	614.3	1133.1	3.6	168.6	354.2	403.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	58.1	0.0	5.7	2.1	0.0	0.4	0.0	3.5	0.0	0.0	0.0	0.2	3355.8	0.0	37.1	0.0	1.3	0.0	0.3	0.0	0.0	0.7	0.0	0.0	1.7	2416.8	0.0	0.0	14.7	0.5	0.3	0.4	1.0	0.0	0.1	1.4	79.1	0.0	1.0	7.4	5.3	2.8	0.0	0.0	0.0	1.1	0.0	8.3	0.0	0.0	0.9	0.0	0.0	0.4	0.8	0.0	0.2	0.0	8.5	7.4	48.2	26.3	0.2	0.7	7.5	3.1	8.7	10.0	4.5	8.3	25.7	142.6	13.4	0.8	101.1	0.3	2806.3	89.5	213.9	152.8	802.0	51.0	108.5	164.5	327.4	35.4	282.8	198.0	283.2	403.4	72.7	0.0	0.0	0.0	56.8	10.6	0.1	0.0	0.0	0.4	11.3	12.3	1.8	55.8	0.1	0.0	0.0	0.0	93.2	3.2	7.9	0.0	6.0	0.5	0.5	20.4	1.2	224916.4	0.0	0.0	0.0	57.9	0.0	0.4	0.0	0.1	151.0	78.8	0.0	0.0	0.0	5.7	0.0	436.7	64.1	22.4	0.0	234.0	4338.2	0.0	12.7	1.3	1166.9	0.0	0.0	0.1	2.8	0.4	0.5	0.2	0.2	11.1	0.0	16.5	0.0	8.7	58.7	1.5	7.6	0.0	13.2	0.0	155.7	0.0	3.2	0.0
HNF1A	"HNF1, LFB1, MODY3, TCF1"	ENSG00000135100	"HNF1 homeobox A"		12	120978543-121002512	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	4	"intestine: 15.5;kidney: 16.2;liver: 35.0;pancreas: 9.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 14.5;Hepatocytes: 15.8;Intestinal goblet cells: 9.4;Paneth cells: 14.8;Proximal enterocytes: 33.4;Proximal tubular cells: 16.0;Undifferentiated cells: 10.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 4.5;liver cancer: 3.6;pancreatic cancer: 1.4;renal cancer: 3.6;stomach cancer: 4.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 8.9;CACO-2: 29.4;Hep G2: 32.5;OE19: 15.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010430, HPA035231"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB010430: AB_2116746, HPA035231: AB_2674528"	"unprognostic (5.92e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.12e-3)"	"unprognostic (6.18e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.77e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.48e-1)"		"unprognostic (6.93e-3)"	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	0.1	4.3	15.5	0.2	0.0	0.1	1.1	0.8	0.0	0.1	0.1	16.2	35.0	0.0	0.0	0.1	0.1	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.2	14.4	0.1	0.0	0.0	4.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.6	0.2	0.0	1.2	4.3	0.0	1.8	0.0	0.1	0.4	14.5	0.0	2.6	0.0	1.3	0.2	0.3	4.8	0.0	0.2	5.3	0.1	0.2	4.6	0.5	0.0	0.1	0.4	15.8	0.1	0.0	0.2	9.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.7	0.5	0.0	0.5	0.0	3.9	14.8	0.0	0.1	0.5	33.4	16.0	0.0	0.3	0.0	0.8	0.3	0.1	0.3	0.0	0.3	0.0	0.5	0.0	10.8	0.4
HSD17B2	"HSD17, SDR9C2"	ENSG00000086696	"Hydroxysteroid 17-beta dehydrogenase 2"	P37059	16	82035004-82098534	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 432.9;liver: 219.6;placenta: 384.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 155.8;Distal enterocytes: 203.4;Hepatocytes: 121.9;Paneth cells: 284.2;Proximal enterocytes: 390.7"	"Group enriched"	"Detected in many"	4	"liver cancer: 10.9;pancreatic cancer: 6.5;stomach cancer: 4.2;urothelial cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 57.9;Hep G2: 47.5;hTERT-HME1: 27.1;OE19: 87.1;RT4: 96.8;TIME: 54.0"	"Group enriched"	"Detected in some"	5	"midbrain: 2.2;pons and medulla: 3.4"	"Not detected"	"Not detected"			"HPA021826, HPA050235"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA021826: AB_10961148, HPA050235: AB_2681059"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-4)"	"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.83e-4)"	0.9	0.0	0.4	4.3	0.3	0.7	26.6	0.9	0.5	4.3	0.2	75.5	432.9	1.2	0.1	9.7	0.1	21.3	0.2	0.3	0.2	5.0	219.6	2.3	0.3	0.1	0.1	0.2	0.3	23.4	0.0	1.2	384.9	0.5	2.0	57.4	17.5	22.3	0.2	0.1	3.1	190.1	2.4	0.0	0.2	20.3	0.3	0.1	0.4	0.1	0.0	3.4	79.3	1.4	0.5	0.4	0.1	0.4	0.0	0.0	0.7	0.7	0.2	57.9	0.0	0.0	10.9	1.7	0.1	11.4	0.0	0.1	0.4	0.0	2.4	0.0	0.1	0.1	0.3	0.3	47.5	0.4	0.3	0.3	0.0	3.1	0.0	27.1	0.6	0.9	0.1	0.1	0.4	8.6	0.1	0.0	0.9	0.2	87.1	21.4	0.1	0.2	1.3	1.0	96.8	0.4	1.5	0.0	2.7	0.2	0.0	0.1	0.1	54.0	0.6	0.5	0.3	0.0	0.2	0.2	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.1	0.2	0.0	0.0	0.4	0.3	0.9	0.5	0.3	0.2	0.1	0.1	0.2	0.5	0.0	0.1	0.5	1.0	3.2	3.9	0.3	0.7	0.4	2.7	16.4	2.2	0.5	45.7	12.3	0.6	155.8	21.4	0.0	0.0	2.7	0.3	203.4	0.0	73.6	0.5	5.9	5.4	21.3	3.0	2.7	0.1	6.0	1.8	38.3	15.3	41.3	0.0	0.0	2.5	121.9	3.5	0.0	0.1	26.3	6.1	3.1	0.0	0.9	0.0	0.4	1.8	0.0	0.0	45.1	0.0	0.0	0.1	20.1	284.2	0.0	0.1	2.7	390.7	1.4	5.6	0.7	0.0	0.4	2.0	0.0	0.1	0.8	1.1	6.4	0.7	0.0	47.1	14.8
HTR1B	"5-HT1B, 5-HT1DB, HTR1D2, S12"	ENSG00000135312	"5-hydroxytryptamine receptor 1B"	P28222	6	77460924-77463491	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.9;placenta: 6.7;stomach 1: 5.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"pancreatic cancer: 0.7;stomach cancer: 0.8;testis cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"HUVEC TERT2: 79.4;TIME: 35.1"	"Region enriched"	"Detected in all"	4	"basal ganglia: 38.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 11.7"	HPA028808	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Plasma membrane"	"Endoplasmic reticulum"	"HPA028808: AB_2672782"	"unprognostic (3.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	0.8	0.6	1.9	0.4	5.7	0.0	0.2	0.0	3.9	0.7	0.0	0.1	0.1	0.5	0.0	0.0	0.5	0.5	0.0	1.2	1.2	0.3	0.0	0.4	0.0	1.2	1.8	1.2	0.4	0.1	0.0	0.2	6.7	1.3	0.2	0.1	0.3	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0.0	5.0	0.5	6.9	0.0	0.2	0.3	0.0	1.3	0.5	1.5	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	3.5	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.4	0.2	0.6	2.2	1.4	79.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	5.7	0.0	3.9	1.2	1.2	1.2	1.8	1.2	1.3	0.1	6.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668507-86736072	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	26	"heart muscle: 1079.8;skeletal muscle: 2973.6;tongue: 1825.5"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 1825.0"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.7;melanoma: 2.5;prostate cancer: 3.6;stomach cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 3.0;hTERT-RPE1: 3.3;SCLC-21H: 4.9;SK-MEL-30: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		750000	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA048955: AB_2680568"	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	9.2	1.4	12.9	2.8	35.5	0.4	6.6	26.8	32.4	9.6	1.7	26.0	2.4	15.2	5.0	55.0	17.4	3.1	1079.8	12.5	23.2	2.0	0.8	5.2	0.5	52.7	36.0	6.5	6.4	1.3	0.5	2.4	2.8	52.5	38.5	5.4	0.7	21.0	25.4	2973.6	4.0	8.9	23.9	32.2	0.6	9.1	4.8	30.8	0.7	5.2	1825.5	0.3	7.0	10.3	76.2	0.1	0.1	0.2	1.7	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.5	0.4	0.4	0.7	0.0	0.0	0.0	0.9	3.0	0.2	0.0	0.0	3.3	0.0	0.3	0.1	1.0	0.0	0.8	0.2	0.1	0.2	0.2	0.2	0.0	1.1	0.0	0.0	0.6	4.9	0.9	0.2	0.1	2.4	0.7	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.9	35.5	26.8	32.4	12.5	23.2	52.7	36.0	6.5	52.5	32.2	30.8	76.2	1.5	0.0	0.0	1.0	0.0	1.0	0.5	0.2	0.0	1.5	0.2	0.3	1825.0	0.0	0.2	1.8	0.0	0.1	0.0	0.0	0.0	0.0	23.4	0.1	0.4	15.5	0.0	0.0	4.5	1.1	0.0	31.5	0.0	0.2	0.0	0.9	0.0	0.0	0.1	0.0	2.6	0.0	4.1	0.0	1.2	19.6	11.1	0.5	1.8	1.9	0.0	0.7	0.0	1.5	245.1	0.1	0.0	6.8	0.0	0.3	0.0	0.1	0.1	4.1	39.5	48.0	54.9	1.0	1.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2
MUC5AC	MUC5	ENSG00000215182	"Mucin 5AC, oligomeric mucus/gel-forming"	P98088	11	1157953-1201138	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"stomach 1: 186.7"	"Cell type enriched"	"Detected in some"	248	"Gastric mucus-secreting cells: 10434.9"	"Group enriched"	"Detected in many"	4	"pancreatic cancer: 25.3;stomach cancer: 61.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"A549: 19.9;OE19: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002774, CAB009395, HPA040615"	Enhanced				"Secreted to digestive system"	NA	NA					"CAB002774: , CAB009395: AB_2146854, HPA040615: AB_2677042"	"unprognostic (2.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.51e-2)"		"unprognostic (4.56e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (8.46e-2)"	"unprognostic (5.83e-4)"	"unprognostic (1.84e-1)"	"unprognostic (9.21e-3)"	"unprognostic (4.07e-1)"	"unprognostic (1.37e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	186.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	13.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	17.4	0.0	0.1	5.4	0.0	0.0	0.1	0.0	2.7	0.0	42.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.8	0.0	2.8	10434.9	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	4.1	0.0	0.0	0.2	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.1	0.0	30.0	8.9	0.0	0.0	10.0	0.0	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.1	7.9	0.0	0.0	28.1
MUC6		ENSG00000184956	"Mucin 6, oligomeric mucus/gel-forming"	Q6W4X9	11	1012823-1036718	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"pancreas: 172.7;stomach 1: 413.2"	"Cell type enriched"	"Detected in some"	4	"Gastric mucus-secreting cells: 278.8"	"Group enriched"	"Detected in many"	4	"pancreatic cancer: 42.9;stomach cancer: 58.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"OE19: 1.7"	"Not detected"	"Not detected"							CAB002165	Enhanced				"Secreted to digestive system"	NA	NA		75000			"CAB002165: AB_442114"	"unprognostic (1.90e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.56e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.23e-2)"	0.2	0.2	1.5	0.0	0.6	0.0	0.9	0.4	0.7	14.1	0.0	1.6	15.8	2.1	0.9	5.3	2.5	0.3	0.1	1.0	0.0	2.5	5.4	0.2	0.0	0.2	0.0	0.8	0.2	172.7	0.0	0.2	0.0	0.9	4.4	0.0	0.0	0.1	28.2	0.1	0.1	0.1	0.0	0.0	0.3	413.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.4	0.7	1.0	0.0	0.2	0.0	0.8	0.9	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	11.3	2.8	1.7	54.3	0.0	9.2	0.0	0.0	0.2	0.1	0.0	12.2	0.1	0.5	0.1	0.1	0.0	0.0	1.2	19.1	0.0	0.1	278.8	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	59.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
NLRP6	"CLR11.4, NALP6, PAN3, PYPAF5"	ENSG00000174885	"NLR family pyrin domain containing 6"	P59044	11	278407-285388	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 40.2"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 9.9;T-cells: 2.6"	"Group enriched"	"Detected in some"	4	"colorectal cancer: 0.9;liver cancer: 1.2;renal cancer: 1.5;stomach cancer: 1.8"	"Region enhanced"	"Detected in some"		"cerebral cortex: 3.1"	"Group enriched"	"Detected in many"	4	"neutrophil: 15.4;non-classical monocyte: 4.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 15.4;monocytes: 4.6"	"Cell line enhanced"	"Detected in some"		"REH: 2.0;U-266/70: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043681, HPA048500"	Supported					NA	NA					"HPA043681: AB_2678614, HPA048500: AB_2680422"	"unprognostic (6.37e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.18e-2)"	"prognostic favorable (4.23e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.11e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.69e-2)"	0.7	0.0	0.1	2.2	0.2	0.6	0.2	0.2	3.1	0.1	0.6	0.4	40.2	0.2	0.1	0.1	0.6	0.3	0.1	0.1	0.9	1.3	2.6	0.9	1.2	0.9	0.3	0.0	0.0	0.5	0.0	0.1	0.1	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	38.4	0.1	0.3	3.6	0.3	0.2	0.2	0.3	0.1	0.1	0.3	0.3	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.6	0.0	0.2	0.2	0.4	0.1	0.0	0.0	2.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.8	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.3	1.4	0.3	1.6	1.1	0.1	0.1	1.8	2.3	15.4	1.0	4.6	0.0	0.0	0.7	0.1	0.2	0.2	3.1	0.1	0.9	0.9	0.3	0.0	1.0	0.3	0.2	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.7	0.0
PDX1	"IDX-1, IPF1, MODY4, PDX-1, STF-1"	ENSG00000139515	"Pancreatic and duodenal homeobox 1"	P52945	13	27920000-27926313	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 42.2;pancreas: 13.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 15.7;Ductal cells: 13.3;Enteroendocrine cells: 13.8;Exocrine glandular cells: 9.8;Gastric mucus-secreting cells: 4.6"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 8.4;pancreatic cancer: 8.6;stomach cancer: 7.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.0;HEK 293: 2.3;HeLa: 5.9;OE19: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025873, HPA059146"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB025873: , HPA059146: AB_2683927"		"unprognostic (2.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.75e-3)"			"unprognostic (7.10e-3)"			"unprognostic (3.83e-2)"	"unprognostic (1.65e-1)"		"unprognostic (1.04e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	42.2	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	4.0	2.3	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	15.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.3	0.0	0.0	0.0	0.0	13.8	0.0	0.0	9.8	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0
PIP5K1B	"MSS4, STM7"	ENSG00000107242	"Phosphatidylinositol-4-phosphate 5-kinase type 1 beta"	O14986	9	68705240-69009176	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 77.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 127.4;Early spermatids: 100.0;Inhibitory neurons: 270.1;Muller glia cells: 120.2"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 10.1;pancreatic cancer: 3.4;stomach cancer: 9.4;testis cancer: 3.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"eosinophil: 34.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 34.5"	"Cell line enhanced"	"Detected in some"		"AF22: 43.8;HEL: 17.0;Hep G2: 13.4;OE19: 73.1;U-266/70: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009687	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA009687: AB_1855391"	"unprognostic (2.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.03e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	3.6	12.0	5.4	6.1	5.2	16.3	4.9	18.0	8.0	6.3	77.5	31.5	35.1	7.5	1.7	1.2	6.1	4.0	32.5	12.2	8.7	7.9	0.3	13.0	2.7	8.1	10.9	4.0	1.0	8.7	13.8	6.7	6.5	7.7	3.1	29.4	38.4	16.5	9.7	2.9	2.1	31.1	2.9	3.8	2.6	26.4	24.9	9.1	1.0	1.2	5.1	3.6	3.3	2.5	6.8	0.0	0.0	43.8	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	4.6	0.0	3.6	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.8	17.0	0.3	13.4	0.0	0.9	4.4	0.0	2.0	0.0	0.0	0.0	0.1	0.5	0.9	9.3	0.3	1.1	0.1	0.2	2.3	73.1	1.4	1.4	0.1	0.3	0.3	3.4	0.9	0.1	0.0	0.1	0.5	1.0	0.2	0.1	0.1	0.0	0.4	0.1	0.0	17.0	3.5	2.3	0.0	3.1	0.0	5.6	0.5	34.5	0.0	0.0	0.0	4.7	0.3	0.1	0.1	5.4	0.7	0.1	1.7	0.0	0.2	1.4	1.6	0.3	5.4	5.2	18.0	8.0	12.2	8.7	8.1	10.9	4.0	7.7	3.8	9.1	6.8	3.6	35.3	34.4	28.7	19.2	0.6	3.2	0.5	0.6	5.1	4.7	3.3	61.6	2.8	2.8	5.5	2.1	21.3	0.0	127.4	27.4	1.6	100.0	12.8	13.6	3.3	37.0	53.6	84.7	14.0	1.3	3.1	40.2	27.5	5.7	3.8	1.4	0.0	3.9	0.0	270.1	32.6	14.2	1.0	1.3	47.6	2.5	5.6	5.4	60.0	2.6	120.2	0.0	80.9	6.4	5.2	46.6	1.5	43.2	2.5	39.2	1.4	6.5	3.3	26.3	2.5	32.2	39.0	4.5	0.7	0.3	8.8	2.1	0.9	29.7	9.8
RBP2	"CRABP-II, CRBP2, CRBPII, RBPC2"	ENSG00000114113	"Retinol binding protein 2"	P50120	3	139452884-139480747	"Metabolic proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	357	"intestine: 2738.0"	"Cell type enriched"	"Detected in some"	26	"Proximal enterocytes: 6095.4"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 7.1;pancreatic cancer: 4.5;stomach cancer: 8.4;testis cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"CACO-2: 78.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA035866	Enhanced		Approved	"Golgi apparatus"		NA	NA		140000	"Golgi apparatus"		"HPA035866: AB_10672232"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.72e-6)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.51e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	0.4	1.1	5.2	1.2	3.3	0.7	0.5	1.3	3.8	0.1	0.0	2.7	2738.0	2.1	0.0	0.2	0.3	1.8	0.2	3.2	6.5	2.6	0.0	7.6	2.2	6.9	6.5	3.5	0.3	3.1	0.0	0.1	0.1	3.6	0.4	2.4	2.2	0.1	0.0	0.2	1.1	1902.4	1.0	5.1	0.1	3.7	1.0	7.0	0.0	0.5	0.0	0.0	0.0	0.0	5.1	0.0	0.2	0.2	0.2	0.0	0.0	7.1	0.0	0.0	0.0	0.0	78.8	0.1	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.9	0.1	0.2	0.1	0.1	0.0	11.7	0.0	0.0	4.0	10.1	0.0	0.1	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.3	1.3	3.8	3.2	6.5	6.9	6.5	3.5	3.6	5.1	7.0	5.1	0.0	9.6	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	12.9	8.4	0.0	0.0	14.0	0.0	0.6	0.0	0.0	0.0	0.2	1.2	0.0	1.0	6.1	0.0	3.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	185.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.5	0.9	6.1	226.3	0.0	0.0	0.0	6095.4	0.0	0.7	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	142.6	0.1
RNF186	FLJ20225	ENSG00000178828	"Ring finger protein 186"	Q9NXI6	1	19814029-19815283	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 67.8;intestine: 132.3;pancreas: 43.8"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 41.6;Enteroendocrine cells: 86.6;Intestinal goblet cells: 46.6;Paneth cells: 123.4;Proximal tubular cells: 142.7;Undifferentiated cells: 110.3"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 18.5;renal cancer: 12.1;stomach cancer: 7.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"RPMI-8226: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034547, HPA035558"	Enhanced					NA	NA					"HPA034547: AB_10670975, HPA035558: AB_2674678"	"unprognostic (1.66e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.93e-3)"			"unprognostic (1.77e-3)"	"unprognostic (3.23e-1)"			"unprognostic (3.05e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.40e-1)"		"unprognostic (8.60e-3)"	0.3	0.0	0.0	5.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	18.8	132.3	0.1	67.8	0.0	0.0	0.4	0.0	0.0	0.0	26.1	0.8	0.0	0.0	0.0	0.0	0.0	0.2	43.8	0.0	0.0	0.0	0.0	0.3	15.5	0.0	0.3	0.4	0.0	0.0	45.2	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	5.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	41.6	5.9	9.6	0.0	0.8	0.1	0.1	86.6	0.0	0.0	18.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	123.4	0.0	0.0	0.1	16.1	142.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	110.3	0.2
SERPINA9	"CENTERIN, GCET1, SERPINA11b"	ENSG00000170054	"Serpin family A member 9"	Q86WD7	14	94462717-94479689	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"lymphoid tissue: 73.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	4	"stomach cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	66	"Daudi: 69.5"	"Region enriched"	"Detected in many"	16	"basal ganglia: 71.8"										"Secreted to blood"	NA	NA						"unprognostic (1.32e-2)"	"unprognostic (1.05e-1)"				"unprognostic (1.94e-2)"	"unprognostic (3.89e-3)"	"unprognostic (6.10e-2)"	"unprognostic (6.67e-2)"		"unprognostic (1.38e-2)"			"unprognostic (1.16e-1)"				0.0	0.0	0.0	13.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	1.7	0.8	0.1	0.0	0.3	0.2	0.0	0.0	1.4	0.0	0.0	73.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	69.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC6A19		ENSG00000174358	"Solute carrier family 6 member 19"	Q695T7	5	1201595-1225111	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"intestine: 143.6;kidney: 89.5"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 561.5"	"Group enriched"	"Detected in many"	4	"renal cancer: 7.9;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 14.3;HEL: 18.3;OE19: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037415, HPA043207"	Enhanced					NA	NA					"HPA037415: AB_10672346, HPA043207: AB_2678363"			"unprognostic (1.26e-1)"				"unprognostic (1.01e-3)"				"unprognostic (6.04e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (4.14e-6)"	"unprognostic (1.37e-1)"	"unprognostic (7.36e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	141.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	89.5	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	5.6	0.0	0.0	0.0	0.0	0.0	143.6	0.3	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	5.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	64.3	0.6	1.8	0.0	0.0	0.0	104.4	1.9	0.1	0.1	0.0	0.0	0.1	4.8	2.7	0.0	0.0	14.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	561.5	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	8.7	0.0
SMPX	"Chisel, Csl, DFN6, DFNX4"	ENSG00000091482	"Small muscle protein X-linked"	Q9UHP9	X	21705978-21758116	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	51	"heart muscle: 764.5;skeletal muscle: 1194.6;tongue: 1107.3"	"Cell type enriched"	"Detected in some"	22	"Cardiomyocytes: 807.6"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 7.2;stomach cancer: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"GAMG: 23.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA077360			Approved	"Plasma membrane"		NA	NA		62000	"Plasma membrane"		"HPA077360: AB_2732342"	"unprognostic (7.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.27e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-2)"		"unprognostic (2.67e-2)"	"unprognostic (2.82e-1)"		"unprognostic (8.38e-2)"	0.2	0.1	2.7	0.5	2.3	0.1	1.1	3.9	3.8	0.3	1.3	17.0	0.7	0.4	0.0	20.2	0.7	0.5	764.5	1.8	3.8	0.1	1.2	0.5	0.2	2.0	3.5	1.8	1.1	0.3	0.0	0.2	0.0	2.0	11.2	3.4	1.7	17.9	0.8	1194.6	0.3	4.1	12.7	1.6	0.1	7.3	0.2	6.1	1.5	0.3	1107.3	0.1	3.2	0.2	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.3	3.9	3.8	1.8	3.8	2.0	3.5	1.8	2.0	1.6	6.1	2.5	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	807.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.6	0.0	0.0	16.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	35.6	9.5	0.1	0.3	0.0	0.0	0.3	0.1	2.1	0.1	0.0
SPRR3		ENSG00000163209	"Small proline rich protein 3"	Q9UBC9	1	153001747-153003856	"Cancer-related genes, Predicted intracellular proteins"	Keratinization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 19659.3;vagina: 6111.4"	"Cell type enriched"	"Detected in some"	11	"Squamous epithelial cells: 987.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 206.3;head and neck cancer: 423.4;stomach cancer: 113.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.5;CAPAN-2: 5.8;hTCEpi: 9.7;OE19: 4.4;RT4: 12.6;TIME: 3.4"	"Not detected"	"Not detected"							HPA044467	Enhanced					NA	NA		5200			"HPA044467: AB_2678952"		"unprognostic (2.78e-2)"	"unprognostic (3.54e-1)"	"unprognostic (8.77e-2)"		"unprognostic (7.50e-3)"		"unprognostic (9.67e-3)"	"unprognostic (2.36e-1)"		"prognostic unfavorable (6.27e-5)"			"unprognostic (9.70e-2)"	"unprognostic (4.66e-2)"		"unprognostic (1.58e-2)"	3.7	3.5	0.0	0.1	0.0	0.0	3.0	0.0	0.0	2034.4	0.0	2.4	0.1	3.5	0.0	19659.3	3.4	38.5	7.4	0.0	0.0	2.5	5.8	1.7	0.0	0.0	0.1	0.0	4.4	8.8	0.0	11.1	0.7	0.0	3.4	0.1	0.0	3182.9	0.0	5.0	5.2	4.3	1.7	0.0	3.4	15.3	2.1	0.0	1.4	2.3	0.0	2420.4	65.8	6111.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	5.8	3.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.1	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.3	0.0	0.0	0.0	4.4	0.0	0.0	1.1	0.0	0.0	12.6	0.0	0.0	0.3	2.7	0.0	0.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.0	7.4	0.0	0.0	0.0	0.1	0.0	41.3	0.0	0.0	5.9	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.2	1.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.3	0.0	0.0	0.0	0.4	0.0	0.1	2.1	0.0	0.0	0.0	1.0	0.0	0.0	987.1	0.0	7.5	0.4	0.1	0.0	89.6
TACR2	"NK2R, NKNAR, SKR, TAC2R"	ENSG00000075073	"Tachykinin receptor 2"	P21452	10	69403903-69416918	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 127.2;stomach 1: 38.2"	"Cell type enhanced"	"Detected in some"		"Horizontal cells: 6.7;Kupffer cells: 2.4;Leydig cells: 2.8"	"Cancer enriched"	"Detected in many"	4	"stomach cancer: 6.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 4.2;U-87 MG: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA076573			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA076573: AB_2732313"	"unprognostic (2.83e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.72e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.88e-4)"	"unprognostic (5.59e-3)"	"unprognostic (4.31e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.32e-1)"	0.8	0.3	1.4	2.5	1.3	0.4	0.8	1.7	1.8	8.5	0.2	127.2	5.0	25.5	0.2	14.9	20.6	0.5	3.2	1.9	0.4	0.3	0.5	0.7	0.3	0.4	0.2	1.0	1.8	0.3	0.0	0.3	0.2	0.8	6.2	9.1	4.1	0.5	1.1	2.8	1.1	31.6	33.4	0.0	0.3	38.2	0.7	0.2	0.1	0.4	0.2	0.1	32.6	8.6	1.0	0.9	0.6	0.2	0.3	1.4	0.1	0.1	0.2	0.1	0.2	0.3	0.3	0.1	0.1	0.2	0.2	0.3	0.3	0.0	0.0	0.0	0.2	0.2	0.8	0.3	0.8	0.1	0.0	1.4	0.2	0.3	0.0	0.0	0.4	0.0	0.0	0.2	1.2	0.0	0.3	0.0	0.2	0.2	0.8	0.9	0.0	0.0	0.0	0.0	0.5	0.3	0.2	0.6	1.2	4.2	0.1	0.5	0.1	0.3	1.4	0.2	0.6	0.5	0.5	0.6	0.1	2.3	0.1	0.8	0.2	0.4	0.0	0.1	1.3	0.1	0.3	0.2	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.1	1.4	1.3	1.7	1.8	1.9	0.4	0.4	0.2	1.0	0.8	0.0	0.2	1.0	0.5	0.0	0.5	0.3	0.1	0.6	0.2	0.2	0.0	0.2	1.1	1.4	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.3	0.6	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.6	0.0	0.2	1.4	0.1	1.2	6.7	0.1	0.3	0.0	2.4	0.4	0.1	2.8	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.4	0.1	1.5	0.2	0.0	1.1	0.7	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.5	0.4
TMEM236	"bA162I21.2, bA16O1.2, FAM23A, FAM23B"	ENSG00000148483	"Transmembrane protein 236"	Q5W0B7	10	17752201-17800868	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"intestine: 33.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 81.1;Enteroendocrine cells: 23.4;Intestinal goblet cells: 28.8;Paneth cells: 48.1;Proximal enterocytes: 96.5;Undifferentiated cells: 19.0"	"Group enriched"	"Detected in some"	4	"colorectal cancer: 1.7;pancreatic cancer: 0.5;stomach cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"MOLT-4: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045096	Enhanced					NA	NA					"HPA045096: AB_2732516"	"unprognostic (4.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.54e-2)"	0.7	0.6	0.3	1.7	0.3	0.5	0.4	0.7	0.4	0.5	0.4	14.3	22.0	0.3	0.2	0.3	0.2	0.4	0.3	0.2	0.0	0.2	0.1	0.7	0.3	0.1	0.0	0.2	0.3	0.5	0.1	0.0	1.5	0.4	0.1	14.2	0.3	0.1	0.2	0.3	0.3	33.8	1.0	0.0	0.3	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.4	0.1	0.7	0.2	0.0	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.3	0.3	0.2	0.0	0.2	0.9	0.1	0.2	0.1	0.0	0.1	0.2	0.4	0.1	0.2	0.1	0.2	10.3	0.1	0.1	0.1	0.0	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.4	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.7	0.4	0.2	0.0	0.1	0.0	0.2	0.4	0.0	0.1	0.7	0.2	0.0	0.5	0.0	0.2	0.1	0.5	0.0	0.0	0.3	7.3	0.3	0.9	0.0	0.0	0.0	0.0	0.1	0.1	81.1	0.0	0.1	1.1	0.1	0.1	0.2	23.4	0.4	0.4	0.9	0.2	0.2	0.0	0.5	1.3	0.1	1.1	0.0	7.2	0.0	0.4	28.8	0.0	4.8	0.8	1.1	0.0	5.9	0.0	3.7	0.0	0.1	0.0	0.0	0.6	0.7	48.1	0.0	0.0	0.4	96.5	0.0	0.0	0.9	0.0	0.7	0.3	0.4	0.1	0.2	0.0	0.3	0.4	0.2	19.0	0.6
TRIM15	"RNF93, ZNF178, ZNFB7"	ENSG00000204610	"Tripartite motif containing 15"	Q9C019	6	30163206-30172693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 17.2;kidney: 5.9;liver: 14.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 139.1;Intestinal goblet cells: 41.5;Paneth cells: 332.0;Proximal enterocytes: 80.0"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 14.4;liver cancer: 5.6;pancreatic cancer: 7.7;renal cancer: 4.4;stomach cancer: 8.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HEL: 16.5;Hep G2: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047527			Approved	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA047527: "	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.71e-1)"		"unprognostic (5.36e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.57e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"		"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.7	17.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	5.9	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.7	12.3	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	11.5	0.0	0.0	0.0	0.0	0.0	139.1	1.9	1.8	0.0	0.0	0.1	0.0	0.0	2.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	332.0	0.0	0.0	0.0	80.0	21.5	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.5	0.0	29.1	0.0
TSPAN8	"CO-029, TM4SF3"	ENSG00000127324	"Tetraspanin 8"	P19075	12	71125085-71441898	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 960.1;stomach 1: 636.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1688.5;Ductal cells: 943.3;Intestinal goblet cells: 886.7;Paneth cells: 2225.8;Proximal enterocytes: 3546.1;Undifferentiated cells: 1583.9"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 283.9;pancreatic cancer: 156.9;stomach cancer: 194.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"OE19: 2160.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA022273, CAB026009, HPA044337"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB026009: , HPA022273: , HPA044337: AB_2678899"	"unprognostic (1.64e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.40e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.01e-3)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (9.66e-5)"	"unprognostic (1.88e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.97e-2)"	"prognostic favorable (7.36e-5)"	11.2	9.8	2.9	128.1	5.8	0.0	17.2	7.0	5.6	28.9	2.8	960.1	924.3	12.6	11.8	5.6	13.5	210.1	3.1	2.8	4.7	58.1	53.6	23.2	4.7	11.5	6.3	2.3	42.1	60.5	0.4	2.5	2.0	10.1	165.3	870.3	0.3	77.0	10.9	64.2	11.6	855.3	39.6	11.0	0.3	636.7	5.8	5.5	1.1	6.5	12.5	3.8	11.1	4.0	17.3	0.0	0.7	0.0	0.0	5.2	0.8	2.8	0.0	0.0	0.0	0.0	48.8	3.1	0.0	0.2	0.0	0.6	6.5	0.0	0.0	0.0	0.2	0.1	0.0	52.2	3.3	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.3	0.0	0.2	3.0	0.3	2160.7	173.3	0.2	0.0	4.9	34.1	41.0	4.1	7.7	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.3	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	5.8	7.0	5.6	2.8	4.7	11.5	6.3	2.3	10.1	11.0	5.5	17.3	0.8	0.0	2.2	0.0	6.1	20.8	32.5	14.0	0.6	0.3	8.5	1.8	0.3	346.0	76.7	44.1	0.0	1.2	0.0	1688.5	127.2	943.3	34.5	3.7	4.5	3.8	174.1	0.0	0.1	654.9	0.6	37.3	645.3	44.8	4.5	0.0	2.2	26.0	0.2	0.0	0.1	886.7	16.2	2.2	29.1	17.9	44.1	2.6	64.0	0.0	7.8	10.3	0.0	0.5	14.3	325.0	2225.8	32.0	2.2	376.2	3546.1	2.5	30.2	0.6	0.0	7.7	23.6	0.5	1.0	2.7	13.5	1.1	5.8	10.7	1583.9	46.0
VIL1	"D2S1471, VIL"	ENSG00000127831	"Villin 1"	P09327	2	218419121-218453295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Actin capping, Actin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"intestine: 439.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 243.8;Enteroendocrine cells: 113.6;Intestinal goblet cells: 143.6;Paneth cells: 216.2;Proximal enterocytes: 558.5;Undifferentiated cells: 161.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 56.4;stomach cancer: 23.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Group enriched"	"Detected in some"	97	"CACO-2: 762.5;Hep G2: 365.3;OE19: 321.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002452, HPA006884, HPA006885"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		6800	"Plasma membrane"		"CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.65e-2)"	0.5	1.1	0.0	10.4	0.1	0.3	0.8	0.3	0.2	0.7	0.0	177.5	398.6	0.5	0.0	0.9	0.7	28.4	0.8	0.0	0.0	26.2	31.7	0.7	0.3	0.0	0.1	0.0	1.1	29.6	0.0	1.4	0.3	0.1	1.0	185.7	0.0	0.6	0.5	0.4	1.0	439.9	8.2	0.0	1.2	6.9	2.0	0.0	0.0	0.6	0.0	0.0	0.8	0.9	0.2	0.0	1.5	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	762.5	0.5	0.1	5.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.3	365.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.1	0.0	1.7	0.8	321.9	0.0	0.0	0.0	1.4	0.0	0.2	0.3	0.7	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	4.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.0	1.3	0.8	0.4	0.1	0.0	1.8	0.3	0.6	0.5	24.3	0.1	0.0	2.1	0.3	0.8	243.8	3.9	12.3	1.9	1.3	0.9	0.4	113.6	3.2	0.7	42.9	0.2	0.8	6.6	1.6	8.9	0.3	0.7	32.6	0.1	1.7	0.5	143.6	0.0	2.2	1.5	0.5	0.0	5.1	0.0	0.0	0.2	0.5	0.0	0.0	0.3	10.9	216.2	0.0	0.3	0.9	558.5	35.1	0.0	1.2	0.0	1.7	0.7	0.8	0.8	0.6	0.9	0.3	1.5	0.0	161.8	0.3
AC243967.1		ENSG00000267881	"Novel protein, readthrough between CEACAM5-CEACAM6"		19	41708657-41756737	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	4	"intestine: 3.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.3"															NA	NA								"unprognostic (1.55e-2)"								"unprognostic (1.15e-2)"			"unprognostic (9.59e-3)"				0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.4	0.4	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACKR4	"CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1"	ENSG00000129048	"Atypical chemokine receptor 4"	Q9NPB9	3	132597270-132618967	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Fibroblasts: 21.4;Proximal enterocytes: 19.1;Respiratory ciliated cells: 15.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 2.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"BJ hTERT+: 285.1"	"Group enriched"	"Detected in some"	7	"cerebellum: 4.7;pons and medulla: 1.5"	"Low region specificity"	"Detected in all"			HPA054926			Approved	Vesicles,Mitochondria		NA	NA			"Vesicles, Mitochondria"		"HPA054926: "	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.27e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.55e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	7.6	1.4	0.6	1.0	0.2	0.8	5.6	0.3	0.4	0.6	0.7	1.8	15.9	3.7	1.7	1.5	2.0	6.6	5.1	0.4	0.3	1.1	1.0	8.1	2.1	0.4	0.4	0.1	1.0	2.6	0.0	6.8	0.2	0.2	0.5	1.3	0.6	7.1	2.0	0.5	8.5	13.1	2.2	0.4	1.6	10.3	0.4	0.1	0.5	1.4	1.0	1.7	4.7	1.1	0.3	0.2	0.0	0.2	0.2	19.9	10.7	0.1	47.7	285.1	2.8	7.9	0.2	0.4	3.3	0.0	29.9	0.2	0.1	0.0	0.0	1.8	1.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.0	1.3	0.0	0.0	4.9	0.1	0.2	0.6	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.2	0.0	0.5	0.1	0.7	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.4	0.4	0.3	0.4	0.4	0.1	0.2	0.4	0.1	0.3	1.6	38.5	1.1	0.7	0.1	6.5	0.6	1.3	0.0	1.6	0.3	0.3	0.7	1.5	2.3	5.5	6.2	0.2	0.1	1.1	0.0	0.2	2.9	2.9	0.6	3.9	0.0	0.0	0.6	12.1	0.1	21.4	10.7	0.6	0.0	0.7	9.7	0.2	0.4	1.7	0.5	0.8	0.0	0.3	5.1	0.4	2.1	0.3	1.8	1.9	6.8	0.9	0.0	0.0	0.3	5.1	0.1	2.6	0.5	0.4	19.1	3.0	15.7	3.4	0.0	1.3	2.6	0.1	0.1	0.6	6.5	0.3	0.5	12.5	3.7	1.2
ACTG2	"ACTA3, ACTL3, ACTSG"	ENSG00000163017	"Actin gamma 2, smooth muscle"	P63267	2	73892314-73919865	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 6240.2;seminal vesicle: 6298.2;smooth muscle: 8688.4"	"Group enriched"	"Detected in many"	4	"Breast myoepithelial cells: 394.2;Smooth muscle cells: 287.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 255.0;stomach cancer: 237.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"T-reg: 8.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 8.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 63.8;BJ hTERT+: 53.5;BJ hTERT+ SV40 Large T+: 214.8;HHSteC: 55.1;SuSa: 52.5;U-251 MG: 229.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"midbrain: 11.8;spinal cord: 4.7"	"HPA041264, HPA041271"	Supported					NA	NA					"HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (5.79e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.50e-1)"	"unprognostic (8.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (3.95e-7)"	"unprognostic (9.30e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.57e-3)"	191.4	37.5	2.5	731.4	3.1	0.0	139.7	2.4	8.9	448.4	12.1	6240.2	395.6	3653.5	125.6	1973.1	864.9	333.3	24.2	2.5	2.6	6.8	10.9	138.8	6.8	4.1	2.9	2.5	89.3	8.2	0.9	6.2	97.2	2.7	2269.1	1189.8	0.0	75.8	6298.2	16.5	78.7	1365.4	8688.4	2.5	16.7	2117.5	4.9	2.6	2.8	34.0	7.0	1.2	2939.0	673.0	2.8	0.7	0.3	20.5	0.3	0.0	0.0	63.8	13.5	53.5	214.8	38.6	6.7	0.0	0.3	0.9	0.0	0.4	0.1	36.9	0.0	28.3	0.1	0.0	0.0	2.9	0.5	55.1	0.2	0.6	0.5	0.3	29.0	0.0	1.5	0.0	0.2	0.0	0.0	0.5	0.0	2.9	7.9	0.2	0.0	0.1	0.2	0.4	3.1	0.5	13.6	0.6	2.3	0.3	2.8	1.2	52.5	0.0	0.3	0.0	1.1	2.3	2.5	229.9	0.1	0.3	0.8	0.7	1.0	0.9	0.2	0.5	0.3	0.2	0.3	0.1	0.1	0.8	0.3	0.4	0.1	0.4	0.5	0.1	0.2	0.4	0.1	8.6	2.4	2.5	3.1	2.4	8.9	2.5	2.6	4.1	2.9	2.5	2.7	2.5	2.6	2.8	3.5	0.0	0.5	0.0	0.4	4.5	2.7	0.5	0.6	0.0	9.8	394.2	14.6	0.0	0.1	0.0	0.0	7.4	0.7	0.0	0.0	0.0	5.8	2.8	1.5	3.1	0.0	0.0	0.1	0.0	36.8	74.1	0.0	4.8	0.0	1.0	22.9	0.3	5.4	0.0	0.1	0.0	0.0	0.0	10.4	26.6	0.3	1.0	7.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	10.8	0.0	0.4	0.8	0.0	6.6	1.8	287.8	0.2	3.2	0.4	7.7	6.4	1.7	8.4	0.0	3.7
ADGRG7	"FLJ14454, GPR128"	ENSG00000144820	"Adhesion G protein-coupled receptor G7"	Q96K78	3	100609601-100695479	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 43.3;liver: 24.9"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 23.9;Paneth cells: 14.0;Proximal enterocytes: 39.4"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 3.4"	"Region enhanced"	"Detected in some"		"white matter: 7.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA056451			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA056451: "		"unprognostic (1.65e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.79e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.71e-2)"			"unprognostic (9.37e-3)"		"unprognostic (2.84e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"		"unprognostic (6.77e-2)"	0.1	0.1	0.0	0.9	0.8	2.2	0.1	0.3	1.2	0.4	0.0	5.3	43.3	0.3	0.0	0.2	0.6	0.7	0.1	0.1	0.1	0.1	24.9	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	1.3	0.2	3.0	0.2	0.1	0.0	0.1	0.1	39.7	1.5	0.0	0.1	0.2	0.1	1.9	0.0	0.1	0.0	0.0	0.7	0.2	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	1.2	0.1	0.1	0.1	0.0	0.0	1.3	0.0	1.9	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.0	0.2	5.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.0	0.0	0.0	0.0	39.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0
AGR2	"AG2, HAG-2, PDIA17, XAG-2"	ENSG00000106541	"Anterior gradient 2, protein disulphide isomerase family member"	O95994	7	16791811-16833433	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 644.1;intestine: 1236.1;stomach 1: 1415.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 1515.8;Distal enterocytes: 1026.4;Gastric mucus-secreting cells: 2605.5;Intestinal goblet cells: 3710.4;Paneth cells: 1101.6;Undifferentiated cells: 1543.1;Urothelial cells: 1017.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 475.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	15	"OE19: 20084.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007912	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		38000	"Endoplasmic reticulum"		"HPA007912: AB_1844879"	"unprognostic (6.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (8.79e-5)"	"unprognostic (6.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.22e-3)"	2.1	0.8	0.0	67.2	0.0	0.0	73.0	0.2	0.4	644.1	0.0	775.3	490.4	14.2	392.6	16.4	309.1	278.3	0.1	0.0	0.0	11.1	0.9	51.2	0.6	0.0	0.1	0.1	0.3	22.3	0.1	31.7	1.6	0.0	229.3	1236.1	0.0	479.3	182.7	0.2	2.1	382.3	45.6	0.0	1.0	1415.0	0.9	0.0	1.8	7.4	0.1	7.3	162.3	4.0	0.4	0.3	265.5	0.0	0.3	0.0	0.1	2.6	0.0	0.0	0.0	0.0	43.5	39.7	0.0	0.2	0.0	6.6	25.2	0.0	34.5	0.2	0.0	0.0	0.0	0.9	3.8	0.0	0.0	1.0	0.0	88.5	0.0	11.4	0.4	0.4	0.3	0.0	0.0	0.2	44.7	1.3	1.8	0.8	20084.0	154.2	1.0	0.0	5.2	631.3	371.6	1.7	2.1	0.0	98.8	0.0	1.0	1319.9	0.0	0.0	0.7	1.2	0.9	0.2	1.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	1.1	51.3	293.1	0.0	19.0	2.8	127.1	539.8	0.6	0.0	169.3	137.4	0.2	268.8	1515.8	80.9	0.0	6.0	0.4	1026.4	0.0	74.1	4.6	301.9	33.9	4.8	522.1	0.0	0.1	835.1	4.5	6.0	2605.5	365.3	43.9	0.0	0.0	1.7	240.8	0.0	0.1	3710.4	386.6	0.8	0.3	0.4	0.3	6.5	3.6	0.0	1.0	0.0	0.0	0.0	0.0	303.1	1101.6	0.0	2.6	426.9	517.9	0.2	781.0	0.0	0.0	0.0	76.9	0.4	0.2	5.3	2.8	3.3	13.1	0.0	1543.1	1017.8
ASB4	ASB-4	ENSG00000005981	"Ankyrin repeat and SOCS box containing 4"	Q9Y574	7	95478444-95540233	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 47.5;skeletal muscle: 34.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 7.2;Cardiomyocytes: 3.2;Early spermatids: 2.3;Late spermatids: 2.0;Respiratory ciliated cells: 2.0"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.9;Hep G2: 7.9;SCLC-21H: 4.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 9.5;hypothalamus: 31.7"	"Region enriched"	"Detected in single"	10	"midbrain: 4.3"	HPA055240	Uncertain					NA	NA					"HPA055240: AB_2682753"	"unprognostic (1.41e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.24e-1)"	"unprognostic (9.13e-7)"	"unprognostic (1.71e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.23e-2)"	0.1	47.5	1.8	0.2	2.4	0.6	0.4	2.4	2.1	0.1	1.2	0.1	0.3	0.1	0.2	0.3	0.3	0.2	1.9	1.9	1.8	0.2	1.5	0.6	0.3	3.2	3.4	1.5	0.2	0.7	0.0	8.4	2.1	2.8	0.2	0.1	1.3	0.6	0.2	34.5	0.3	0.5	0.1	1.9	0.3	0.6	0.3	2.4	0.2	0.3	10.6	0.1	0.0	0.0	2.9	0.2	4.9	0.2	1.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.8	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	7.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	4.7	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.4	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	2.4	2.4	2.1	1.9	1.8	3.2	3.4	1.5	2.8	1.9	2.4	2.9	0.1	0.0	0.5	7.2	0.0	0.1	0.1	0.5	0.0	0.0	0.4	0.1	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	2.0	0.6	0.0	0.0	1.0	0.0	0.0	1.0	1.0	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.4	2.0	0.0	0.0	0.7	0.1	0.9	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.1
BARX1		ENSG00000131668	"BARX homeobox 1"	Q9HBU1	9	93951627-93955355	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"stomach 1: 167.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.0;Early spermatids: 2.6;Fibroblasts: 2.9;Smooth muscle cells: 1.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 19.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 29.5;HMC-1: 69.8;NTERA-2: 20.7;THP-1: 28.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055858			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA055858: AB_2682947"	"unprognostic (6.19e-4)"	"unprognostic (4.81e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (8.16e-6)"	"unprognostic (4.96e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.46e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.23e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (9.68e-13)"	"unprognostic (7.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.16e-2)"	7.8	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.5	0.0	0.3	0.0	0.8	0.4	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.6	15.2	1.5	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	167.9	3.9	0.0	0.0	1.0	0.5	0.4	0.0	0.0	0.0	0.0	2.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.6	0.0	4.3	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	69.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.4	20.7	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.3	5.8	0.0	28.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.9	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPIFB1	"bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP"	ENSG00000125999	"BPI fold containing family B member 1"	Q8TDL5	20	33273480-33309871	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 571.7;salivary gland: 273.3;stomach 1: 516.9"	"Cell type enriched"	"Detected in many"	5	"Club cells: 5748.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 75.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.7;OE19: 3.8;RT4: 2.2;SK-BR-3: 4.3"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 4.8"	"Low region specificity"	"Detected in many"			HPA024256	Enhanced				"Secreted in other tissues"	NA	NA		2700000			"HPA024256: AB_1845664"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-2)"		"unprognostic (3.67e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.36e-7)"	"unprognostic (3.30e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	0.1	0.1	0.1	0.0	0.3	0.0	0.9	0.0	0.2	571.7	0.0	0.2	25.9	0.0	0.0	47.5	0.1	3.5	0.0	0.4	0.0	0.0	0.1	113.5	0.2	0.2	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.1	1.2	0.0	0.0	273.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	516.9	3.5	0.0	0.2	0.0	0.0	1.2	8.3	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	3.8	0.0	0.4	0.0	0.1	0.0	2.2	0.0	0.0	0.0	4.3	0.0	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.6	22.7	0.0	0.0	1.3	1.4	614.0	0.0	0.0	2.0	1.3	0.4	2.8	5748.4	0.0	0.0	0.2	0.0	0.0	0.0	0.3	63.6	0.4	0.1	1.1	0.0	0.0	0.2	0.2	0.1	3.0	31.1	0.6	3.8	0.0	0.4	0.1	0.2	0.0	0.1	0.0	1021.3	0.0	1.9	82.9	0.3	1.5	1.8	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.7	0.0	2.0	0.0	0.0	1027.4	0.0	0.0	0.4	305.5	5.8	0.8	11.6	0.4	0.1	1.0	0.0	0.0	95.9
CCDC68	SE57-1	ENSG00000166510	"Coiled-coil domain containing 68"	Q9H2F9	18	54901509-54959461	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0;placenta: 32.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 95.2;Early spermatids: 95.4;Pancreatic endocrine cells: 87.9;Paneth cells: 68.7;Proximal enterocytes: 61.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 10.8;HHSteC: 13.6;HSkMC: 14.9;RT4: 10.5;TIME: 28.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA040865, HPA048197"	Supported		Approved	"Golgi apparatus,Cytosol"		No	NA			"Golgi apparatus"	Cytosol	"HPA040865: AB_2677176, HPA048197: AB_2680310"	"unprognostic (1.36e-2)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.65e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (1.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.38e-1)"	5.6	3.9	1.8	4.1	1.6	0.5	3.4	1.5	2.8	4.2	2.5	19.1	20.4	3.4	0.8	1.8	2.4	5.1	5.3	1.6	3.3	2.8	9.6	13.1	0.9	2.0	2.3	1.3	15.9	2.8	0.8	3.6	32.7	2.3	4.2	18.3	0.7	1.8	1.3	1.5	0.9	25.0	2.8	1.2	7.3	14.5	8.9	3.4	0.6	2.7	4.4	1.3	2.3	1.9	1.7	10.8	3.3	0.0	0.0	3.0	8.3	0.0	0.3	4.2	0.6	0.7	5.9	6.2	0.0	7.6	0.0	0.1	0.1	0.7	6.8	0.5	0.0	1.6	0.8	3.6	1.2	13.6	0.0	0.0	14.9	0.0	3.2	0.1	0.0	4.9	0.0	0.0	0.1	0.4	0.8	0.0	0.2	0.0	7.6	3.6	0.3	0.0	0.3	1.2	10.5	0.1	2.5	3.3	1.0	0.1	1.2	0.0	0.0	28.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.8	1.6	1.5	2.8	1.6	3.3	2.0	2.3	1.3	2.3	1.2	3.4	1.7	38.5	19.2	10.3	0.3	1.0	0.3	7.4	4.8	1.2	0.1	2.0	1.9	5.5	10.0	13.3	1.8	0.0	2.3	0.3	95.2	1.9	7.2	95.4	15.0	2.5	40.8	6.0	3.6	5.7	35.6	2.7	9.6	38.2	27.1	8.8	2.6	37.5	7.0	0.4	0.0	0.5	21.8	8.2	3.2	1.3	36.7	3.4	0.6	0.0	12.2	1.0	3.3	1.0	0.0	0.1	87.9	68.7	0.7	0.0	32.4	61.1	5.3	4.2	0.2	6.6	0.9	3.0	1.2	2.2	1.1	0.0	6.0	0.4	3.8	20.2	6.4
CCKAR		ENSG00000163394	"Cholecystokinin A receptor"	P32238	4	26481396-26490484	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"gallbladder: 29.4;stomach 1: 16.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Group enriched"	"Detected in some"	4	"amygdala: 1.4;hypothalamus: 2.6;midbrain: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 7.2"	"Region enhanced"	"Detected in all"		"midbrain: 12.6"	HPA073900			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA073900: "	"unprognostic (7.48e-2)"				"unprognostic (3.70e-2)"	"unprognostic (7.13e-2)"					"unprognostic (3.08e-2)"	"unprognostic (3.36e-1)"		"unprognostic (3.79e-1)"				0.0	0.0	1.4	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	29.4	0.0	0.6	2.6	0.1	0.0	0.0	0.0	0.7	5.3	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	16.7	0.1	0.7	0.3	0.0	0.0	3.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.3	0.6	2.6	0.7	5.3	0.2	0.7	0.3	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCL11	"eotaxin, MGC22554, SCYA11"	ENSG00000172156	"C-C motif chemokine ligand 11"	P51671	17	34285742-34288334	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 36.1;lymphoid tissue: 31.7;stomach 1: 35.4;urinary bladder: 41.4"	"Cell type enriched"	"Detected in some"	15	"Fibroblasts: 38.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 12.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"BJ hTERT+: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	88500					"unprognostic (4.61e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (8.70e-4)"	"unprognostic (8.18e-2)"		"prognostic favorable (1.99e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.64e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.72e-2)"	1.7	0.8	0.0	31.7	0.0	0.0	0.2	0.0	0.0	2.4	0.0	32.1	33.5	1.7	0.0	12.5	0.7	4.8	9.8	0.0	0.0	4.2	0.6	9.2	0.0	0.0	0.0	0.0	0.3	2.9	1.7	1.0	0.0	0.0	2.7	14.9	0.0	0.1	1.0	0.0	0.0	36.1	20.7	0.0	2.8	35.4	0.0	0.0	0.3	0.0	0.0	0.7	41.4	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	9.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	38.9	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.1	1.9	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.1
CEACAM18		ENSG00000213822	"CEA cell adhesion molecule 18"	A8MTB9	19	51478622-51490952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	26	"intestine: 10.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.8;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"CACO-2: 4.3;OE19: 3.5;RT4: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059487	Uncertain		Approved	Midbody		Yes	NA			Midbody		"HPA059487: AB_2684036"			"unprognostic (1.12e-1)"								"unprognostic (1.87e-2)"			"unprognostic (1.00e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHRDL2	BNF1	ENSG00000054938	"Chordin like 2"	Q6WN34	11	74696429-74731426	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 146.3;gallbladder: 107.0;lymphoid tissue: 116.8;smooth muscle: 123.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 194.1;Hepatocytes: 112.2;Skeletal myocytes: 533.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 14.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.4;PC-3: 1.3;SiHa: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA021771, HPA076522"	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		9700000	Vesicles		"HPA021771: AB_1846689, HPA076522: "	"unprognostic (2.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.41e-3)"	"unprognostic (9.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.33e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.58e-6)"	"unprognostic (8.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (6.08e-4)"	2.7	0.2	0.6	116.8	0.4	0.0	5.2	0.4	0.7	61.1	0.1	61.6	4.1	146.3	0.8	4.2	9.5	107.0	23.3	0.4	0.7	2.9	46.6	2.9	0.4	0.9	0.5	0.4	2.5	3.1	0.4	0.4	4.6	0.6	22.8	2.6	0.5	0.5	9.0	6.7	1.0	10.9	123.2	1.2	1.3	58.2	3.5	0.6	0.0	0.9	4.8	2.8	46.7	21.4	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.4	0.3	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.4	0.7	0.4	0.7	0.9	0.5	0.4	0.6	1.2	0.6	0.8	1.2	0.0	2.6	0.7	0.3	0.3	0.5	0.2	0.0	0.0	194.1	3.8	2.2	15.7	0.1	9.2	0.0	0.0	0.8	0.0	0.0	13.8	31.4	0.6	0.2	2.1	0.0	0.0	0.1	10.3	0.1	5.3	0.0	0.5	0.0	0.2	2.9	112.2	0.1	0.0	0.2	0.0	0.0	2.4	0.0	2.4	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.5	0.1	4.1	0.0	0.7	0.1	0.9	0.0	0.0	0.0	0.0	0.0	533.4	1.2	0.6	4.3	0.0	0.0	0.1	0.5	0.4	0.0	0.5
CHRM2		ENSG00000181072	"Cholinergic receptor muscarinic 2"	P08172	7	136868652-137020255	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 36.5;intestine: 14.9"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 59.9;Excitatory neurons: 49.4;Inhibitory neurons: 119.2"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 86.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022338, HPA029795"	Approved					NA	NA					"CAB022338: , HPA029795: AB_10601357"			"unprognostic (3.51e-2)"	"unprognostic (3.73e-4)"	"unprognostic (5.77e-2)"			"unprognostic (1.78e-2)"		"unprognostic (1.97e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.43e-2)"	"unprognostic (1.80e-1)"		"unprognostic (1.35e-3)"	0.1	0.2	2.6	1.3	1.7	0.1	0.0	0.1	3.3	0.3	0.0	14.9	0.7	0.4	0.0	0.3	0.3	10.8	36.5	0.5	2.6	0.0	1.1	0.8	0.0	8.1	5.7	1.0	0.2	0.1	0.0	0.0	1.5	9.2	0.2	3.5	0.8	0.0	0.0	0.0	0.1	4.4	9.7	1.5	0.0	5.9	0.6	7.9	0.1	0.0	0.0	0.0	9.0	0.6	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	17.6	0.2	0.0	0.0	0.0	0.0	0.0	86.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.7	0.1	3.3	0.5	2.6	8.1	5.7	1.0	9.2	1.5	7.9	10.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	59.9	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.2	0.2	0.0	0.0	49.4	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.4	0.1	0.1	0.0	119.2	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
CHRNA7		ENSG00000175344	"Cholinergic receptor nicotinic alpha 7 subunit"	P36544	15	31923438-32173018	"FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 7.9;intestine: 9.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 9.0;Gastric mucus-secreting cells: 26.0;Horizontal cells: 16.8;Inhibitory neurons: 30.7;Proximal enterocytes: 14.4"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.3;RT4: 12.9;SH-SY5Y: 8.3;SK-BR-3: 13.3;U-2 OS: 10.8"									"HPA029422, CAB033624"	Enhanced					NA	NA					"CAB033624: AB_784835, HPA029422: AB_10600863"	"unprognostic (3.43e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.61e-4)"	"unprognostic (6.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.36e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.41e-3)"	"unprognostic (2.43e-1)"	0.3	7.9	1.9	0.5	1.0	0.9	1.0	1.7	1.9	0.4	1.8	1.5	4.4	0.5	0.3	0.3	0.4	0.9	0.4	1.0	4.8	0.4	0.1	0.5	0.7	3.7	2.7	0.9	1.6	2.4	6.4	1.0	0.0	5.0	1.2	2.3	2.6	0.5	0.7	0.5	0.3	9.7	0.4	1.2	1.2	6.7	2.6	2.8	0.4	2.2	0.8	0.7	1.5	0.8	2.7	0.0	1.3	2.7	6.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	3.1	0.0	0.0	0.0	1.7	0.6	0.0	2.2	0.0	0.4	1.0	0.0	0.0	0.2	0.0	0.1	0.4	2.5	0.0	0.2	0.3	0.2	0.0	0.2	1.5	3.7	0.0	0.0	4.2	0.3	0.5	12.9	0.5	8.3	0.2	13.3	0.0	0.7	0.0	0.5	1.2	0.0	10.8	0.3	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.9	1.0	1.7	1.9	1.0	4.8	3.7	2.7	0.9	5.0	1.2	2.8	2.7	0.5	0.0	0.0	1.0	0.0	0.3	3.0	0.0	7.4	1.8	1.1	1.3	1.1	2.8	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.3	0.1	0.2	0.3	1.5	3.0	0.0	9.0	2.5	0.0	0.4	26.0	0.6	1.3	4.6	0.7	0.0	0.1	16.8	30.7	8.9	0.0	0.0	0.9	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.5	1.1	1.6	2.9	0.0	0.2	0.7	14.4	0.2	0.0	0.0	0.0	0.4	0.3	0.2	5.9	3.2	0.0	0.0	0.1	0.2	2.0	1.2
CNN1	"Sm-Calp, SMCC"	ENSG00000130176	"Calponin 1"	P51911	19	11538767-11550323	"Cancer-related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 1888.1;intestine: 1864.8;seminal vesicle: 1600.6;smooth muscle: 2227.2"	"Group enriched"	"Detected in many"	5	"Breast myoepithelial cells: 191.0;Early spermatids: 335.0;Late spermatids: 554.6;Peritubular cells: 221.2;Smooth muscle cells: 180.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 142.1;stomach cancer: 103.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 91.5;BJ hTERT+: 34.9;BJ hTERT+ SV40 Large T+: 48.0;BJ hTERT+ SV40 Large T+ RasG12V: 64.6;HBF TERT88: 71.2;K-562: 35.8;SuSa: 72.5;U-2 OS: 34.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000007, HPA014263"	Enhanced		Approved	"Actin filaments"		No	No			"Actin filaments"		"CAB000007: AB_2082148, HPA014263: AB_1847039"	"unprognostic (4.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (5.43e-6)"	"unprognostic (1.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.78e-3)"	"unprognostic (6.11e-3)"	112.7	59.0	5.7	162.0	6.7	0.0	90.5	5.1	14.3	354.9	12.5	1864.8	137.5	1888.1	178.5	683.9	661.4	236.4	234.2	6.0	7.1	21.9	10.6	99.6	7.3	7.0	6.3	5.5	115.1	24.4	3.0	9.0	28.7	6.6	681.8	329.4	0.7	62.1	1600.6	21.9	48.8	435.0	2227.2	5.4	22.3	679.4	92.1	6.3	2.6	38.8	11.8	0.9	1398.2	308.3	5.9	0.1	1.3	5.9	1.0	0.6	0.2	3.2	91.5	34.9	48.0	64.6	27.9	0.0	0.4	2.7	26.1	4.4	0.3	0.0	0.0	71.2	0.0	0.2	0.1	0.1	2.3	2.5	0.0	0.4	3.0	0.1	28.7	0.1	1.6	0.0	0.0	35.8	0.0	0.0	0.0	0.3	3.8	2.9	0.0	0.7	0.2	0.6	3.8	0.0	0.0	0.1	1.3	0.1	0.2	0.2	72.5	0.1	0.1	0.4	0.4	34.6	1.2	1.2	0.1	0.4	0.1	3.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.7	6.7	5.1	14.3	6.0	7.1	7.0	6.3	5.5	6.6	5.4	6.3	5.9	2.4	0.0	0.0	0.0	0.2	4.8	4.1	1.6	0.6	0.0	4.2	191.0	51.4	0.0	0.3	1.8	0.0	0.8	0.7	0.0	0.0	14.5	335.0	3.1	20.7	2.4	0.0	0.0	0.5	0.4	1.0	21.5	0.5	0.7	0.0	0.5	6.8	0.0	2.3	0.0	0.3	0.0	0.0	0.0	9.4	554.6	8.4	0.9	3.6	2.8	0.6	0.5	0.0	0.0	0.1	0.9	0.0	221.2	0.0	4.0	0.0	0.4	0.4	0.0	39.5	1.1	180.9	8.3	19.5	0.4	7.1	0.7	1.1	0.7	0.0	1.1
CR2	"C3DR, CD21"	ENSG00000117322	"Complement C3d receptor 2"	P20023	1	207454230-207489895	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 175.4"	"Group enriched"	"Detected in some"	17	"B-cells: 54.9;Plasma cells: 14.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 7.1;stomach cancer: 5.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 17.5;naive B-cell: 20.3"	"Lineage enriched"	"Detected in many"	8	"B-cells: 20.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 24.0;JURKAT: 4.0;MOLT-4: 13.4;RPMI-8226: 4.7"	"Not detected"	"Not detected"							"CAB002659, HPA052942, HPA060715"	Enhanced					NA	NA		220000000			"CAB002659: , HPA052942: AB_2681994, HPA060715: AB_2684349"	"prognostic favorable (6.90e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.35e-2)"	2.0	0.0	0.1	53.6	0.1	0.8	0.6	0.0	0.2	0.0	0.0	5.2	0.9	0.4	0.0	0.7	0.1	2.0	0.2	0.2	0.1	6.2	0.4	1.1	175.4	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.1	1.1	4.0	0.0	4.3	0.0	0.2	0.0	16.9	0.4	0.0	73.9	7.0	0.5	0.1	15.4	0.8	0.0	172.4	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.1	13.4	0.0	2.1	0.0	0.3	0.0	0.2	4.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	17.5	1.0	0.6	0.0	20.3	2.4	2.2	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	54.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.2	1.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	14.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	1.0	0.1	0.0	0.0
CT83	"CXorf61, FLJ20611, FLJ22913, KK-LC-1"	ENSG00000204019	"Cancer/testis antigen 83"	Q5H943	X	116461686-116462976	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 64.5"	"Group enriched"	"Detected in some"	153	"Early spermatids: 817.7;Late spermatids: 3229.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 7.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 77.6;OE19: 77.0;RPMI-8226: 25.6;U-266/70: 108.5;U-266/84: 61.5"					"Not detected"	"Not detected"									NA	NA													"unprognostic (1.59e-2)"						"unprognostic (1.69e-2)"	"unprognostic (8.70e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	64.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.2	0.0	0.0	0.0	0.0	0.0	77.0	0.8	0.0	0.0	25.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.1	0.0	108.5	61.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	817.7	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3229.1	8.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	13.2	7.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2
CTSE		ENSG00000196188	"Cathepsin E"	P14091	1	206008535-206023909	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 1178.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 105.8;Exocrine glandular cells: 262.8;Gastric mucus-secreting cells: 553.5;Pancreatic endocrine cells: 260.0;Paneth cells: 208.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 297.4;stomach cancer: 200.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	46	"OE19: 1799.1"	"Not detected"	"Not detected"							"HPA012674, HPA012940, CAB032687"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"CAB032687: AB_637901, HPA012674: , HPA012940: AB_2668773"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.72e-2)"		"unprognostic (1.35e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.61e-2)"	"prognostic favorable (5.26e-5)"	0.1	0.0	0.2	9.6	0.1	30.3	0.1	0.4	0.3	0.0	0.1	15.5	231.9	0.3	1.7	0.8	1.2	15.1	0.2	0.1	0.1	0.2	0.2	50.2	0.5	0.3	0.1	0.1	0.1	3.7	0.0	1.2	1.3	0.3	0.2	26.0	0.1	0.0	1.6	0.0	0.1	56.0	0.3	0.1	0.6	1178.9	0.1	0.2	0.5	9.0	0.0	10.8	5.8	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.8	0.8	0.0	3.8	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.2	2.4	0.0	1.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.8	1.5	0.7	1799.1	0.1	0.4	0.0	0.8	0.7	39.4	0.2	0.5	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.2	0.5	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.6	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.4	0.3	0.1	0.1	0.3	0.1	0.1	0.3	0.1	0.2	0.5	0.0	105.8	27.9	0.0	0.6	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.5	10.0	42.3	0.0	0.0	0.0	0.0	34.1	0.0	52.0	0.0	0.3	0.0	0.3	2.4	60.6	0.0	262.8	0.1	14.7	553.5	0.6	0.0	0.0	0.0	0.2	0.2	0.0	0.0	21.1	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	1.6	0.0	0.0	0.0	0.1	260.0	208.9	0.0	0.7	0.1	4.0	0.1	7.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	10.4	0.4
CXCL3	"CINC-2b, GRO3, GROg, MIP-2b, SCYB3"	ENSG00000163734	"C-X-C motif chemokine ligand 3"	P19876	4	74036589-74038807	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 21.0;cervix: 20.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2244.7;Club cells: 738.5;Ionocytes: 724.2;Langerhans cells: 2366.2;Macrophages: 718.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.4;stomach cancer: 18.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 48.5;hTEC/SVTERT24-B: 75.0;RPTEC TERT1: 43.8"														"Secreted to blood"	NA	NA	28700					"unprognostic (2.12e-3)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.97e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-6)"	"unprognostic (2.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.20e-1)"	21.0	1.0	0.6	14.6	0.4	15.9	1.6	0.3	2.0	20.9	1.0	4.1	0.7	0.8	0.0	1.0	1.3	7.0	4.5	0.4	1.5	1.4	3.9	15.9	0.7	0.6	0.5	0.3	1.0	1.8	0.1	0.5	0.6	0.5	1.7	9.3	0.1	5.9	0.3	0.5	0.5	2.6	1.6	0.4	2.0	9.0	0.3	2.2	2.1	0.7	1.1	0.7	16.1	0.6	0.6	0.5	3.7	1.5	0.0	0.8	1.4	0.0	5.3	48.5	1.3	2.9	0.1	5.9	0.0	5.2	0.0	17.6	0.2	0.3	1.7	10.5	0.0	0.0	4.1	0.6	0.0	5.7	0.5	0.0	1.1	1.2	75.0	7.3	1.2	1.1	0.8	0.9	0.0	2.1	0.0	1.1	0.2	0.7	7.0	1.5	0.1	1.7	0.0	43.8	1.3	0.0	0.0	0.5	0.0	1.1	0.7	0.2	0.0	2.0	10.5	0.6	5.3	13.7	0.0	0.0	0.0	11.9	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.6	0.4	0.3	2.0	0.4	1.5	0.6	0.5	0.3	0.5	0.4	2.2	0.6	34.2	99.3	244.9	1.6	10.1	228.4	205.6	2244.7	340.9	0.0	123.0	79.9	14.8	125.8	738.5	5.5	0.0	0.7	5.9	137.1	0.0	217.6	1.7	103.4	24.3	113.7	52.9	0.0	0.0	96.7	1.1	161.0	408.7	157.2	27.3	0.2	15.7	1.4	72.2	0.0	0.0	168.3	724.2	162.9	2366.2	5.6	14.0	718.0	188.5	1.0	28.1	0.0	0.0	0.0	0.0	186.1	33.5	0.4	5.1	225.9	95.7	0.2	144.2	0.0	39.5	78.5	92.6	1.7	8.3	50.3	148.6	8.1	14.0	0.1	197.5	79.7
DES	"CMD1I, CSM1, CSM2"	ENSG00000175084	Desmin	P17661	2	219418377-219426734	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 9831.5;skeletal muscle: 16668.0"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2531.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 562.1;stomach cancer: 400.2"	"Region enhanced"	"Detected in all"		"cerebral cortex: 13.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 70.2;LHCN-M2: 145.3;NB-4: 39.5;RH-30: 333.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"midbrain: 29.5"	"CAB000034, HPA018803"	Enhanced		Supported	"Intermediate filaments"		NA	NA		1600000	"Intermediate filaments"		"CAB000034: , HPA018803: AB_1847616"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.76e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-3)"	170.8	57.6	1.7	440.0	3.3	1.1	51.7	1.8	13.7	490.7	19.3	5828.2	293.9	3040.5	86.7	1494.9	1094.5	456.2	9831.5	2.0	2.0	17.0	15.6	175.5	7.3	4.2	2.6	1.8	173.3	14.7	0.5	8.5	53.2	2.0	2237.7	247.9	0.0	257.4	2274.3	16668.0	123.2	1355.1	2581.7	2.0	25.4	1982.2	16.2	2.0	3.2	66.7	5804.8	1.2	4801.7	675.1	2.5	0.0	0.0	0.1	0.0	0.0	2.2	5.3	0.2	0.0	0.1	0.1	0.5	0.0	0.0	9.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	17.0	0.1	1.3	70.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	145.3	0.0	0.0	39.5	0.5	0.0	0.0	0.0	333.1	2.1	0.0	0.0	0.2	1.2	0.0	0.0	0.0	9.2	0.0	5.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.7	3.3	1.8	13.7	2.0	2.0	4.2	2.6	1.8	2.0	2.0	2.0	2.5	0.4	0.0	0.0	0.0	0.0	4.1	2.7	0.0	0.0	0.0	0.1	0.0	2531.9	1.5	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	90.6	0.5	6.7	22.7	0.0	0.0	0.1	0.0	5.2	104.6	0.0	0.1	0.0	0.0	1.8	0.0	5.6	0.0	0.0	0.9	0.0	0.0	10.7	71.6	28.9	2.8	12.4	0.0	0.6	0.0	0.0	0.5	0.0	0.5	0.0	50.4	0.0	8.7	0.0	0.1	0.0	0.0	46.0	497.8	210.5	5.0	5.1	0.1	9.8	8.5	2.4	0.0	0.2	2.9
DMBT1	"Gp-340, GP340, hensin, muclin, SALSA, vomeroglandin"	ENSG00000187908	"Deleted in malignant brain tumors 1"	Q9UGM3	10	122560665-122643736	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Antiviral defense, Differentiation, Host-virus interaction, Protein transport, Transport"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	19	"intestine: 1666.4;salivary gland: 523.1"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 192.9;Intestinal goblet cells: 113.4;Paneth cells: 388.2;Proximal enterocytes: 167.8;Undifferentiated cells: 314.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 47.6;stomach cancer: 76.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 9.9;LHCN-M2: 16.4;RH-30: 40.3"	"Not detected"	"Not detected"							HPA040778	Enhanced		Approved	"Centriolar satellite"	"Secreted in other tissues"	NA	NA		5200000	"Centriolar satellite"		"HPA040778: AB_2677132"	"unprognostic (3.32e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.43e-4)"	"unprognostic (8.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.08e-9)"	"unprognostic (2.26e-1)"	"unprognostic (2.92e-4)"	"unprognostic (2.00e-3)"	"unprognostic (2.22e-1)"	0.5	0.2	1.2	45.7	2.5	0.1	0.3	4.1	2.4	12.9	0.1	46.4	1666.4	1.8	0.0	1.6	3.9	46.2	0.1	0.7	1.8	0.1	0.1	58.9	1.0	6.0	5.2	0.2	0.1	1.8	0.0	0.2	0.0	6.8	1.7	17.2	0.0	523.1	0.0	0.3	0.1	523.0	15.4	3.5	0.0	3.9	1.5	3.7	0.1	0.0	0.2	0.2	15.5	0.0	7.7	0.2	0.2	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.5	0.2	1.1	0.0	0.4	0.0	0.2	0.0	0.0	3.2	0.5	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.0	1.3	0.5	9.9	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	2.6	0.2	0.0	0.0	0.0	40.3	6.0	0.0	0.0	0.1	3.0	0.3	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.8	0.5	2.3	5.7	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.5	4.1	2.4	0.7	1.8	6.0	5.2	0.2	6.8	3.5	3.7	7.7	0.0	6.4	192.9	0.7	1.1	0.0	7.0	0.4	0.0	0.0	1.5	0.9	0.7	0.0	3.8	0.0	0.0	0.0	0.0	52.4	0.0	2.1	2.9	1.1	0.2	7.3	0.0	0.0	0.0	15.1	0.0	0.4	0.0	3.5	10.1	0.0	0.0	0.0	0.0	0.0	0.1	113.4	0.0	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.7	388.2	0.0	0.0	1.7	167.8	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.8	0.0	0.0	0.0	1.8	0.0	314.4	20.3
EFNA2	"ELF-1, EPLG6, LERK6"	ENSG00000099617	"Ephrin A2"	O43921	19	1285873-1301431	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 12.4;liver: 13.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.5;Cardiomyocytes: 4.9;Inhibitory neurons: 1.6;Oligodendrocyte precursor cells: 5.0;Paneth cells: 2.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.5;stomach cancer: 8.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 10.3;CACO-2: 6.2;Hep G2: 13.5;NTERA-2: 6.8;OE19: 6.0;REH: 6.8;SH-SY5Y: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067567			Approved	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Mitochondria, Cytosol"		"HPA067567: AB_2732771"	"unprognostic (1.98e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.34e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-4)"	"unprognostic (1.94e-1)"	0.0	0.0	1.5	1.5	1.4	0.0	0.0	1.1	1.1	0.0	0.2	7.6	10.0	0.0	0.0	0.4	0.0	3.5	0.0	1.3	1.8	0.4	13.0	0.0	0.0	1.6	2.8	1.1	0.0	0.1	0.2	0.3	0.2	1.8	0.0	4.5	0.6	0.0	0.0	0.2	0.1	12.4	0.0	1.3	0.0	0.2	0.6	2.9	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.2	10.3	3.1	0.0	0.0	3.7	0.2	0.0	0.0	0.0	6.2	0.1	0.0	1.8	0.0	0.0	0.0	4.8	0.0	0.0	0.0	1.4	0.0	0.0	13.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.1	0.1	0.1	0.0	1.4	0.0	0.1	6.8	6.0	0.0	6.8	1.0	0.1	0.0	0.4	0.0	13.3	0.7	0.0	0.2	3.5	0.4	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.5	1.4	1.1	1.1	1.3	1.8	1.6	2.8	1.1	1.8	1.3	2.9	1.3	0.1	0.0	0.0	1.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	1.0	0.0	2.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.2	0.0
FBP2		ENSG00000130957	"Fructose-bisphosphatase 2"	O00757	9	94558720-94593824	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"skeletal muscle: 760.7;tongue: 388.7"	"Group enriched"	"Detected in some"	7	"Gastric mucus-secreting cells: 11.2;Skeletal myocytes: 8.7;Spermatogonia: 8.5"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.2"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 6.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.9;CACO-2: 2.1;HMC-1: 2.2;MCF7: 3.0;OE19: 2.9;PC-3: 2.0;SiHa: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA012513, HPA077371"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		960000	"Plasma membrane, Cytosol"		"HPA012513: AB_1848446, HPA077371: "	"unprognostic (3.88e-2)"	"unprognostic (3.54e-4)"	"unprognostic (2.38e-1)"	"unprognostic (6.03e-2)"		"unprognostic (2.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.40e-4)"	"unprognostic (3.95e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.48e-4)"	0.1	0.9	0.1	0.1	0.0	0.0	0.2	1.2	1.4	0.0	55.3	0.3	5.3	0.0	0.0	8.2	0.0	0.1	0.2	6.2	0.0	0.2	0.2	0.4	0.4	0.6	1.1	0.0	0.0	4.4	50.2	0.0	0.1	0.1	1.3	0.0	0.0	4.2	3.3	760.7	0.1	0.9	0.0	0.9	0.0	36.4	1.4	1.2	0.2	0.3	388.7	1.0	0.3	0.0	0.0	0.3	1.3	0.0	1.4	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.2	1.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	2.9	2.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	2.8	0.6	0.0	0.1	0.2	0.1	0.0	0.0	1.2	1.2	0.0	0.0	0.0	0.6	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	1.4	6.2	0.0	0.6	1.1	0.0	0.1	0.9	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.5	1.3	0.0	0.0	11.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.2	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GATA4		ENSG00000136574	"GATA binding protein 4"	P43694	8	11676959-11760002	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 85.8;ovary: 96.2;pancreas: 53.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 41.4;Exocrine glandular cells: 33.7;Gastric mucus-secreting cells: 61.2;Granulosa cells: 158.4;Hepatic stellate cells: 57.8;Late spermatids: 37.0;Leydig cells: 41.3;Peritubular cells: 41.3;Theca cells: 80.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 21.8;testis cancer: 12.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 19.7;HHSteC: 20.9;OE19: 6.2;SH-SY5Y: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013125, HPA073899"	Uncertain		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"CAB013125: AB_2533804, HPA073899: AB_2686641"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.68e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.02e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.67e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"		"unprognostic (1.29e-2)"	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	20.4	0.2	0.0	0.0	2.3	4.0	85.8	0.0	0.0	0.0	36.9	0.2	0.0	0.0	0.0	0.0	96.2	53.9	0.0	0.1	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.1	35.5	32.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	19.7	20.9	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.2	1.3	0.0	0.0	1.5	20.5	0.0	0.0	0.1	3.9	1.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.4	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	16.1	0.0	0.1	6.1	0.0	0.0	0.1	33.7	0.2	12.0	61.2	0.0	0.0	158.4	57.8	12.1	0.6	0.0	0.1	0.8	0.0	2.8	0.0	37.0	41.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.0	41.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	5.3	2.4	2.2	0.0	0.0	0.8	0.1	80.1	0.9	0.0
GATA5	"bB379O24.1, GATAS"	ENSG00000130700	"GATA binding protein 5"	Q9BWX5	20	62463497-62475995	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 11.3;stomach 1: 10.9;testis: 11.6;urinary bladder: 15.5"	"Cell type enhanced"	"Detected in some"		"Gastric mucus-secreting cells: 22.4;Hepatic stellate cells: 7.9;Intestinal goblet cells: 8.7;Proximal enterocytes: 38.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.4;HEL: 2.9;K-562: 4.6;SiHa: 2.0;T-47d: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA067583			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA067583: AB_2685867"	"unprognostic (2.21e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.34e-2)"		"unprognostic (1.69e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.39e-3)"	1.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.1	11.3	3.5	0.3	0.1	9.6	1.4	1.9	0.0	0.0	3.9	0.7	2.0	0.0	0.0	0.0	0.0	0.7	0.1	3.4	0.4	0.4	0.0	5.5	0.0	0.0	0.3	0.3	0.0	0.2	10.1	0.7	0.0	0.0	10.9	11.6	0.0	0.0	0.6	0.2	0.0	15.5	1.6	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	2.0	0.0	0.0	0.8	4.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.2	1.7	22.4	0.2	0.0	0.0	7.9	0.0	0.3	0.0	0.0	8.7	0.0	0.0	0.3	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.1	0.0	0.1	0.0	0.0	0.0	3.4	0.0
GATA6		ENSG00000141448	"GATA binding protein 6"	Q92908	18	22169589-22202528	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 58.3;ovary: 73.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 97.6;Gastric mucus-secreting cells: 100.9;Granulosa cells: 52.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 26.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	23	"basophil: 4.0"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 54.8;CACO-2: 69.7;hTERT-RPE1: 25.5;OE19: 37.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB011581, HPA066629"	Approved		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"CAB011581: AB_732529, HPA066629: AB_2685695"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.45e-3)"	"prognostic unfavorable (1.92e-9)"	"unprognostic (8.75e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-2)"	12.2	58.3	0.0	2.5	0.1	0.0	3.8	0.0	0.8	4.5	3.3	11.5	23.0	19.9	1.2	0.8	29.1	11.2	43.2	0.1	0.1	3.0	12.7	14.9	1.9	0.1	0.1	0.0	73.6	22.9	0.3	0.6	6.6	0.1	5.5	11.1	0.1	0.8	0.7	0.8	1.3	20.9	9.6	0.2	15.1	50.1	6.3	0.1	0.4	5.4	0.6	0.2	23.2	3.2	0.0	10.1	1.4	0.0	0.0	2.1	1.0	54.8	0.3	0.4	0.8	1.0	69.7	3.8	0.0	3.2	1.2	3.4	10.8	0.4	4.5	1.4	0.0	13.6	0.0	4.3	6.1	14.3	0.6	0.6	0.4	8.9	12.1	9.1	25.5	9.5	0.0	0.5	0.0	0.0	1.5	0.0	0.2	0.1	37.6	9.8	0.0	1.1	0.2	0.4	2.8	0.9	0.1	10.7	6.1	3.0	2.7	1.7	0.0	0.7	1.4	1.6	11.4	1.7	0.0	0.0	0.0	6.2	0.3	9.9	4.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	7.3	44.8	30.2	0.0	0.0	0.9	4.0	4.6	1.8	0.0	3.4	2.7	97.6	30.0	6.1	0.0	0.0	0.9	0.9	50.0	0.0	28.4	44.7	6.3	6.3	11.5	26.0	2.7	0.1	19.6	11.2	24.4	100.9	16.6	5.1	52.9	28.5	11.1	1.6	0.0	0.1	45.8	2.0	0.6	0.9	8.8	3.4	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.2	36.8	27.7	10.1	0.2	4.1	43.3	0.0	3.9	0.0	32.9	0.4	8.6	1.4	1.4	0.9	0.9	1.9	1.3	11.4	47.2	2.9
GHRL	"ghrelin, MTLRP, obestatin"	ENSG00000157017	"Ghrelin and obestatin prepropeptide"	Q9UBU3	3	10285666-10292947	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"stomach 1: 359.0"	"Cell type enriched"	"Detected in many"	52	"Gastric mucus-secreting cells: 1123.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 3.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 17.5;classical monocyte: 11.0;eosinophil: 12.4;myeloid DC: 41.8;neutrophil: 25.7;plasmacytoid DC: 28.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 41.8;granulocytes: 25.7;monocytes: 11.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 14.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA014246, CAB022731"	Enhanced				"Secreted to blood"	NA	NA	2580000	350000			"CAB022731: , HPA014246: AB_1849659"	"unprognostic (1.74e-2)"	"unprognostic (3.01e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.52e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.79e-4)"	0.6	0.5	3.6	3.1	3.9	4.5	1.6	4.3	6.0	0.5	3.0	1.4	19.1	0.7	4.8	1.8	0.7	2.3	1.3	3.4	2.7	0.9	1.4	1.1	7.5	3.3	3.0	3.4	1.3	4.1	0.7	0.8	0.5	3.9	1.0	0.6	2.0	1.4	0.3	2.1	2.1	3.2	0.9	2.2	2.5	359.0	1.1	2.8	1.3	1.3	0.2	3.1	1.4	0.5	3.7	0.6	0.2	2.6	2.0	1.8	0.0	4.8	2.4	0.0	0.7	0.2	2.9	0.5	1.5	0.9	0.1	2.1	0.4	0.0	0.6	0.0	0.4	2.9	3.1	2.1	6.3	0.0	3.2	5.3	0.3	0.0	0.0	0.1	0.2	0.5	1.9	1.3	14.4	0.0	0.7	1.2	4.3	1.3	0.5	5.3	0.8	0.2	0.8	0.0	2.4	1.9	0.3	1.6	1.1	0.1	1.7	1.1	3.8	2.6	1.2	0.7	1.1	1.7	1.7	2.6	2.9	0.4	3.5	0.5	17.5	11.0	12.4	0.2	5.5	0.1	2.1	0.2	0.0	41.8	1.0	0.3	0.1	25.7	4.4	0.4	28.5	0.2	3.8	3.6	3.9	4.3	6.0	3.4	2.7	3.3	3.0	3.4	3.9	2.2	2.8	3.7	0.6	0.0	1.1	1.3	4.9	1.3	4.6	0.2	0.0	7.8	0.8	0.6	0.3	0.0	0.2	1.8	10.4	1.7	10.5	0.5	0.0	1.0	0.3	0.2	0.7	1.5	0.0	0.0	1.0	1.3	1.5	1.0	1123.8	0.8	0.0	0.6	1.8	0.1	1.8	3.3	0.6	0.1	0.0	3.8	8.8	1.0	0.3	5.7	1.8	2.8	7.4	2.2	21.6	0.0	0.7	0.9	0.1	0.4	0.7	4.9	1.5	0.2	0.2	9.1	6.6	4.0	0.9	1.7	1.3	0.0	0.6	0.3	4.0	0.7	0.8	2.2
GJD3	"Cx30.2, CX31.9, GJA11, GJC1"	ENSG00000183153	"Gap junction protein delta 3"	Q8N144	17	40360652-40364737	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 28.3;MCF7: 10.6;T-47d: 10.2"	"Not detected"	"Not detected"													NA	NA							"unprognostic (5.54e-4)"	"unprognostic (4.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.84e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.75e-3)"		"unprognostic (7.89e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.43e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.73e-4)"	1.9	1.0	0.3	2.4	0.3	0.3	0.4	0.1	0.3	1.4	0.1	2.0	2.4	1.4	1.3	3.4	1.8	2.8	2.4	0.3	0.6	1.4	1.5	3.9	2.3	0.4	0.4	0.3	0.5	1.7	0.4	0.0	0.8	0.4	2.5	0.9	0.1	1.7	3.4	1.7	2.8	2.5	1.6	0.1	8.1	2.3	0.8	0.7	1.7	4.3	1.5	0.6	2.3	0.2	0.2	2.4	6.0	0.6	2.2	0.0	0.0	8.9	2.7	0.1	0.4	1.2	0.4	1.2	0.0	2.1	1.5	0.1	8.0	0.0	0.0	0.0	2.5	4.6	0.5	0.8	6.5	28.3	1.2	3.3	1.7	0.0	0.1	0.0	2.3	0.0	1.8	5.2	0.0	0.0	10.6	0.7	3.5	0.7	0.8	1.4	2.9	0.0	0.4	0.1	8.7	0.6	2.4	4.0	0.3	1.2	0.7	10.2	3.9	3.1	0.1	0.2	2.0	0.0	0.7	0.0	1.1	0.6	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.3	0.3	0.6	0.4	0.4	0.3	0.4	0.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
GPR25		ENSG00000170128	"G protein-coupled receptor 25"	O00155	1	200872981-200874178	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"stomach 1: 2.0"	"Group enriched"	"Detected in some"	7	"Plasma cells: 15.1;T-cells: 6.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 27.5;T-reg: 44.1"	"Group enriched"	"Detected in many"	57	"B-cells: 14.4;T-cells: 44.1"	"Cell line enriched"	"Detected in single"	6	"U-266/70: 1.3"	"Low region specificity"	"Detected in many"													NA	NA						"unprognostic (2.80e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.25e-4)"	"unprognostic (2.21e-3)"	"unprognostic (4.49e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.29e-6)"	"unprognostic (1.48e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.22e-6)"	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	2.0	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	11.2	14.4	27.5	8.6	0.0	1.4	0.8	2.4	0.2	0.5	0.0	0.1	44.1	6.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.9	0.0	0.0	0.0
GREM1	"CKTSF1B1, CRAC1, DAND2, DRM, gremlin, HMPS"	ENSG00000166923	"Gremlin 1, DAN family BMP antagonist"	O60565	15	32718004-32745106	"Disease related genes, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 113.9;smooth muscle: 68.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 66.2;Granulosa cells: 121.1;Oligodendrocytes: 40.5;Skeletal myocytes: 181.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 24.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 294.7;BJ hTERT+: 468.5;BJ hTERT+ SV40 Large T+ RasG12V: 286.8;fHDF/TERT166: 957.0;hTEC/SVTERT24-B: 227.8"	"Group enriched"	"Detected in many"	5	"hippocampal formation: 3.2;olfactory bulb: 10.9"	"Low region specificity"	"Detected in many"			HPA007526	Uncertain				"Secreted to blood"	NA	NA	242000000				"HPA007526: AB_1849971"	"unprognostic (4.74e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (5.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.13e-11)"	"unprognostic (1.77e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.16e-3)"	16.1	0.5	1.2	6.6	2.9	0.2	5.6	0.7	3.5	40.0	0.0	32.6	2.6	9.7	0.0	13.7	1.1	113.9	0.8	1.3	1.6	0.9	1.1	2.2	1.1	3.0	2.9	0.6	0.3	2.2	0.0	0.2	0.3	3.0	8.3	27.0	0.1	0.6	3.8	0.6	5.9	52.7	68.9	0.6	0.8	37.1	0.5	2.4	0.0	2.3	0.0	1.7	21.9	50.8	5.1	0.0	3.5	0.0	0.0	11.1	12.5	0.0	294.7	468.5	112.5	286.8	0.3	0.0	0.0	0.0	957.0	0.0	0.0	0.0	0.0	109.7	0.0	0.1	0.0	0.1	0.0	3.3	0.0	0.0	3.1	0.0	227.8	0.1	70.6	0.0	0.0	0.0	0.0	143.4	0.1	0.0	0.0	1.2	0.0	0.9	0.0	20.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	57.7	0.0	0.1	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	2.9	0.7	3.5	1.3	1.6	3.0	2.9	0.6	3.0	0.6	2.4	5.1	0.7	0.0	0.0	0.3	0.4	6.6	6.5	0.0	0.6	2.1	1.7	0.9	3.4	0.0	0.0	66.2	2.1	0.2	0.7	0.4	0.0	0.4	0.2	0.6	2.3	1.9	0.0	0.0	2.5	0.0	0.1	17.7	0.0	0.7	0.0	121.1	0.7	1.2	1.0	1.7	0.5	0.6	0.0	0.3	12.8	0.0	0.0	2.3	3.6	0.0	2.7	0.3	0.0	1.5	40.5	0.3	0.0	0.4	0.2	9.9	0.1	0.3	0.0	1.3	0.0	181.4	16.1	0.1	1.4	0.3	4.5	0.3	2.1	0.1	0.1	6.5
HAND2	"bHLHa26, dHand, Hed, Thing2"	ENSG00000164107	"Heart and neural crest derivatives expressed 2"	P61296	4	173524969-173530229	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.2;intestine: 43.0"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 100.3;Endometrial stromal cells: 317.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 5.5;stomach cancer: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	24	"SH-SY5Y: 410.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019591, CAB025576"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB025576: , HPA019591: AB_2670199"	"unprognostic (4.11e-2)"	"unprognostic (7.50e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-1)"		"unprognostic (3.27e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.39e-3)"	3.1	28.3	0.0	5.4	0.0	0.0	2.1	0.5	0.0	19.3	0.0	43.0	2.6	33.7	0.3	1.1	16.2	16.4	37.2	0.0	0.0	0.1	5.5	0.0	0.2	0.0	0.0	0.0	15.4	4.2	0.0	0.1	21.0	0.8	1.3	4.4	0.0	0.8	1.0	0.2	1.3	11.1	27.5	0.0	1.1	22.3	0.4	0.0	0.4	1.5	1.1	0.8	12.5	5.3	0.0	0.0	0.1	0.0	0.0	16.6	7.7	0.3	2.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	17.3	0.0	0.1	1.7	0.0	3.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	410.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	1.3	4.1	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.2	0.0	0.1	0.1	100.3	2.8	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.6	0.2	9.0	317.1	2.7	0.0	0.0	0.0	0.4	1.4	30.4	0.0	5.3	0.0	0.0	6.8	0.1	2.5	0.0	0.0	0.0	0.0	0.0	2.3	0.9	39.4	1.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.9	0.1	0.3	0.2	0.3	2.3	1.3	0.6	0.0	0.0
HMX3	NKX5-1	ENSG00000188620	"H6 family homeobox 3"	A6NHT5	10	123135970-123139423	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"brain: 5.8"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 5.8"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.1;HEL: 6.1;HeLa: 7.0;K-562: 17.9;NB-4: 13.4;SiHa: 7.0;THP-1: 5.7"	"Region enriched"	"Detected in single"	4	"hypothalamus: 1.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 1.4;hypothalamus: 4.8"	HPA069659			Approved	"Nucleoplasm,Centriolar satellite"		Yes	No			Nucleoplasm	"Centriolar satellite"	"HPA069659: AB_2686165"			"unprognostic (1.79e-1)"								"unprognostic (9.65e-2)"			"unprognostic (6.07e-2)"				0.9	0.1	0.6	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.2	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.1	0.0	0.0	0.1	1.4	2.0	0.1	0.0	0.1	0.0	0.2	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	8.1	0.0	0.0	0.7	0.4	6.1	7.0	0.2	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	17.9	0.1	0.0	0.0	0.0	13.4	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	7.0	0.0	0.1	0.0	0.0	5.7	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	1.6	0.3	0.4	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.3	0.9	0.4	0.2	0.4	0.2	0.1	0.6	0.2	0.2	0.2	0.0	5.8	1.4	2.0	0.1	1.0	0.1	2.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HOXC12	"HOC3F, HOX3, HOX3F"	ENSG00000123407	"Homeobox C12"	P31275	12	53954903-53958956	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"skin 1: 2.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 1.8;stomach cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 23.4;OE19: 35.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055632	Uncertain					NA	NA					"HPA055632: AB_2682867"	"unprognostic (6.95e-2)"	"unprognostic (2.34e-2)"				"unprognostic (1.10e-1)"		"unprognostic (4.37e-2)"	"unprognostic (5.98e-2)"			"unprognostic (1.45e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.84e-2)"	"unprognostic (2.55e-1)"			0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.6	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	1.1	0.2	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSPB6	"FLJ32389, Hsp20, PPP1R91"	ENSG00000004776	"Heat shock protein family B (small) member 6"	O14558	19	35754566-35758079	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 2994.4;tongue: 1774.7"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 165.7;Fibroblasts: 125.2;Leydig cells: 271.8;Peritubular cells: 220.4;Smooth muscle cells: 102.6;Theca cells: 311.0"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 93.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1774.3;ASC TERT1: 742.0;HHSteC: 599.9;HSkMC: 700.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001974, HPA044153, HPA054811"	Enhanced		Supported	"Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		310000	Cytosol	"Nucleoli, Golgi apparatus"	"CAB001974: , HPA044153: AB_2678836, HPA054811: AB_2682610"	"unprognostic (3.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.21e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (3.32e-2)"	"unprognostic (6.65e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.43e-6)"	623.6	417.4	34.4	45.8	38.0	0.4	398.3	30.9	49.6	569.2	25.2	499.6	28.3	569.8	102.5	113.3	499.4	98.8	952.4	27.1	40.0	68.6	42.7	127.7	5.7	62.4	39.6	23.4	459.0	50.9	4.2	17.6	40.5	66.5	273.5	44.4	21.3	116.8	196.5	2994.4	35.3	181.5	280.7	49.4	15.9	365.2	61.1	46.8	6.3	100.4	1774.7	2.7	541.8	293.1	48.0	0.6	0.7	2.1	2.5	1774.3	742.0	1.2	83.0	1.3	4.9	9.3	1.1	0.4	0.7	0.6	252.4	0.0	0.2	0.4	0.7	3.9	0.9	0.5	0.4	1.3	0.5	599.9	0.2	0.9	700.3	0.0	19.1	0.9	2.2	5.4	0.3	0.5	1.0	0.2	0.3	0.4	1.9	1.2	2.3	0.6	1.5	0.5	0.7	0.0	0.1	0.8	0.7	0.1	0.2	0.7	0.3	0.3	0.5	0.1	153.2	0.9	17.3	0.6	1.0	2.8	0.3	20.5	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.4	38.0	30.9	49.6	27.1	40.0	62.4	39.6	23.4	66.5	49.4	46.8	48.0	11.1	3.2	0.6	1.6	0.1	1.8	0.4	0.0	3.4	7.8	0.5	0.5	29.7	0.0	0.0	0.0	0.0	2.5	0.1	0.1	0.0	0.1	27.0	4.9	165.7	3.6	0.0	5.2	0.2	0.0	2.5	125.2	4.1	3.5	0.0	3.6	17.5	0.3	5.0	0.0	0.5	0.0	0.0	0.3	3.6	18.9	271.8	2.7	1.8	0.0	0.6	44.5	0.0	0.0	0.1	0.2	0.0	220.4	0.1	0.4	0.0	0.4	0.0	2.8	26.3	38.0	102.6	2.3	1.4	1.9	2.0	4.8	1.8	311.0	0.0	0.5
IGHD5-12	"DK1, IGHD512"	ENSG00000211921	"Immunoglobulin heavy diversity 5-12"		14	105902649-105902671	"Immunoglobulin genes, Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"stomach cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3-7		ENSG00000211938	"Immunoglobulin heavy variable 3-7"	P01780	14	106062151-106062683	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 465.8;lymphoid tissue: 979.9"	"Cell type enriched"	"Detected in some"	255	"Plasma cells: 20463.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 18.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	147	"memory B-cell: 134.0;naive B-cell: 107.0"	"Lineage enriched"	"Detected in single"	163	"B-cells: 134.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.6;HL-60: 3.1;K-562: 3.0;NB-4: 3.0;RPMI-8226: 5.8;SH-SY5Y: 4.8;TIME: 2.9"														"Immunoglobulin genes"	NA	NA		39000000000				"unprognostic (1.29e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.37e-2)"			"prognostic favorable (1.47e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (4.35e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.70e-2)"	48.2	10.2	0.8	50.5	0.8	71.8	204.9	0.6	3.3	88.1	0.8	465.8	155.4	38.1	8.3	17.9	13.6	37.3	2.1	0.3	0.3	17.4	20.5	56.9	103.4	2.0	1.9	0.3	24.9	4.8	2.9	1.9	0.3	3.5	9.2	306.6	0.0	267.6	23.2	1.3	9.7	207.7	3.6	3.7	615.3	232.6	13.3	0.4	0.0	21.3	0.1	979.9	43.3	15.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.0	0.4	2.6	5.8	0.0	0.0	2.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.7	0.0	1.2	1.6	0.0	0.1	0.0	0.6	0.0	0.4	0.8	0.2	0.1	0.0	0.2	134.0	0.2	0.2	0.3	107.0	0.1	0.1	0.1	0.1	0.2	0.6	0.2	12.6	0.8	0.8	0.6	3.3	0.3	0.3	2.0	1.9	0.3	3.5	3.7	0.4	1.4	0.0	0.0	0.0	0.0	80.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	30.5	0.0	5.3	0.0	0.0	0.0	4.4	31.1	0.0	0.0	0.0	2.2	1.9	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20463.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	7.4	0.0	0.5	0.0
IGHV3OR16-13	IGHV3/OR16-13	ENSG00000271178	"Immunoglobulin heavy variable 3/OR16-13 (non-functional)"		16	33827214-33827661	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 32.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"stomach cancer: 4.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	28	"memory B-cell: 18.1"	"Lineage enriched"	"Detected in single"	181	"B-cells: 18.1"	"Cell line enriched"	"Detected in some"	818	"Daudi: 1604.0"															NA	NA						"unprognostic (7.59e-4)"	"unprognostic (4.14e-2)"	"unprognostic (1.47e-2)"			"prognostic favorable (3.23e-5)"		"unprognostic (1.34e-1)"		"unprognostic (2.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.26e-5)"	"unprognostic (6.83e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.04e-1)"	0.1	0.0	0.1	5.4	0.0	0.6	0.4	0.0	0.1	1.3	0.0	6.6	6.1	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.2	0.3	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.9	0.0	7.0	0.0	0.0	0.0	4.0	0.1	0.0	32.5	4.2	0.0	0.0	1.0	0.3	0.0	10.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1604.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV4OR15-8	"IGHV4/OR15-8, IGHV4OR158, VSIG6"	ENSG00000259261	"Immunoglobulin heavy variable 4/OR15-8 (non-functional)"		15	22184967-22185402	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 1.9;lymphoid tissue: 1.4;urinary bladder: 2.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"stomach cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA											"unprognostic (1.68e-3)"		"unprognostic (9.63e-2)"						"unprognostic (1.17e-1)"				0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.9	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	1.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1-12	"IGKV112, L19"	ENSG00000243290	"Immunoglobulin kappa variable 1-12"	A0A0C4DH73	2	89040224-89040745	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 399.6;lymphoid tissue: 795.5"	"Cell type enriched"	"Detected in some"	92	"Plasma cells: 12442.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 17.2"	"Region enhanced"	"Detected in some"		"midbrain: 3.1"	"Group enriched"	"Detected in some"	820	"memory B-cell: 259.8;naive B-cell: 164.2"	"Lineage enriched"	"Detected in single"	1005	"B-cells: 259.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;Daudi: 2.1;RPMI-8226: 1.9;SH-SY5Y: 1.9"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		13000000000			"HPA048721: "	"prognostic favorable (6.09e-4)"	"prognostic favorable (1.59e-4)"	"unprognostic (7.33e-2)"	"unprognostic (3.74e-2)"		"prognostic favorable (3.85e-5)"		"unprognostic (5.89e-2)"	"unprognostic (5.74e-1)"	"unprognostic (7.13e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (6.59e-8)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.71e-1)"	10.3	146.2	0.1	203.6	0.2	73.7	118.0	0.0	0.3	51.2	0.2	399.6	242.8	7.3	0.0	57.6	16.3	70.2	10.0	0.1	1.1	13.6	18.0	65.9	240.6	0.7	3.1	0.0	18.3	7.3	0.2	1.4	0.0	1.0	7.3	281.3	0.0	220.8	5.4	0.4	2.8	233.1	11.3	0.9	363.3	257.1	6.8	0.1	70.2	33.0	0.0	795.5	245.3	9.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	259.8	0.0	0.1	0.1	164.2	0.0	0.1	0.2	0.1	0.1	0.1	0.1	24.3	0.1	0.2	0.0	0.3	0.1	1.1	0.7	3.1	0.0	1.0	0.9	0.1	1.4	0.0	0.0	0.0	0.0	134.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	20.4	0.0	0.0	0.0	1.8	1.6	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12442.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.3	5.0	0.0	0.0	0.0
IGKV1-33	"IGKV133, O18"	ENSG00000242076	"Immunoglobulin kappa variable 1-33"	P01594	2	89266494-89268506	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Bence-Jones protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1742.2;stomach 1: 633.2;urinary bladder: 629.1"	"Cell type enriched"	"Detected in some"	131	"Plasma cells: 2044.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.5"	"Group enriched"	"Detected in many"	11	"hypothalamus: 9.0;midbrain: 14.7;spinal cord: 11.3"	"Group enriched"	"Detected in some"	378	"memory B-cell: 369.6;naive B-cell: 441.5"	"Lineage enriched"	"Detected in many"	411	"B-cells: 441.5"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 2.7;SCLC-21H: 9.1;SH-SY5Y: 8.8;U-251 MG: 3.5"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA					"HPA048721: "	"unprognostic (1.76e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.52e-2)"			"prognostic favorable (4.58e-5)"		"unprognostic (5.06e-2)"		"unprognostic (8.55e-3)"	"unprognostic (2.31e-1)"			"unprognostic (1.63e-2)"	"unprognostic (2.57e-1)"		"unprognostic (4.66e-1)"	51.0	22.1	0.2	268.7	0.5	140.8	323.7	0.8	1.0	130.9	0.4	476.0	298.9	20.9	2.8	107.2	33.7	189.0	23.4	0.3	9.0	36.3	38.2	131.5	533.9	0.5	14.7	0.1	37.4	8.4	1.9	2.7	0.4	0.7	18.9	516.7	0.2	480.4	129.0	0.7	2.1	177.4	14.6	11.3	827.4	633.2	13.7	0.2	385.5	54.4	0.2	1742.2	629.1	26.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.1	1.9	2.7	0.0	0.0	9.1	8.8	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.4	3.5	0.7	0.0	0.2	0.0	0.6	0.0	0.4	0.3	0.4	0.1	0.0	0.1	369.6	0.2	0.1	0.3	441.5	0.2	0.1	1.0	0.2	0.3	0.3	0.2	39.5	0.2	0.5	0.8	1.0	0.3	9.0	0.5	14.7	0.1	0.7	11.3	0.2	1.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2044.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0
IGKV1-39		ENSG00000242371	"Immunoglobulin kappa variable 1-39"	P01597	2	89319625-89320146	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 75.0;lymphoid tissue: 256.9;salivary gland: 152.5;stomach 1: 83.9"	"Cell type enriched"	"Detected in some"	151	"Plasma cells: 16225.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 13.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	388	"memory B-cell: 1069.8;naive B-cell: 935.1"	"Lineage enriched"	"Detected in many"	415	"B-cells: 1069.8"	"Cell line enriched"	"Detected in some"	21	"Daudi: 194.2"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8000000000			"HPA048721: "	"prognostic favorable (1.76e-4)"	"unprognostic (5.10e-3)"	"unprognostic (4.71e-2)"			"prognostic favorable (1.70e-5)"		"unprognostic (2.38e-1)"		"unprognostic (7.33e-2)"	"unprognostic (1.78e-1)"		"unprognostic (6.62e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.25e-1)"	6.0	9.2	0.0	55.2	0.0	14.3	17.8	0.0	0.1	13.9	0.0	62.9	71.1	5.7	0.0	11.7	12.6	14.4	1.6	0.2	0.0	10.7	6.8	27.4	36.8	0.1	0.0	0.0	1.8	3.2	0.0	0.5	0.0	0.1	4.3	13.5	0.0	152.5	1.0	0.2	0.8	75.0	1.2	0.0	256.9	83.9	0.3	0.0	6.0	31.3	0.0	42.8	17.7	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	194.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	1.8	0.0	9.0	0.0	0.0	0.0	0.9	1.0	0.7	0.3	0.3	0.3	1069.8	0.5	0.4	1.1	935.1	0.3	0.6	2.5	0.4	0.6	1.3	0.8	136.4	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	10.7	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16225.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	4.9	0.0	0.3	0.0
IGKV1D-33		ENSG00000239975	"Immunoglobulin kappa variable 1D-33"	P01593	2	89913982-89916052	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.5;salivary gland: 73.9"	"Cell type enriched"	"Detected in some"	410	"Plasma cells: 5131.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.0"	"Region enriched"	"Detected in single"	11	"midbrain: 6.9"	"Group enriched"	"Detected in some"	116	"memory B-cell: 6.3;naive B-cell: 16.8"	"Lineage enriched"	"Detected in single"	169	"B-cells: 16.8"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		4900000000			"HPA048721: "	"unprognostic (5.10e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.11e-2)"			"unprognostic (2.03e-4)"		"unprognostic (7.90e-2)"		"unprognostic (6.50e-2)"	"unprognostic (6.82e-2)"			"unprognostic (4.54e-2)"	"unprognostic (4.23e-2)"			1.8	0.5	0.0	3.9	0.1	2.3	8.4	0.0	0.1	2.3	0.1	18.6	1.4	1.4	0.0	4.7	2.8	2.7	0.2	0.1	0.6	3.9	2.2	18.0	6.8	0.1	6.9	0.0	0.4	0.5	0.0	0.1	0.0	0.0	1.6	2.1	0.0	73.9	8.6	0.0	0.3	19.3	0.0	0.4	63.5	21.4	0.1	0.0	4.8	3.3	0.2	9.1	16.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.1	0.6	0.1	6.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5131.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
IGKV1D-39		ENSG00000251546	"Immunoglobulin kappa variable 1D-39"	P04432	2	89862482-89862981	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 2950.1;lymphoid tissue: 6546.1;stomach 1: 2280.3"	"Cell type enriched"	"Detected in some"	298	"Plasma cells: 7890.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 12.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	226	"memory B-cell: 470.5;naive B-cell: 733.0"	"Lineage enriched"	"Detected in many"	275	"B-cells: 733.0"	"Group enriched"	"Detected in some"	36	"Daudi: 731.4;U-698: 516.7"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA					"HPA048721: "	"prognostic favorable (1.88e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.14e-3)"			"prognostic favorable (5.99e-5)"		"unprognostic (3.84e-1)"		"unprognostic (4.34e-2)"	"unprognostic (1.28e-1)"			"unprognostic (9.06e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.84e-1)"	148.7	182.8	0.7	1625.0	1.4	470.4	1000.3	0.7	4.6	372.1	2.9	2950.1	2073.9	80.8	52.9	616.8	133.3	635.6	88.2	0.5	5.8	81.0	173.3	691.4	1985.4	2.5	7.4	0.5	216.7	26.8	3.5	5.5	1.3	3.1	81.6	2282.9	0.4	1240.9	149.9	2.3	33.4	1266.3	89.5	4.0	1725.6	2280.3	27.8	1.6	777.6	211.1	0.0	6546.1	1831.8	47.3	2.4	0.3	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	731.4	0.5	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	3.2	0.0	0.0	0.0	5.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	2.3	6.6	2.4	0.0	0.0	1.0	2.9	10.3	0.0	0.0	11.1	17.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.8	2.5	0.0	0.1	516.7	0.0	1.6	0.0	0.5	0.4	0.8	0.6	0.2	0.4	470.5	0.3	0.3	0.4	733.0	0.5	0.2	2.6	0.8	0.4	0.4	0.3	47.6	0.7	1.4	0.7	4.6	0.5	5.8	2.5	7.4	0.5	3.1	4.0	1.6	2.4	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7890.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	14.0	0.0	0.0	0.0
IGKV2-30		ENSG00000243238	"Immunoglobulin kappa variable 2-30"	P06310	2	89244781-89245596	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 637.0;lymphoid tissue: 675.5;stomach 1: 326.0"	"Cell type enriched"	"Detected in some"	365	"Plasma cells: 25365.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 26.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	316	"memory B-cell: 561.0;naive B-cell: 325.4"	"Lineage enriched"	"Detected in many"	400	"B-cells: 561.0"	"Cell line enriched"	"Detected in some"	388	"U-698: 8426.0"														"Immunoglobulin genes"	NA	NA		6800000000				"prognostic favorable (6.84e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.41e-1)"		"prognostic favorable (6.78e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (4.53e-6)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.50e-1)"	15.2	9.5	0.1	162.2	0.3	76.6	239.4	0.1	1.3	14.1	0.6	637.0	397.9	5.7	0.8	38.2	11.6	35.4	18.0	0.1	0.3	15.0	29.9	67.9	178.1	1.3	0.4	0.1	15.9	7.8	0.1	2.4	0.2	0.2	7.9	327.5	0.0	222.3	23.5	0.6	1.2	262.3	19.3	0.4	675.5	326.0	21.4	0.2	41.3	19.0	0.0	605.4	209.4	21.6	1.5	5.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	13.1	4.6	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.3	0.0	0.0	0.1	2.7	1.9	0.0	0.4	0.0	0.9	3.8	0.0	2.6	0.0	0.0	5.6	0.0	0.0	21.7	0.1	2.6	0.3	1.7	8426.0	0.0	2.7	0.0	0.5	0.4	0.2	0.2	0.0	0.2	561.0	0.1	0.2	0.4	325.4	0.0	0.2	1.4	0.2	0.3	0.7	0.3	53.3	0.1	0.3	0.1	1.3	0.1	0.3	1.3	0.4	0.1	0.2	0.4	0.2	1.5	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	30.5	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25365.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.3	0.0
IGKV2D-30		ENSG00000239571	"Immunoglobulin kappa variable 2D-30"	A0A075B6S6	2	89936859-89937679	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.5;lymphoid tissue: 33.8;stomach 1: 22.4"	"Cell type enriched"	"Detected in some"	222	"Plasma cells: 1314.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	379	"memory B-cell: 124.9;naive B-cell: 164.0"	"Lineage enriched"	"Detected in single"	430	"B-cells: 164.0"	"Cell line enriched"	"Detected in some"	6	"U-698: 51.7"														"Immunoglobulin genes"	NA	NA						"unprognostic (1.17e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.58e-1)"			"unprognostic (2.98e-4)"		"unprognostic (5.74e-3)"		"unprognostic (3.19e-2)"	"unprognostic (1.10e-1)"			"unprognostic (4.12e-2)"	"unprognostic (3.55e-1)"			0.3	0.4	0.0	6.4	0.0	4.3	6.0	0.0	0.1	0.8	0.0	15.5	11.9	0.4	0.0	1.0	0.4	0.8	0.8	0.1	0.0	1.3	0.7	2.9	6.8	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.5	11.3	0.0	13.1	4.6	0.0	1.3	8.6	2.0	0.0	29.6	22.4	0.1	0.0	1.6	0.8	0.0	33.8	5.6	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	51.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	124.9	0.0	0.1	0.1	164.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	19.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1314.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0
IL17C	"CX2, IL-17C, IL-21, MGC126884, MGC138401"	ENSG00000124391	"Interleukin 17C"	Q9P0M4	16	88638572-88640468	"Predicted secreted proteins"	"Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 2.1;urinary bladder: 1.7"	"Group enriched"	"Detected in some"	6	"Basal respiratory cells: 210.7;Club cells: 191.2;Ionocytes: 52.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA065051	Supported				"Secreted to blood"	NA	NA	30500				"HPA065051: AB_2685413"	"unprognostic (1.60e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.45e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.93e-2)"		"unprognostic (3.50e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.73e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.56e-3)"	"unprognostic (8.37e-3)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	210.7	0.0	0.0	0.1	0.0	0.1	4.3	191.2	0.0	0.0	0.0	1.6	0.7	0.0	0.9	0.0	0.9	0.2	0.1	0.0	0.0	0.0	4.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	52.9	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.3	0.1	21.8	0.0	0.0	0.0	1.3	0.4	0.5	0.0	0.0	0.3	0.3	0.0	0.0	0.4
IL17REL	FLJ41993	ENSG00000188263	"Interleukin 17 receptor E like"	Q6ZVW7	22	49994513-50012659	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 4.3;stomach 1: 2.3"	"Cell type enriched"	"Detected in single"	21	"Gastric mucus-secreting cells: 12.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA045546	Supported					NA	NA					"HPA045546: AB_10963836"	"unprognostic (3.33e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.65e-4)"	"unprognostic (2.72e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-2)"	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.2	1.0	2.3	0.1	0.8	3.9	0.0	0.0	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.0	0.4	0.2	0.2	0.0	0.2	0.2	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP3-1	KAP3.1	ENSG00000212901	"Keratin associated protein 3-1"	Q9BYR8	17	41008521-41019324	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	285	"skin 1: 140.6"	"Cell type enriched"	"Detected in some"	4	"Basal prostatic cells: 581.4"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.8;urothelial cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.0;BJ: 4.9;CACO-2: 12.7;HaCaT: 2.4;T-47d: 2.0"	"Not detected"	"Not detected"													NA	NA									"unprognostic (4.24e-1)"				"unprognostic (3.00e-2)"				"unprognostic (7.37e-2)"						0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	140.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	581.4	0.0	4.0	0.0	0.9	0.0	0.0	0.0	3.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.1	0.3	1.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	139.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	1.3	0.0	1.4	11.2	0.0	0.0	71.8
LCN2	"24p3, NGAL"	ENSG00000148346	"Lipocalin 2"	P80188	9	128149071-128153453	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Innate immunity, Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 2795.5;gallbladder: 2244.1;salivary gland: 1319.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 4054.2;Club cells: 5757.0;Ductal cells: 6457.0;Pancreatic endocrine cells: 5424.3;Respiratory ciliated cells: 3161.5;Urothelial cells: 7112.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 944.6"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	88	"basophil: 9.8;neutrophil: 11.9;non-classical monocyte: 4.7"	"Group enriched"	"Detected in many"	83	"granulocytes: 11.9;monocytes: 4.7"	"Group enriched"	"Detected in many"	11	"CAPAN-2: 3623.8;EFO-21: 1450.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"cerebellum: 149.7;spinal cord: 102.4"	"HPA002695, CAB016549, CAB016550"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA	297000000	590000000	"Endoplasmic reticulum"		"CAB016549: , CAB016550: , HPA002695: AB_1852758"	"prognostic favorable (9.61e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.11e-2)"	5.0	3.6	0.0	126.7	0.2	2795.5	22.1	0.2	0.5	817.3	2.4	251.4	34.7	14.4	20.7	683.0	53.1	2244.1	2.8	0.0	0.1	31.0	68.3	76.7	1.1	0.3	0.4	0.1	1.1	75.5	7.4	21.4	2.6	0.4	75.2	132.3	0.0	1319.0	13.6	1.2	24.6	158.6	12.0	0.1	82.6	367.0	0.5	0.4	14.3	27.3	0.3	200.8	675.7	484.6	1.0	117.7	35.1	0.0	4.5	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	3623.8	0.2	1450.9	0.0	3.7	236.4	0.0	6.9	0.1	5.3	0.0	30.4	0.0	0.8	0.2	0.0	1.1	0.1	230.4	0.0	12.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	1.9	80.9	0.2	0.2	0.3	0.3	1.0	20.1	0.1	0.1	2.0	65.3	1.0	0.0	8.4	1.8	0.0	2.9	16.9	0.0	2.9	0.6	4.6	4.7	0.2	0.6	2.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	4.7	0.0	0.0	12.1	0.0	0.2	0.2	0.5	0.0	0.1	0.3	0.4	0.1	0.4	0.1	0.4	1.0	0.2	0.0	20.8	0.0	15.9	0.3	376.6	4054.2	1.8	0.0	38.1	29.3	0.2	1328.2	5757.0	138.0	0.0	0.8	1.2	315.6	0.0	6457.0	2.0	25.6	4.3	11.5	57.9	11.2	0.0	1837.0	0.3	12.2	237.0	52.3	13.4	0.0	2.2	43.2	0.6	0.0	0.0	264.3	956.2	2.7	0.0	15.8	3.4	34.9	0.0	0.0	60.3	0.0	1.0	0.0	0.0	5424.3	183.4	0.0	1.4	420.6	509.8	1.6	3161.5	0.0	0.0	0.0	337.7	0.0	0.3	51.1	0.0	0.3	7.7	0.0	475.5	7112.9
LGALS9B		ENSG00000170298	"Galectin 9B"	Q3B8N2	17	20449395-20467539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 15.5;intestine: 11.2;stomach 1: 31.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 17.7;Gastric mucus-secreting cells: 109.1;Intestinal goblet cells: 32.6;NK-cells: 28.8;Paneth cells: 42.3"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	17	"NK-cell: 12.7"	"Lineage enriched"	"Detected in single"	17	"NK-cells: 12.7"	"Group enriched"	"Detected in some"	7	"CAPAN-2: 8.5;U-937: 2.8"									"HPA046876, HPA047218"	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (4.69e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.05e-1)"	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.7	0.0	7.6	3.3	0.0	0.0	15.5	0.0	7.5	0.0	0.1	0.0	0.0	0.1	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	11.2	0.0	2.2	0.0	0.0	0.5	3.4	0.3	0.0	0.6	31.2	0.1	0.0	0.0	0.0	0.0	1.7	0.0	4.3	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.2	0.1	0.0	0.3	0.2	0.1	0.3	0.1	12.7	0.3	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	2.3	0.3	1.1	0.6	0.0	0.0	0.0	0.1	1.5	2.2	0.0	0.0	0.0	9.9	17.7	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	109.1	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	32.6	2.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	28.8	0.0	0.0	0.6	42.3	0.0	1.2	0.2	7.7	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	2.1	0.0	6.6	0.3
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348381-69354234	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 10678.5;salivary gland: 21288.2;stomach 1: 9016.5"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 3106.1;Kupffer cells: 2841.2;Langerhans cells: 4859.1;Macrophages: 4870.7;monocytes: 7063.0;Pancreatic endocrine cells: 3152.5"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 976.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 25266.2;myeloid DC: 14438.7"	"Group enriched"	"Detected in all"	20	"dendritic cells: 14438.7;monocytes: 25266.2"	"Cell line enriched"	"Detected in many"	13	"OE19: 12130.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA	1500000000	1500000000	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741"	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	96.7	28.0	3.4	809.3	5.5	10678.5	129.5	3.9	18.7	157.5	17.4	311.9	3637.9	66.3	4.2	107.2	34.2	1063.7	35.1	2.6	19.3	32.6	139.2	1367.2	745.7	7.4	5.9	2.4	20.6	63.7	13.9	7.2	92.1	6.5	40.6	276.4	4.5	21288.2	22.0	34.3	59.2	1333.1	125.1	5.4	626.4	9016.5	22.0	9.2	324.8	28.1	36.7	658.1	432.4	16.3	11.3	0.6	0.1	0.0	0.2	0.0	0.0	4.8	0.0	0.0	0.0	0.3	9.5	6.5	4.2	1.5	0.0	3.6	1.2	0.0	0.0	0.2	1.2	0.1	62.4	1.0	960.4	0.0	110.6	50.5	0.0	0.1	0.0	0.0	0.2	0.0	0.3	7.7	0.3	0.0	0.2	2.6	109.5	2.3	12130.8	0.2	1.6	1.4	16.7	0.3	0.5	0.8	3.6	0.5	0.1	0.5	0.7	0.0	489.0	0.6	0.0	2.6	2.3	0.9	2.6	1.1	1.2	0.1	518.5	0.0	443.4	25266.2	298.2	32.6	4798.4	52.3	100.5	20.1	22.7	14438.7	20.8	20.0	17.8	1007.7	108.1	880.1	301.2	31.1	25392.1	3.4	5.5	3.9	18.7	2.6	19.3	7.4	5.9	2.4	6.5	5.4	9.2	11.3	24.0	86.6	285.8	0.0	80.8	57.2	1.7	1.2	1.2	0.3	1205.7	32.3	0.2	734.9	51.1	27.6	0.0	5.6	39.6	32.1	0.0	55.1	1.9	2.6	1.9	25.1	12.5	264.6	0.2	547.3	9.4	26.8	3106.1	2.9	123.6	0.5	29.6	25.4	887.1	0.0	0.2	112.4	0.0	2841.2	4859.1	17.4	4.1	4870.7	53.4	0.0	7063.0	0.1	176.1	0.0	0.3	3152.5	600.5	2.2	9.0	2.7	41.8	6.6	33.8	1.0	39.5	7.4	9.9	0.7	3.9	1.5	38.2	8.5	50.6	0.3	111.4	38.3
MALRD1	"bA265G8.2, C10orf112, Diet1"	ENSG00000204740	"MAM and LDL receptor class A domain containing 1"	Q5VYJ5	10	19048801-19790401	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 31.4"	"Group enriched"	"Detected in some"	4	"Astrocytes: 37.9;Oligodendrocyte precursor cells: 76.4;Proximal enterocytes: 69.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.9;stomach cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Karpas-707: 44.2"	"Not detected"	"Not detected"							"HPA035732, HPA038106, HPA046848"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035732: AB_2674756, HPA038106: AB_2675836, HPA046848: AB_2679837"	"unprognostic (9.03e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.78e-4)"	0.5	0.7	1.8	0.2	1.8	0.4	0.6	1.1	1.3	0.6	1.2	0.4	30.9	0.6	2.2	0.2	0.2	0.4	0.9	1.7	3.6	1.5	0.1	0.9	0.1	1.4	1.1	1.2	1.2	0.1	0.0	1.5	0.4	1.4	0.6	0.1	0.3	0.1	0.3	0.6	0.2	31.4	0.4	1.5	0.2	0.3	2.1	1.4	1.9	0.5	0.1	0.0	0.6	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.8	0.0	2.6	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	44.2	0.0	4.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.8	1.8	1.1	1.3	1.7	3.6	1.4	1.1	1.2	1.4	1.5	1.4	1.6	0.0	0.0	1.8	37.9	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.6	1.6	0.0	0.0	0.0	0.0	0.8	1.3	0.0	1.9	0.1	7.9	0.1	0.3	0.1	0.0	4.2	11.6	0.0	0.8	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	11.0	9.5	0.0	0.0	0.3	1.8	0.0	0.0	0.0	5.6	0.0	1.4	0.0	76.4	4.9	0.0	13.8	0.7	0.0	0.2	69.3	0.2	0.0	0.0	0.0	0.1	0.2	9.0	4.1	0.1	0.1	0.3	0.0	1.9	9.7	0.0
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269855-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	61	"bone marrow: 4058.2"	"Cell type enriched"	"Detected in some"	30	"Erythroid cells: 87.4"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 6.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	94	"HL-60: 3517.4;NB-4: 4589.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	No	NA	576000000	24000000	Vesicles	Nucleoplasm	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.4	0.4	0.7	0.7	0.6	4058.2	0.3	0.6	1.1	0.0	0.2	0.1	0.0	0.2	1.1	0.1	0.2	0.3	0.9	0.7	0.6	0.2	1.8	8.4	1.7	0.8	0.8	0.5	0.1	0.1	0.0	1.6	1.4	0.7	0.2	0.2	0.4	66.9	0.1	1.1	4.4	0.2	0.3	0.7	21.9	0.1	0.4	0.6	11.0	0.3	0.3	0.2	0.5	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	3517.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4589.9	0.0	0.0	0.0	5.3	3.2	0.6	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	4.0	0.0	0.0	6.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.1	7.5	0.7	0.6	0.6	1.1	0.7	0.6	0.8	0.8	0.5	0.7	0.7	0.6	0.8	0.0	0.0	0.5	0.7	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.9	0.0	0.5	0.1	0.0	0.1	0.0	87.4	0.3	0.2	0.9	0.7	0.0	0.0	0.0	0.0	0.7	0.3	0.9	0.0	0.2	0.0	0.0	1.2	0.0	1.3	0.0	2.9	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.1	0.3	0.1	0.0	0.1	0.6	0.0	0.0	0.0
MTRNR2L10		ENSG00000256045	"MT-RNR2 like 10"	P0CJ77	X	55181392-55182442	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	7	"brain: 1176.5"	"Cell type enriched"	"Detected in many"	9	"Cardiomyocytes: 9177.9"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.6"	"Region enriched"	"Detected in all"	43	"cerebral cortex: 1176.5"	"Group enriched"	"Detected in all"	5	"basophil: 171.3;eosinophil: 137.1;neutrophil: 395.3"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 395.3"	"Cell line enhanced"	"Detected in many"		"A549: 178.6;HeLa: 834.8;Hep G2: 578.6"														"Secreted to blood"	NA	NA						"unprognostic (4.42e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.97e-4)"	38.6	32.5	14.4	5.8	14.5	8.3	3.8	14.4	1176.5	0.7	14.4	39.3	11.4	12.1	38.8	23.3	17.1	10.7	162.7	27.1	14.4	123.1	80.2	3.4	2.6	24.8	14.4	14.3	15.0	24.0	5.2	0.0	6.7	16.9	8.4	66.7	2.5	28.0	3.5	129.1	12.8	10.6	24.8	15.9	8.5	10.8	22.7	14.5	1.0	5.7	15.1	21.4	4.4	0.0	14.8	10.5	178.6	2.4	49.1	4.5	2.2	12.8	16.1	0.8	0.9	0.5	12.1	25.7	24.2	3.4	1.1	2.1	36.6	0.1	1.2	0.5	7.0	36.4	12.3	834.8	578.6	1.1	4.1	6.5	6.2	2.7	0.3	2.0	42.0	0.7	18.4	21.8	13.7	1.9	67.9	3.8	28.8	1.1	0.9	14.0	9.2	9.9	11.3	4.0	111.5	2.5	10.2	4.7	4.3	18.1	23.2	14.4	21.1	25.7	18.0	3.8	6.2	1.6	4.4	3.1	2.0	11.2	5.3	4.0	171.3	50.3	137.1	9.5	25.1	11.4	38.2	14.8	12.7	21.7	36.5	19.1	22.3	395.3	22.8	24.5	26.2	16.2	63.8	14.4	14.5	14.4	1176.5	27.1	14.4	24.8	14.4	14.3	16.9	15.9	14.5	14.8	3.8	0.0	0.0	0.0	4.9	8.2	411.9	1.0	0.0	0.0	15.8	6.6	9177.9	2.8	0.6	42.3	0.0	0.3	1.3	0.0	84.1	0.0	0.3	11.5	6.5	296.2	0.0	0.0	0.0	0.0	0.3	289.5	0.0	16.0	0.0	4.0	1.8	6.2	0.6	0.0	0.0	0.0	2.0	5.5	23.2	1.1	0.6	75.9	16.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.5	222.0	0.0	611.6	0.6	0.0	0.0	995.2	385.1	0.6	0.9	0.0	9.1	0.3	70.1	4.3	0.0	449.2
MTRNR2L12		ENSG00000269028	"MT-RNR2 like 12"	P0DMP1	3	96617188-96618236	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 101422.8;choroid plexus: 51606.2"	"Cell type enriched"	"Detected in many"	11	"Cardiomyocytes: 34487.4"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 14.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 23357.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 23357.3"	"Cell line enhanced"	"Detected in all"		"HeLa: 19226.4"														"Secreted to blood"	NA	NA						"unprognostic (3.79e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.81e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.90e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.85e-2)"	7120.5	9579.0	51610.0	1624.6	51611.2	2421.9	2927.0	51618.4	101422.8	1327.3	51606.2	7196.9	3229.9	1509.9	1904.2	3978.8	1605.5	2160.6	24920.5	53545.8	51603.5	11585.0	11053.5	1417.5	1120.3	54530.7	51614.8	51605.7	1484.0	3730.2	5549.5	0.9	1878.1	52543.9	2615.5	5726.5	5562.2	4112.2	3351.7	37038.2	4056.6	3660.9	2302.8	51767.6	2007.2	5188.3	3883.1	51612.3	1103.2	1317.5	22800.5	2003.2	1757.2	0.7	51668.4	3129.7	3743.3	2766.3	9914.1	4165.4	2220.4	2507.6	3970.8	808.2	749.3	954.5	2070.2	4888.5	6887.0	3132.2	1502.3	436.5	8365.9	196.7	1668.9	1010.6	2008.1	3570.2	7299.3	19226.4	8838.4	1579.3	1469.9	3824.2	4061.3	1945.5	784.9	2127.7	4578.8	844.6	3040.7	5258.3	2276.0	2553.9	1634.8	1252.5	4510.6	808.3	1892.5	1113.4	1992.1	2667.8	2102.8	4420.6	2269.6	1246.8	2408.9	2618.4	2595.6	3524.2	2439.6	2667.3	4152.9	3817.7	3062.1	2505.1	3462.1	1143.3	1197.9	802.7	3365.5	1896.5	8908.3	850.3	10533.0	3473.8	6467.2	1043.1	1696.3	1353.8	2636.4	1309.8	1129.5	1256.2	2611.9	1648.9	1580.6	23357.3	1490.6	1781.5	2078.4	1275.7	2740.2	51610.0	51611.2	51618.4	101422.8	53545.8	51603.5	54530.7	51614.8	51605.7	52543.9	51767.6	51612.3	51668.4	1081.2	2705.1	2934.5	0.0	291.8	112.5	420.7	10.3	3.4	0.0	702.7	1431.3	34487.4	147.3	1441.4	84.6	0.0	8.4	394.0	24.5	62.6	1.1	19.7	1096.7	707.4	1236.7	4.9	182.7	0.0	1.8	8.6	1698.5	29.6	1465.4	1715.6	334.8	100.3	171.7	12.3	0.0	0.0	7.1	4.1	126.9	333.5	49.0	42.9	633.1	193.9	0.0	29.8	0.0	28.8	0.0	0.0	1.4	8.4	23.0	213.1	337.3	6.6	521.0	1431.8	0.0	46.0	2907.6	1520.5	36.3	39.6	3.3	80.7	10.5	625.8	220.9	5.2	397.1
MTRNR2L6		ENSG00000270672	"MT-RNR2 like 6"	P0CJ73	7	142666272-142667718	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 962.6;choroid plexus: 385.4;skeletal muscle: 372.8"	"Group enriched"	"Detected in many"	10	"Cardiomyocytes: 1037.7;Proximal tubular cells: 454.5"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 169.7;eosinophil: 127.3;neutrophil: 431.2"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 431.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 194.4;Hep G2: 136.7"														"Secreted to blood"	NA	NA						"unprognostic (5.34e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.80e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.69e-1)"	"unprognostic (3.03e-2)"		"unprognostic (2.66e-2)"	"unprognostic (8.07e-3)"	44.3	73.5	385.4	13.9	385.5	11.9	8.9	385.4	962.6	2.9	385.4	41.7	18.9	11.3	7.2	22.6	7.2	9.6	164.8	435.8	385.4	71.0	53.4	6.6	5.6	421.9	385.4	385.4	7.1	27.8	20.9	0.0	11.3	402.7	13.9	27.5	36.2	28.1	8.8	372.8	22.1	31.0	8.7	389.3	14.9	27.4	24.1	385.4	5.5	3.6	76.7	11.7	6.2	0.0	386.7	17.9	29.5	9.8	67.9	11.2	5.7	16.5	18.3	1.7	1.8	3.1	9.7	31.5	15.2	23.0	3.5	1.4	60.6	0.3	3.6	1.6	9.7	11.2	21.3	194.4	136.7	3.7	4.4	21.7	9.8	4.3	1.5	4.8	37.9	1.7	18.1	18.6	22.2	5.4	9.9	8.8	48.3	3.8	9.6	3.5	14.0	8.4	11.6	11.6	25.5	6.5	24.1	4.9	11.4	39.0	14.1	15.9	29.8	21.3	19.3	19.3	23.2	6.4	8.8	4.2	10.4	11.5	26.9	4.8	169.7	49.8	127.3	12.4	26.8	12.2	45.0	15.0	15.0	23.0	36.7	16.4	21.2	431.2	24.8	25.3	22.9	17.2	62.4	385.4	385.5	385.4	962.6	435.8	385.4	421.9	385.4	385.4	402.7	389.3	385.4	386.7	0.8	38.5	47.7	0.0	1.9	6.4	8.5	1.5	0.0	0.0	1.8	1.9	1037.7	0.0	70.7	33.1	0.0	0.5	0.3	0.1	45.0	0.0	0.3	1.8	0.9	32.4	0.0	2.7	0.0	0.0	0.6	67.0	0.0	2.2	55.5	1.1	1.1	2.7	0.7	0.0	0.0	0.1	2.0	1.6	15.9	2.0	2.5	14.8	3.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.5	0.0	454.5	41.3	0.0	0.0	6.6	54.7	1.0	2.3	0.0	4.4	0.3	8.8	4.3	0.0	5.1
MTRNR2L8		ENSG00000255823	"MT-RNR2 like 8"	P0CJ75	11	10507894-10509186	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 15956.5;choroid plexus: 6507.5;skeletal muscle: 7622.1"	"Cell type enriched"	"Detected in many"	11	"Cardiomyocytes: 32407.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 6.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 3689.6;eosinophil: 2784.3;neutrophil: 9219.1"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 9219.1"	"Cell line enhanced"	"Detected in all"		"HeLa: 3532.5;Hep G2: 1873.3"														"Secreted to blood"	NA	NA						"unprognostic (6.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.96e-2)"	1009.0	1793.9	6511.6	333.8	6511.8	484.6	252.0	6510.4	15956.5	106.7	6507.5	914.8	618.2	225.0	266.1	648.5	202.7	303.4	3901.3	6888.0	6511.1	1796.8	1291.3	191.9	200.2	7062.6	6512.3	6503.2	241.3	618.4	514.2	1.3	238.5	6699.1	345.4	748.5	872.2	749.3	274.4	7622.1	626.6	729.9	288.4	6567.0	378.9	687.7	604.5	6511.8	97.7	150.8	1913.9	269.2	203.4	0.6	6538.8	527.3	715.6	334.3	1521.1	294.0	151.4	438.7	562.6	61.4	61.1	75.9	427.1	742.2	698.2	544.0	91.4	54.0	1407.6	10.0	103.2	66.3	307.0	613.3	685.6	3532.5	1873.3	109.4	143.3	625.4	277.5	137.1	58.0	141.0	578.3	54.0	412.8	543.6	353.2	180.7	260.8	202.2	910.4	124.0	222.2	194.5	333.0	287.7	352.4	328.7	447.0	186.5	418.8	248.4	399.0	703.2	282.9	418.6	836.4	416.2	433.8	414.5	508.2	189.6	213.6	116.4	414.1	313.4	1053.0	125.3	3689.6	1275.5	2784.3	319.4	577.0	409.2	944.6	407.8	353.4	445.8	957.8	509.9	480.1	9219.1	466.8	613.2	688.5	439.4	1155.3	6511.6	6511.8	6510.4	15956.5	6888.0	6511.1	7062.6	6512.3	6503.2	6699.1	6567.0	6511.8	6538.8	649.6	830.1	866.0	0.0	131.5	471.7	1069.8	27.1	1.2	0.0	599.2	1010.1	32407.2	124.4	492.7	57.0	0.0	6.9	118.0	2.1	72.4	0.0	23.1	785.5	473.5	1034.0	0.0	139.8	0.0	0.0	6.9	1450.7	3.1	916.4	543.7	140.3	119.2	384.5	12.8	0.0	0.0	0.5	4.1	129.6	1091.1	52.7	65.6	420.6	723.9	0.0	14.5	0.0	8.2	0.0	0.3	0.1	0.3	44.8	92.0	618.5	0.3	770.4	481.4	0.0	65.7	2750.1	1533.4	30.9	38.2	0.8	488.9	11.2	370.6	42.0	0.5	1232.9
MUC13	DRCC1	ENSG00000173702	"Mucin 13, cell surface associated"	Q9H3R2	3	124905442-124953819	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 620.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 853.2;Intestinal goblet cells: 418.5;Paneth cells: 641.9;Proximal enterocytes: 422.5;Undifferentiated cells: 207.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 198.4;stomach cancer: 152.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"OE19: 220.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045163, HPA079663"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA045163: AB_10960396, HPA079663: "	"unprognostic (8.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.64e-2)"	"prognostic unfavorable (9.73e-5)"	"unprognostic (2.05e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.42e-1)"	0.8	0.8	0.0	62.6	0.0	0.1	0.5	0.0	0.1	0.8	0.0	307.4	620.2	1.5	0.0	0.8	2.8	48.3	0.0	0.0	0.0	17.7	3.7	0.3	0.4	0.2	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.3	2.1	304.2	0.0	0.0	0.8	0.0	0.2	507.9	11.0	0.0	0.1	35.7	0.3	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.0	0.0	7.4	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.1	6.4	13.6	0.0	0.8	0.2	0.1	1.0	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.9	0.1	0.0	0.0	1.0	0.0	220.9	1.1	0.0	0.1	2.7	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	3.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	25.8	0.8	0.0	0.0	0.0	0.0	853.2	0.0	24.7	0.9	120.0	1.5	0.4	153.8	0.0	0.1	31.4	0.0	0.0	36.7	6.1	8.9	0.0	0.0	0.0	0.0	0.0	0.2	418.5	0.0	0.3	0.0	4.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.8	641.9	0.7	0.0	1.5	422.5	7.7	10.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	1.5	0.0	207.9	1.4
MUC17		ENSG00000169876	"Mucin 17, cell surface associated"	Q685J3	7	101020072-101058859	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	62	"intestine: 43.0"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 320.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 22.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA031634	Enhanced				"Intracellular and membrane"	NA	NA					"HPA031634: AB_10603021"			"unprognostic (2.37e-2)"	"unprognostic (2.41e-1)"		"unprognostic (8.17e-3)"					"unprognostic (5.57e-3)"	"unprognostic (6.07e-2)"	"unprognostic (8.79e-8)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	43.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.9	14.8	0.0	0.0	0.1	320.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	22.0	0.0
MYOCD	MYCD	ENSG00000141052	Myocardin	Q8IZQ8	17	12665890-12768949	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 47.3;Endometrial stromal cells: 48.5;Peritubular cells: 100.8;Sertoli cells: 26.3;Smooth muscle cells: 32.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 6.5;BJ hTERT+: 6.4;HBF TERT88: 10.4;hTEC/SVTERT24-B: 11.7;REH: 8.4;SuSa: 12.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 4.1"	"CAB046485, HPA071528, HPA072582"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB046485: AB_10600720, HPA071528: , HPA072582: "	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.79e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.15e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (2.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.91e-2)"	3.3	1.1	0.4	4.3	0.6	0.0	1.2	0.3	2.0	8.4	2.7	17.3	2.6	13.1	2.4	13.2	8.6	4.7	14.3	0.5	0.4	0.7	0.2	2.7	0.1	0.6	0.6	0.3	4.4	0.3	0.1	0.2	3.4	0.6	8.8	4.9	0.0	0.2	20.9	0.5	1.1	5.1	15.9	0.5	0.6	6.2	2.1	0.6	0.1	0.7	0.9	0.1	17.3	4.4	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.5	6.4	2.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.4	1.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	12.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.3	2.0	0.5	0.4	0.6	0.6	0.3	0.6	0.5	0.6	0.7	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	47.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	2.0	48.5	1.2	7.8	0.0	1.2	0.2	0.1	3.6	0.0	1.0	0.0	8.4	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	1.0	0.5	0.6	0.2	0.0	9.4	0.0	0.0	0.0	1.0	0.3	0.0	0.0	100.8	0.0	0.1	0.0	0.1	0.0	0.0	26.3	0.2	32.9	0.3	0.8	0.1	0.9	0.5	0.4	6.0	0.0	0.1
NEUROG3	"Atoh5, bHLHa7, Math4B, ngn3"	ENSG00000122859	"Neurogenin 3"	Q9Y4Z2	10	69571698-69573422	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"brain: 4.6;intestine: 2.6"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 9.5;Enteroendocrine cells: 5.3"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.4"	"Group enriched"	"Detected in some"	23	"cerebral cortex: 4.5;hippocampal formation: 4.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"THP-1: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039785	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA039785: AB_10795114"	"unprognostic (1.22e-2)"		"unprognostic (7.33e-2)"		"unprognostic (3.04e-2)"			"unprognostic (2.42e-1)"		"unprognostic (1.10e-1)"	"unprognostic (1.65e-2)"		"unprognostic (5.85e-5)"	"unprognostic (4.58e-2)"	"unprognostic (4.19e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	4.5	0.0	0.0	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.5	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
NKX6-3	FLJ25169	ENSG00000165066	"NK6 homeobox 3"	A6NJ46	8	41645177-41650817	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 10.9;stomach 1: 28.2"	"Cell type enriched"	"Detected in single"	5	"Gastric mucus-secreting cells: 2.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.1;stomach cancer: 3.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Daudi: 4.9;THP-1: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.87e-1)"	"unprognostic (9.91e-3)"		"unprognostic (4.04e-1)"	"unprognostic (5.73e-2)"			"unprognostic (1.98e-1)"		"unprognostic (1.65e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.13e-1)"		"unprognostic (2.17e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.78e-1)"		0.0	0.0	0.4	0.1	0.6	0.1	0.0	2.6	1.1	0.0	0.4	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	1.5	0.5	1.1	0.5	0.0	0.9	1.8	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.3	28.2	0.1	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	2.6	1.1	0.5	0.5	0.5	1.1	0.5	1.3	0.5	0.4	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NMUR2	NMU2R	ENSG00000132911	"Neuromedin U receptor 2"	Q9GZQ4	5	152391546-152433368	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 6.2"	"Group enriched"	"Detected in some"	13	"Gastric mucus-secreting cells: 5.1;Oligodendrocytes: 8.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8;stomach cancer: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 9.6"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.7"	"Low region specificity"	"Detected in all"			"HPA027800, HPA045836"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA027800: , HPA045836: AB_10968856"	"unprognostic (1.82e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.44e-3)"		"unprognostic (3.13e-1)"		"unprognostic (6.47e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.90e-5)"	"unprognostic (1.48e-2)"	"unprognostic (9.24e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.29e-1)"	0.0	0.1	1.0	0.0	3.1	0.0	0.0	1.1	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.6	2.6	0.2	0.0	0.3	0.0	3.9	2.1	0.3	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.1	0.0	1.0	1.5	2.7	0.6	0.5	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	9.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.1	1.1	1.8	0.6	2.6	3.9	2.1	0.3	3.8	3.1	2.7	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	5.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
NOTUM		ENSG00000185269	"Notum, palmitoleoyl-protein carboxylesterase"	Q6P988	17	81952507-81961840	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"placenta: 136.8"	"Cell type enriched"	"Detected in some"	45	"Extravillous trophoblasts: 1002.5"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 48.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 428.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022851			Approved	"Endoplasmic reticulum"	"Secreted in female reproductive system"	NA	NA		1900000	"Endoplasmic reticulum"		"HPA022851: "	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.02e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.48e-6)"	"unprognostic (1.76e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.00e-1)"	0.0	0.1	1.3	0.0	1.5	0.0	0.2	0.5	1.7	0.2	0.0	0.0	1.1	2.1	0.3	0.3	0.4	0.2	0.2	0.9	0.8	0.6	10.1	2.2	0.0	2.0	2.6	0.9	0.1	0.4	0.9	0.2	136.8	1.3	0.3	0.0	0.0	0.6	0.2	8.3	1.9	0.3	0.1	0.6	0.2	2.1	2.8	1.3	0.0	0.0	0.5	0.0	1.4	0.2	1.4	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.1	10.0	0.4	0.0	1.8	0.3	0.2	0.4	2.4	0.0	0.0	0.1	1.1	2.2	2.8	428.6	0.2	0.4	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.2	11.2	0.0	0.0	0.6	0.0	0.2	0.1	67.9	0.4	0.0	0.2	0.1	0.0	0.2	15.7	1.6	4.2	1.7	6.2	2.3	0.1	4.9	0.0	0.5	6.3	0.0	0.2	0.1	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	0.5	1.7	0.9	0.8	2.0	2.6	0.9	1.3	0.6	1.3	1.4	0.0	0.0	3.7	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.6	1.3	1.2	0.0	0.0	0.0	0.0	10.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.8	0.0	0.0	0.6	0.0	1002.5	1.2	1.5	0.3	0.0	0.1	0.0	3.6	18.4	0.0	1.1	0.1	0.0	0.0	0.3	0.2	0.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.5	12.7	0.0	0.0	22.0	0.1	0.0	0.3	0.0
PABPC3	"PABP3, PABPL3, tPABP"	ENSG00000151846	"Poly(A) binding protein cytoplasmic 3"	Q9H361	13	25096136-25099254	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	42	"testis: 37.1"	"Group enriched"	"Detected in many"	14	"Early spermatids: 217.6;Late spermatids: 135.4;Spermatocytes: 190.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"U-266/84: 6.8"									"HPA045423, HPA067156"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA045423: AB_2679320, HPA067156: AB_2685793"	"unprognostic (2.17e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (8.00e-4)"	"unprognostic (5.26e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.61e-3)"	0.4	0.2	0.1	0.0	0.2	0.0	0.4	0.2	0.2	0.3	0.0	0.3	0.0	0.3	0.0	0.8	0.2	0.0	0.1	0.2	0.1	0.1	0.2	0.4	0.0	0.2	0.2	0.1	0.5	0.4	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.7	0.0	0.1	0.5	0.3	0.0	0.2	0.2	0.3	37.1	0.2	0.0	0.2	0.0	0.0	0.3	0.6	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	6.8	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.4	0.3	0.3	0.3	0.2	0.4	0.2	0.4	0.4	0.1	0.3	0.4	0.2	0.3	0.5	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.1	0.0	0.0	0.0	1.3	11.7	9.9	2.8	0.0	0.1	0.4	0.0	5.3	0.0	1.3	0.0	0.0	2.0	4.0	0.9	0.0	0.3	217.6	0.2	0.4	2.5	4.2	2.7	0.0	0.4	1.8	2.0	0.0	0.1	4.5	0.1	2.5	1.0	1.6	1.7	0.0	1.6	2.0	5.7	12.7	135.4	3.1	1.9	5.4	0.0	2.1	1.3	0.0	0.0	0.0	0.1	3.0	4.9	0.0	4.5	0.5	2.0	1.0	0.0	6.6	4.8	10.5	190.8	5.1	0.0	12.9	2.9	2.5	0.2	2.7	5.0
PGC		ENSG00000096088	Progastricsin	P20142	6	41736711-41754109	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	45	"stomach 1: 60305.0"	"Group enriched"	"Detected in some"	10	"Gastric mucus-secreting cells: 5737.5;Pancreatic endocrine cells: 1449.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 1050.3"	"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Hep G2: 253.1;OE19: 152.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031717, HPA031718"	Enhanced		Approved	Nucleoplasm	"Secreted to digestive system"	NA	NA			Nucleoplasm		"HPA031717: AB_10670130, HPA031718: AB_10610148"	"unprognostic (9.18e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.50e-2)"		"unprognostic (1.86e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"		"unprognostic (8.74e-2)"	10.0	7.1	0.1	0.3	0.1	0.2	6.6	1.1	0.5	5.1	0.0	14.9	1339.4	2.8	0.9	86.2	9.3	2.4	4.3	0.1	0.0	5.0	11.1	382.0	0.3	0.1	0.1	0.0	3.9	137.4	0.0	7.5	2.9	0.6	84.6	0.3	0.1	4.6	441.7	2.5	3.3	3.2	0.0	0.0	7.8	60305.0	4.2	0.0	0.1	2.2	0.0	0.3	3.8	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.1	0.0	0.0	18.4	0.0	0.0	0.6	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	253.1	0.0	0.3	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.9	5.7	152.2	0.0	2.9	0.0	6.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	3.7	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.5	0.1	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.4	0.0	25.6	335.2	0.0	4.4	0.4	2.8	0.0	0.0	0.0	0.3	0.8	0.3	87.2	5.0	0.0	0.0	1.2	0.0	0.3	0.0	4.6	0.0	0.4	0.0	1.1	0.0	0.0	0.3	131.2	1.5	0.9	5737.5	0.1	10.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	1.7	0.0	0.0	2.0	0.0	0.0	0.0	0.1	1449.1	2.1	0.0	2.4	85.2	0.1	0.2	3.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	4.1	2.6	0.0	0.2	4.2
PIK3C2G		ENSG00000139144	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma"	O75747	12	18242961-18648416	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Chemotaxis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 16.8;stomach 1: 21.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 44.9;Breast glandular cells: 30.4;Breast myoepithelial cells: 37.6;Collecting duct cells: 40.5;Gastric mucus-secreting cells: 140.6"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 1.2;HaCaT: 2.1;hTERT-HME1: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.29e-1)"	"unprognostic (1.61e-1)"		"unprognostic (6.21e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.46e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.98e-1)"		"unprognostic (2.37e-2)"	0.0	0.6	0.5	0.0	0.1	0.1	9.8	0.4	0.4	0.1	0.1	0.1	0.5	0.1	16.8	2.4	1.2	6.3	0.0	0.2	1.0	4.6	12.1	0.3	0.1	0.1	0.1	0.2	0.0	1.4	4.8	0.0	0.0	0.1	0.9	0.2	0.1	3.7	9.5	0.0	9.7	3.4	0.0	0.4	0.1	21.9	0.4	0.3	0.1	0.0	0.1	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.4	0.4	0.2	1.0	0.1	0.1	0.2	0.1	0.4	0.3	0.3	1.1	0.0	0.0	1.3	0.7	17.5	8.5	0.3	44.9	0.0	30.4	37.6	0.3	27.1	0.8	40.5	0.0	1.2	0.4	0.2	1.9	2.0	9.0	4.5	1.5	1.2	0.0	2.7	2.9	0.0	4.8	0.4	140.6	10.1	0.0	0.0	0.7	27.4	0.2	0.0	1.8	2.3	0.0	0.8	1.1	1.8	0.0	0.5	1.8	7.5	0.0	0.0	0.0	1.5	1.4	0.8	5.1	0.0	1.3	0.8	18.4	1.3	0.1	0.0	0.0	0.1	0.5	2.4	3.0	27.3	21.5	0.8	1.0	0.0	3.0	1.6
PLA2G10	GXPLA2	ENSG00000069764	"Phospholipase A2 group X"	O15496	16	14672548-14694308	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 27.6;pancreas: 10.6;stomach 1: 42.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 280.1;Exocrine glandular cells: 116.3;Gastric mucus-secreting cells: 116.2;Intestinal goblet cells: 137.7;Paneth cells: 225.3"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 6.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.6;CAPAN-2: 6.4;HaCaT: 2.2;MCF7: 2.3;OE19: 5.9;SK-BR-3: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA041893	Uncertain				"Secreted in other tissues"	NA	NA					"HPA041893: AB_10794495"	"unprognostic (8.44e-3)"	"unprognostic (2.37e-1)"	"unprognostic (6.72e-2)"	"prognostic favorable (5.74e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-2)"	"unprognostic (9.97e-3)"	0.0	0.2	0.1	2.4	0.1	0.1	0.1	0.1	0.2	1.4	0.1	27.6	7.7	0.1	0.0	0.2	4.5	3.5	0.0	0.1	0.1	0.0	0.0	4.8	0.2	0.1	0.1	0.1	0.0	10.6	0.0	0.0	0.3	0.1	0.4	23.8	0.0	0.1	0.0	0.0	0.0	7.0	0.6	0.1	0.0	42.2	2.2	0.1	0.0	0.0	0.0	0.3	4.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.5	6.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	5.9	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	3.4	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	35.3	23.1	0.7	0.3	0.0	0.9	3.7	0.6	0.0	0.7	0.5	0.1	5.7	17.9	1.8	0.0	0.6	0.1	280.1	0.0	2.6	0.3	25.1	3.5	0.2	12.7	0.0	0.5	116.3	56.7	0.1	116.2	45.7	0.0	0.4	0.0	0.0	0.9	0.0	0.3	137.7	24.4	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	20.5	225.3	0.0	0.7	1.3	16.1	0.0	60.1	0.0	0.0	0.0	2.0	1.1	1.2	1.7	0.0	0.5	0.5	0.0	57.3	14.6
PLAC8	"C15, onzin"	ENSG00000145287	"Placenta associated 8"	Q9NZF1	4	83090048-83137075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 369.2;esophagus: 92.8;intestine: 238.2;lymphoid tissue: 156.4;stomach 1: 118.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 1118.2;Distal enterocytes: 1514.4;Extravillous trophoblasts: 572.2;NK-cells: 1103.0;Paneth cells: 865.7;Respiratory ciliated cells: 549.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 17.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 2310.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 183.2;CAPAN-2: 510.7;HL-60: 329.1;NB-4: 160.1;RPMI-8226: 238.2;THP-1: 187.8;U-937: 149.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040465, HPA077912"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA040465: AB_10794875, HPA077912: AB_2686870"	"unprognostic (6.82e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-7)"	"unprognostic (3.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	9.3	2.0	2.5	82.1	4.5	369.2	3.8	2.7	4.2	33.1	1.5	238.2	79.6	2.7	1.2	92.8	18.9	6.6	2.2	1.9	2.6	2.6	35.7	41.5	94.5	5.1	2.9	2.1	1.1	1.6	0.5	2.0	34.0	6.0	3.7	164.8	1.1	6.7	2.3	2.1	1.0	89.3	18.7	1.5	156.4	118.6	0.8	7.3	40.8	2.6	0.8	138.6	11.1	5.9	10.3	183.2	1.3	0.5	1.1	0.0	0.2	28.6	4.6	1.1	11.1	13.7	3.5	510.7	30.7	1.5	52.3	17.0	18.7	3.2	1.4	41.6	0.2	0.6	0.8	33.4	15.2	1.8	329.1	1.7	0.9	3.6	1.8	2.4	0.3	0.8	16.0	0.4	2.6	29.5	0.8	62.6	160.1	1.0	14.4	0.9	8.0	10.6	238.2	0.9	5.4	25.8	0.5	1.2	29.1	0.6	9.0	1.6	187.8	1.3	1.1	31.7	0.9	0.9	1.8	0.4	81.7	2.3	149.7	0.2	49.2	139.2	95.9	392.1	635.8	299.4	523.8	185.1	229.2	129.5	481.1	225.9	263.4	29.7	1053.3	358.9	2310.7	13.8	577.1	2.5	4.5	2.7	4.2	1.9	2.6	5.1	2.9	2.1	6.0	1.5	7.3	10.3	4.3	195.5	39.2	0.3	247.4	0.4	1.7	77.3	0.0	0.3	0.9	1.4	0.5	2.8	119.1	0.0	0.0	18.5	1118.2	1514.4	0.0	0.3	0.5	45.6	1.1	95.0	86.8	58.4	0.1	3.6	572.2	3.1	119.8	2.9	26.6	0.6	141.0	8.4	21.7	1.7	0.1	231.2	67.1	384.5	7.4	0.6	0.0	213.3	7.2	1.0	157.3	1.2	1103.0	0.0	0.2	99.0	865.7	0.0	35.7	1.1	374.4	1.4	549.6	0.3	6.6	0.7	8.0	0.2	0.8	10.1	0.1	14.2	150.6	0.1	104.2	9.0
PRRG3	TMG3	ENSG00000130032	"Proline rich and Gla domain 3"	Q9BZD7	X	151694607-151705924	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.5;epididymis: 7.5"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 18.4;Excitatory neurons: 12.7;Fibroblasts: 15.2;Inhibitory neurons: 8.9;Langerhans cells: 22.4;Suprabasal keratinocytes: 22.6"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.3"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.0;SuSa: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060566	Uncertain					NA	NA					"HPA060566: AB_2684321"	"unprognostic (1.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.42e-4)"	"unprognostic (7.24e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.84e-2)"	1.9	0.2	6.1	0.2	9.4	0.2	1.8	0.0	11.5	5.0	0.3	1.0	0.1	1.7	7.5	2.3	0.9	2.0	1.3	7.2	5.2	0.4	0.0	1.2	0.1	2.1	2.8	9.3	2.1	0.1	0.2	1.5	0.8	3.5	0.6	0.6	0.7	1.7	0.2	2.4	1.5	0.4	1.4	0.0	1.7	0.6	0.3	5.9	1.2	0.9	2.0	0.2	1.1	2.7	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.2	0.3	0.2	0.2	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.6	0.5	0.4	0.3	0.2	0.2	6.1	9.4	0.0	11.5	7.2	5.2	2.1	2.8	9.3	3.5	0.0	5.9	7.6	7.4	0.0	0.0	0.7	0.1	18.4	0.4	0.0	2.8	0.1	0.6	1.7	4.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	3.9	0.0	0.0	0.2	0.7	5.7	0.0	0.0	12.7	0.0	0.0	15.2	0.0	0.5	0.0	0.5	1.4	0.2	0.1	0.0	8.9	0.0	0.0	0.0	22.4	0.0	0.3	0.3	7.2	1.0	0.0	0.1	0.0	1.0	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.3	0.0	3.1	2.1	0.0	0.1	0.2	22.6	0.0	1.3	0.3	0.0	0.3
PRTN3	"ACPA, AGP7, C-ANCA, MBT, P29, PR-3"	ENSG00000196415	"Proteinase 3"	P24158	19	840999-848175	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"bone marrow: 2115.4"	"Cell type enriched"	"Detected in some"	17	"Erythroid cells: 26.5"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.0"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.0"	"Cell line enriched"	"Detected in some"	6	"THP-1: 2054.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005938, CAB017558"	Enhanced		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		390000	Cytosol	Vesicles	"CAB017558: AB_2172317, HPA005938: AB_1855764"	"unprognostic (2.81e-2)"			"unprognostic (2.10e-1)"	"unprognostic (3.83e-3)"		"unprognostic (4.20e-1)"	"unprognostic (3.31e-2)"		"unprognostic (3.34e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.67e-2)"	"unprognostic (8.62e-6)"	"unprognostic (5.31e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.14e-2)"		0.5	0.2	0.5	0.0	0.7	2115.4	0.4	0.2	1.3	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	1.1	0.6	0.4	0.3	2.8	11.8	0.4	0.3	0.4	0.5	0.1	0.1	0.2	1.3	0.6	0.4	0.3	0.0	0.0	1.6	0.0	0.3	1.3	0.0	0.0	0.2	38.5	0.1	0.2	0.5	7.2	0.4	0.0	0.0	0.0	0.1	0.4	1.2	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	343.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2054.4	0.0	0.0	0.0	0.2	0.9	0.0	0.2	0.3	0.0	14.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	9.9	0.5	0.7	0.2	1.3	0.6	0.4	0.3	0.4	0.5	0.4	0.2	0.5	0.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.8	1.3	0.4	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	26.5	0.4	0.0	0.9	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	1.5	0.0	0.1	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.1
RFLNA	"Cfm2, FAM101A, FLJ44614, RefilinA"	ENSG00000178882	"Refilin A"	Q6ZTI6	12	123973241-124316024	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 95.5"	"Cell type enriched"	"Detected in some"	22	"Pancreatic endocrine cells: 113.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 19.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 13.8;HUVEC TERT2: 19.8;LHCN-M2: 34.8;OE19: 37.0;RH-30: 11.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA058911, HPA078021"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA058911: AB_2683853, HPA078021: AB_2732368"	"unprognostic (1.71e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.78e-4)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.16e-5)"	"unprognostic (8.87e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.77e-8)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.37e-2)"	1.8	1.1	4.0	2.3	3.7	0.0	1.8	5.2	5.4	9.4	6.0	15.4	14.1	1.7	0.4	0.6	3.0	0.6	0.4	3.1	5.2	1.4	0.1	1.2	0.2	15.6	6.6	2.2	2.9	0.3	0.3	2.1	0.6	19.1	4.3	10.5	0.3	2.3	0.3	5.5	1.3	15.3	0.5	3.3	0.1	95.5	0.2	4.0	0.2	0.1	3.2	0.1	0.5	1.3	11.9	0.0	0.0	2.7	0.0	0.0	0.0	3.5	0.0	0.0	0.4	0.4	1.8	1.3	0.0	0.1	4.9	0.2	0.0	2.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.2	0.8	0.0	13.8	0.1	0.8	19.8	2.1	0.0	0.0	34.8	0.0	0.1	0.0	2.9	37.0	0.0	0.0	11.1	0.2	0.0	0.0	1.4	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.7	5.2	5.4	3.1	5.2	15.6	6.6	2.2	19.1	3.3	4.0	11.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.5	0.0	0.1	0.5	0.1	0.0	0.0	0.0	2.6	0.1	0.6	0.0	0.2	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RGS13		ENSG00000127074	"Regulator of G protein signaling 13"	O14921	1	192636138-192660311	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 48.4"	"Cell type enriched"	"Detected in some"	16	"granulocytes: 520.0"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	39	"basophil: 6.8"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 6.8"	"Cell line enriched"	"Detected in some"	20	"Daudi: 47.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA076656	Enhanced					NA	NA					"HPA076656: "	"unprognostic (1.99e-2)"	"unprognostic (6.08e-3)"	"unprognostic (3.25e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.96e-1)"	0.5	0.0	0.0	9.6	0.0	0.7	2.3	0.0	0.0	1.6	0.0	2.3	3.1	1.0	0.7	1.7	0.3	3.7	0.1	0.0	0.0	0.0	0.0	4.0	48.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	1.6	0.0	0.3	0.6	0.0	0.3	5.7	1.2	0.0	0.3	2.1	0.1	0.0	1.3	0.0	0.2	35.4	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	30.8	0.0	4.8	1.9	2.1	0.0	0.0	0.0	0.1	0.3	0.3	0.0	1.3	0.0	0.0	0.0	2.9	0.1	0.0	0.1	0.0	0.0	0.0	0.3	7.1	0.0	0.2	0.0	0.0	0.9	12.2	0.0	520.0	0.0	0.0	0.0	0.3	0.0	0.6	0.6	0.0	0.6	7.1	0.0	0.0	3.8	7.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	3.9	1.7	0.2	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.3	0.0	7.9	0.5	1.6	0.1
SI		ENSG00000090402	Sucrase-isomaltase	P14410	3	164978898-165078496	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	150	"intestine: 550.1"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 1083.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 6.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;CACO-2: 1.5;HeLa: 1.2;NB-4: 1.3;RPMI-8226: 2.0;SH-SY5Y: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011897	Enhanced					NA	NA					"HPA011897: AB_1856840"			"unprognostic (2.71e-2)"								"unprognostic (1.62e-2)"	"unprognostic (2.68e-1)"		"unprognostic (2.05e-1)"	"unprognostic (4.41e-2)"			0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	550.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	31.3	0.0	0.0	0.0	0.0	0.0	451.9	0.9	0.0	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	9.7	0.0	0.0	0.1	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	123.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	124.7	0.0	0.0	0.3	1083.9	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	77.8	0.0
SLC28A2	"CNT2, HCNT2, HsT17153, SPNT1"	ENSG00000137860	"Solute carrier family 28 member 2"	O43868	15	45252234-45277846	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 93.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.6;Paneth cells: 35.7;Proximal enterocytes: 43.4;Undifferentiated cells: 48.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 3.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046068, HPA055623"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA046068: AB_2679523, HPA055623: AB_2682866"	"unprognostic (2.75e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.40e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.95e-2)"	0.1	0.3	0.5	0.7	0.5	0.1	0.0	0.3	0.6	2.6	0.0	9.6	68.6	0.5	0.4	0.1	0.1	9.9	0.3	0.4	0.1	3.6	0.8	0.1	0.3	1.2	0.4	0.2	0.3	0.3	0.0	0.0	0.6	1.1	0.1	35.0	0.7	0.2	0.0	0.3	0.3	93.0	0.0	0.1	0.2	23.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.6	0.4	0.1	1.2	0.4	0.2	1.1	0.1	0.2	0.7	0.5	0.0	8.1	1.6	0.9	0.1	0.4	0.4	0.0	2.9	0.3	0.0	0.7	8.6	4.5	0.0	2.1	12.3	0.3	19.6	0.0	0.1	0.7	1.0	0.4	1.0	13.9	2.7	1.8	0.0	2.7	1.0	4.6	1.2	8.8	0.7	0.7	0.3	0.9	1.7	1.5	14.5	0.0	0.3	0.4	0.4	0.0	1.3	0.0	0.0	0.2	1.0	2.1	2.0	2.0	0.0	35.7	0.7	0.4	0.2	43.4	1.2	4.6	6.6	0.0	0.3	0.2	2.4	2.1	0.0	0.3	4.7	1.3	0.2	48.9	0.2
SLC9A3	NHE3	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470456-524449	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 45.8;intestine: 95.1;kidney: 63.1;stomach 1: 50.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Proximal tubular cells: 40.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 37.8"	"Region enriched"	"Detected in single"	14	"cerebellum: 4.1"	"Low region specificity"	"Detected in many"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (1.27e-1)"	"unprognostic (4.88e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-1)"	2.9	4.4	2.9	10.5	3.1	2.0	3.1	5.5	5.2	3.8	1.4	95.1	46.4	2.9	4.0	8.8	4.9	45.8	3.2	4.9	2.2	63.1	2.4	2.8	3.9	3.4	2.4	3.0	4.3	6.7	6.3	0.7	2.1	3.8	7.3	10.9	1.7	10.0	3.8	6.2	19.1	68.6	3.3	1.6	3.7	50.6	5.9	4.2	3.6	4.9	4.0	3.4	2.5	2.5	3.9	6.7	5.1	10.4	10.5	2.5	3.0	7.8	5.3	3.9	8.0	5.0	11.0	7.4	14.0	7.5	3.0	5.5	10.0	6.1	4.0	3.9	37.8	10.7	6.7	23.4	5.4	3.9	5.5	8.2	4.2	8.1	3.5	5.4	3.9	2.4	6.3	9.6	7.5	2.9	9.0	6.0	24.3	4.0	17.8	8.3	8.6	9.3	8.3	2.8	4.8	11.5	5.0	19.0	5.3	4.2	4.5	12.3	4.2	2.9	8.0	7.2	5.3	3.9	12.4	5.8	8.5	5.2	21.2	5.6	0.0	0.7	0.1	2.6	0.3	2.2	0.9	3.3	2.4	0.9	1.0	3.9	3.1	0.1	2.4	0.2	1.2	2.7	1.8	2.9	3.1	5.5	5.2	4.9	2.2	3.4	2.4	3.0	3.8	1.6	4.2	3.9	3.8	16.0	5.8	0.0	1.5	0.0	0.0	0.0	0.0	0.0	7.3	8.9	0.7	0.0	5.6	16.5	0.0	0.0	3.4	0.7	5.9	9.0	0.0	3.8	3.6	2.3	0.0	0.0	0.3	8.8	0.0	2.2	0.0	2.6	2.5	5.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	4.6	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.7	0.0	1.1	40.7	2.9	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	2.3	5.4	0.0	0.0
SMYD1	"BOP, KMT3D, ZMYND22"	ENSG00000115593	"SET and MYND domain containing 1"	Q8NB12	2	88067825-88113384	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"heart muscle: 157.9;skeletal muscle: 498.3;tongue: 304.0"	"Cell type enriched"	"Detected in some"	27	"Cardiomyocytes: 208.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.9;stomach cancer: 1.6"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HSkMC: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA062282	Enhanced					NA	NA					"HPA062282: AB_2684736"	"unprognostic (1.93e-2)"		"unprognostic (2.49e-1)"		"unprognostic (4.09e-2)"	"unprognostic (8.51e-3)"			"unprognostic (2.74e-1)"		"unprognostic (3.91e-1)"			"unprognostic (8.81e-3)"	"unprognostic (1.40e-1)"			0.0	0.0	0.2	0.2	3.1	0.0	5.4	0.1	1.0	0.0	0.0	12.0	2.0	0.0	0.0	7.4	0.0	0.0	157.9	0.4	0.1	0.0	0.0	0.1	0.0	1.3	0.2	0.7	0.0	0.3	2.5	0.0	0.0	0.3	4.1	1.9	0.0	4.0	0.0	498.3	0.1	7.0	28.3	0.1	0.0	7.4	0.3	0.1	0.4	0.1	304.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.1	0.1	1.0	0.4	0.1	1.3	0.2	0.7	0.3	0.1	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.7	208.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPDYE2	MGC119295	ENSG00000205238	"Speedy/RINGO cell cycle regulator family member E2"	Q495Y8	7	102551232-102562308	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.9;testis: 10.9"	"Group enriched"	"Detected in some"	4	"Astrocytes: 7.2;Excitatory neurons: 9.1;Inhibitory neurons: 7.0;Microglial cells: 6.5;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 6.2"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 14.5;Karpas-707: 10.5"									HPA051750	Supported					NA	NA					"HPA051750: AB_2681590"	"unprognostic (2.04e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.49e-3)"	"unprognostic (7.94e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.04e-1)"	0.8	0.9	2.9	2.6	2.1	5.2	0.8	1.4	3.7	1.0	0.8	1.0	1.1	1.2	0.0	1.2	0.9	0.5	1.1	2.1	0.2	1.0	0.9	1.2	2.6	2.3	2.3	0.5	1.2	1.5	0.0	1.3	0.7	7.9	1.2	0.0	2.3	1.2	0.1	5.0	3.8	1.7	0.0	0.1	2.5	1.3	10.9	1.4	0.0	1.7	0.1	0.0	1.0	1.2	4.9	3.0	4.9	2.1	2.9	0.0	0.0	3.9	2.3	0.0	0.0	0.0	2.3	2.0	3.5	1.8	0.0	0.6	3.1	0.0	0.0	0.0	2.2	2.4	1.5	14.5	1.3	0.0	4.2	1.1	0.0	0.0	0.0	0.0	0.6	0.0	1.8	4.6	10.5	0.0	6.0	2.2	2.3	1.8	0.9	0.6	3.5	0.8	3.5	0.0	5.5	2.0	1.2	8.0	1.0	0.7	3.2	2.0	1.1	1.9	6.9	1.7	3.5	3.5	2.4	1.8	2.3	1.1	4.8	2.7	2.6	2.0	0.4	1.7	0.8	1.2	1.6	1.5	1.1	0.6	2.2	1.2	1.1	3.1	0.5	0.9	2.5	0.8	0.6	2.9	2.1	1.4	3.7	2.1	0.2	2.3	2.3	0.5	7.9	0.1	1.4	4.9	0.0	0.0	1.1	7.2	0.3	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	9.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	6.5	0.0	0.0	0.0	4.5	6.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0
TMEM238		ENSG00000233493	"Transmembrane protein 238"	C9JI98	19	55379244-55384292	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.0;stomach 1: 16.7"	"Group enriched"	"Detected in many"	4	"Breast glandular cells: 102.2;Breast myoepithelial cells: 233.7;Endometrial ciliated cells: 80.6;Glandular and luminal cells: 104.2"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 52.1;stomach cancer: 48.5"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 30.6;CAPAN-2: 18.3;HaCaT: 27.3;RPMI-8226: 19.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.90e-2)"	"unprognostic (7.93e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.49e-2)"	"unprognostic (5.33e-2)"	"prognostic favorable (8.84e-6)"	"unprognostic (1.78e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.17e-3)"	1.1	1.0	0.6	2.5	0.5	1.1	2.4	2.4	1.0	1.3	2.5	16.0	14.0	0.5	0.2	8.9	1.5	0.1	0.3	0.6	0.5	4.8	9.0	3.2	0.8	1.0	0.9	0.5	0.4	13.5	1.1	3.1	0.1	1.2	4.4	2.0	0.1	9.3	0.4	1.0	6.8	14.5	0.1	0.5	1.6	16.7	0.3	0.6	0.3	6.3	0.0	0.6	1.9	3.3	0.7	30.6	2.1	0.1	1.7	0.0	0.0	1.7	1.3	0.1	0.0	0.0	1.3	18.3	13.8	5.5	0.1	0.0	27.3	0.5	0.7	0.1	4.0	0.8	0.4	2.6	0.0	0.1	2.9	0.5	0.0	3.7	0.1	0.6	0.2	0.0	2.5	1.8	11.3	0.0	6.8	3.7	1.6	0.8	7.6	9.5	6.8	0.2	19.0	1.2	9.6	9.1	2.9	1.2	14.2	2.1	0.1	10.8	1.7	0.0	0.3	2.4	0.1	0.3	7.5	5.1	3.5	0.1	1.6	0.2	0.0	0.0	0.1	0.4	0.0	1.0	0.6	1.0	0.7	0.0	0.4	0.7	0.6	0.0	0.2	0.0	0.2	1.3	0.1	0.6	0.5	2.4	1.0	0.6	0.5	1.0	0.9	0.5	1.2	0.5	0.6	0.7	13.0	0.0	2.4	0.0	20.2	8.5	3.7	0.5	1.2	0.3	102.2	233.7	1.1	27.1	0.5	7.3	0.0	0.0	21.4	29.1	1.9	1.9	0.0	80.6	8.2	2.4	13.8	0.4	0.4	4.3	0.1	2.0	4.1	104.2	0.0	4.5	1.4	13.6	0.3	3.3	0.4	22.8	0.0	2.8	4.9	0.0	0.0	4.3	1.8	0.0	0.7	8.6	2.1	0.0	0.4	3.9	12.9	0.0	16.5	2.3	12.3	1.8	0.5	1.5	0.0	6.3	2.6	0.0	0.0	3.1	26.0	0.0	19.9	2.7	20.3	3.8
TRAJ19		ENSG00000211870	"T cell receptor alpha joining 19 (non-functional)"		14	22525263-22525322	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.5;retina: 20.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.7;memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Group enriched"	"Detected in some"	22	"U-266/84: 2.3;U-698: 2.0"															NA	NA																			"unprognostic (2.39e-2)"				0.0	2.2	4.7	2.4	3.4	2.0	1.3	2.8	1.7	0.0	1.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.3	0.0	1.0	7.5	1.7	0.9	1.0	0.0	0.0	0.0	0.0	1.0	2.3	0.4	0.8	20.9	0.0	0.0	0.0	3.4	0.0	1.3	0.8	1.9	3.3	0.6	1.3	7.1	0.4	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.9	1.7	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.3	4.7	3.4	2.8	1.7	0.7	1.2	1.7	0.9	1.0	2.3	0.8	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRAJ2		ENSG00000211887	"T cell receptor alpha joining 2 (non-functional)"		14	22544071-22544136	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	5	"retina: 73.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.7"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.7;memory CD8 T-cell: 2.6"	"Lineage enriched"	"Detected in single"	27	"T-cells: 2.6"	"Cell line enriched"	"Detected in some"	9	"JURKAT: 73.0"															NA	NA																			"unprognostic (1.43e-1)"				0.0	0.0	0.4	7.5	0.9	2.2	0.0	0.6	1.4	2.4	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	4.9	10.0	1.6	0.4	0.1	0.0	0.0	0.0	0.0	0.6	0.6	0.7	4.6	73.7	0.0	0.0	0.0	0.0	8.1	0.0	0.9	15.6	6.7	0.1	0.6	13.0	0.0	0.0	2.7	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	73.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.7	2.6	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.9	0.6	1.4	0.3	0.2	1.6	0.4	0.1	0.6	0.9	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRAJ35		ENSG00000211854	"T cell receptor alpha joining 35 (non-functional)"		14	22506644-22506702	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	4	"lymphoid tissue: 6.8;retina: 14.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	17	"gdT-cell: 39.7;MAIT T-cell: 28.6;memory CD4 T-cell: 56.7;memory CD8 T-cell: 41.6;naive CD4 T-cell: 71.1;naive CD8 T-cell: 47.3;T-reg: 73.5"	"Lineage enriched"	"Detected in many"	24	"T-cells: 73.5"	"Group enriched"	"Detected in some"	7	"AF22: 9.5;U-266/84: 35.6"															NA	NA																			"unprognostic (1.05e-1)"				0.0	0.0	0.5	0.0	0.6	0.0	0.0	1.4	0.7	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	1.2	2.4	0.0	0.4	3.3	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	14.3	1.6	0.0	0.0	0.0	0.0	1.3	0.6	0.0	1.3	0.0	0.7	6.8	0.0	0.0	3.1	0.1	0.0	2.2	1.9	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.6	3.1	0.0	0.0	0.0	0.3	0.4	0.1	39.7	0.0	28.6	0.4	56.7	41.6	0.4	0.3	71.1	47.3	3.0	0.0	0.6	0.1	73.5	19.7	0.5	0.6	1.4	0.7	0.5	1.2	1.0	0.7	0.0	0.7	0.6	0.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRAJ36		ENSG00000276699	"T cell receptor alpha joining 36"		14	22505110-22505167	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	5	"retina: 26.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	24	"memory CD4 T-cell: 61.3;memory CD8 T-cell: 53.5;naive CD4 T-cell: 64.1;naive CD8 T-cell: 46.3;T-reg: 116.9"	"Lineage enriched"	"Detected in single"	135	"T-cells: 116.9"	"Cell line enhanced"	"Detected in some"		"JURKAT: 6.4;SCLC-21H: 2.2;U-698: 1.2"															NA	NA																			"unprognostic (8.03e-3)"				0.0	0.0	0.8	2.2	3.1	3.8	0.6	2.0	1.9	0.0	1.5	0.4	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.8	2.9	0.4	0.0	0.0	3.2	2.8	1.6	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.9	26.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.5	0.0	0.0	1.3	2.0	0.0	0.0	5.6	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.5	0.0	2.7	0.0	2.5	0.4	61.3	53.5	0.0	0.1	64.1	46.3	0.8	0.1	0.0	0.0	116.9	24.1	0.8	3.1	2.0	1.9	0.8	2.9	2.8	1.6	0.2	1.6	1.6	1.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM40	RNF35	ENSG00000204614	"Tripartite motif containing 40"	Q6P9F5	6	30136124-30148735	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 3.0;liver: 1.6;testis: 1.4"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 20.1;Paneth cells: 24.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.7;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HEL: 1.1"	"Region enriched"	"Detected in single"	18	"thalamus: 3.1"	"Low region specificity"	"Detected in many"			HPA043818	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA043818: AB_10963090"		"unprognostic (2.88e-1)"	"unprognostic (5.20e-2)"			"unprognostic (4.11e-1)"	"unprognostic (1.13e-1)"				"unprognostic (1.77e-1)"			"unprognostic (4.84e-2)"				0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.7	0.0	0.0	0.0	3.8	0.5	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0
VCX2	VCX-2r	ENSG00000177504	"Variable charge X-linked 2"	Q9H322	X	8169944-8171267	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	283	"testis: 28.2"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 306.0;Spermatogonia: 414.0"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 0.8;testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044642, HPA044996, HPA049357"	Enhanced					NA	NA					"HPA044642: AB_2679033, HPA044996: AB_2679174, HPA049357: AB_2680727"															"unprognostic (1.34e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.0	4.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	59.2	0.0	0.0	306.0	414.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZBTB20	"DKFZp566F123, DPZF, ODA-8S, ZNF288"	ENSG00000181722	"Zinc finger and BTB domain containing 20"	Q9HC78	3	114314500-115147288	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 66.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1998.0;Microglial cells: 855.4;Oligodendrocyte precursor cells: 1908.5;Oligodendrocytes: 2090.4"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015551, HPA016815"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA015551: AB_2669217, HPA016815: AB_1858947"	"unprognostic (1.79e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.81e-1)"	4.2	4.0	27.2	1.1	43.2	2.5	3.4	59.4	44.2	3.4	4.1	1.7	0.8	3.6	9.7	1.2	2.4	2.3	3.6	60.4	66.9	5.2	5.4	1.8	1.8	45.3	32.2	5.9	6.8	3.5	2.3	1.4	1.0	34.0	5.4	1.4	8.6	3.1	4.9	7.9	2.3	0.8	2.9	26.4	2.5	1.7	15.9	33.4	1.9	5.0	9.0	1.8	1.6	0.7	40.8	1.4	2.7	1.0	2.8	4.2	1.8	0.0	1.3	2.5	0.8	0.6	1.7	0.5	0.4	3.7	3.2	0.8	0.0	4.0	0.6	0.7	0.3	0.1	0.4	1.7	1.3	0.8	0.1	0.0	1.8	0.2	1.4	0.4	2.4	0.8	0.2	0.1	0.6	4.4	0.0	0.1	0.1	0.3	0.0	0.1	0.1	3.4	0.0	2.9	0.0	0.3	0.7	0.5	0.0	0.9	0.1	0.0	0.3	4.8	1.0	3.5	0.2	1.8	0.9	0.0	0.1	1.7	0.2	1.3	9.7	1.5	6.4	6.8	2.3	4.6	20.4	6.4	6.4	1.9	11.3	8.3	6.8	3.5	5.3	4.6	4.9	3.6	3.5	27.2	43.2	59.4	44.2	60.4	66.9	45.3	32.2	5.9	34.0	26.4	33.4	40.8	278.1	160.3	122.6	1998.0	115.4	25.7	38.2	11.3	22.2	123.6	103.7	81.8	48.5	108.7	25.2	294.3	60.5	0.2	56.1	10.3	49.0	231.4	450.3	109.8	628.3	106.4	31.8	20.4	72.3	82.9	0.6	174.5	36.7	170.5	80.6	194.5	56.0	106.0	4.3	80.8	462.3	14.5	40.7	20.4	28.5	111.1	105.6	36.0	32.0	855.4	29.3	127.7	36.0	1908.5	2090.4	107.8	10.5	120.7	58.4	28.0	19.2	198.4	36.4	108.6	85.5	301.2	124.6	6.9	8.7	14.2	18.5	0.5	67.4	140.7	17.2	25.0
ZFPM1	"FOG, FOG1, ZC2HC11A, ZNF89A"	ENSG00000179588	"Zinc finger protein, FOG family member 1"	Q8IX07	16	88453280-88537031	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 35.3;Muller glia cells: 58.0;Theca cells: 37.4"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 12.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 19.3;K-562: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046603	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA046603: AB_2679718"	"unprognostic (1.29e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.49e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (4.24e-4)"	1.7	2.5	4.5	1.9	2.1	9.3	1.9	5.1	5.8	2.3	3.1	1.6	12.6	2.2	1.1	1.8	4.0	1.5	3.9	5.5	1.9	2.4	8.7	2.2	2.7	3.1	2.2	2.2	2.3	10.5	1.4	5.6	0.9	3.0	3.2	0.8	0.7	2.8	1.3	1.6	3.4	6.9	0.2	1.2	5.0	13.8	5.8	2.3	1.6	4.0	0.3	1.2	2.3	2.1	1.8	1.4	3.8	2.8	5.9	0.5	0.1	11.9	4.0	0.5	1.3	0.4	12.1	1.5	5.9	3.0	0.6	1.4	9.5	0.1	3.3	0.3	4.6	2.5	19.3	8.1	10.7	2.1	1.1	6.2	1.3	2.1	1.4	0.5	1.4	1.3	1.6	29.2	0.4	1.0	7.3	6.9	7.0	1.9	9.3	3.2	2.0	1.3	2.9	1.3	4.8	7.7	12.8	4.9	0.3	3.9	1.4	3.1	3.1	4.8	4.9	3.1	2.2	0.8	1.4	1.0	0.5	1.4	2.3	4.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	2.1	5.1	5.8	5.5	1.9	3.1	2.2	2.2	3.0	1.2	2.3	1.8	16.7	3.2	2.2	12.4	4.8	0.9	6.1	0.7	0.0	20.7	13.5	25.8	17.2	5.7	0.4	1.8	29.2	0.4	27.5	10.8	1.9	1.3	0.7	24.1	23.7	6.3	6.0	4.8	6.8	5.1	0.2	10.9	14.3	20.1	0.0	16.0	5.0	8.8	0.9	35.3	8.0	6.7	0.0	5.3	1.2	1.1	0.9	7.5	1.8	8.4	1.6	58.0	2.1	5.5	13.4	2.9	6.2	1.5	9.5	1.4	1.3	1.3	0.4	23.9	0.0	16.1	12.4	0.7	1.0	1.9	1.4	0.3	9.6	37.4	5.2	2.1
ZNF460	"HZF8, ZNF272"	ENSG00000197714	"Zinc finger protein 460"	Q14592	19	57280051-57294069	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 37.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 22.2;Squamous epithelial cells: 21.5"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 3.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 13.5"									"HPA053004, HPA066506"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053004: AB_2682012, HPA066506: AB_2685681"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.20e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.10e-2)"	1.6	5.0	4.8	0.7	7.4	6.0	1.6	7.7	8.0	1.2	4.0	0.8	0.3	1.0	0.8	1.3	1.0	1.0	1.3	3.1	37.8	1.1	1.5	1.4	0.9	7.6	7.6	4.4	2.3	1.0	1.3	1.7	1.4	11.2	1.1	0.6	2.6	1.3	1.1	1.5	1.7	0.7	1.1	5.7	1.4	0.9	1.8	5.6	1.0	1.4	1.3	1.0	1.1	1.3	19.5	1.2	1.9	1.5	2.1	1.5	1.3	3.8	0.8	1.2	0.9	2.8	2.4	0.7	1.9	0.9	1.0	0.8	0.8	2.0	1.0	1.6	1.4	3.9	1.8	1.6	1.2	1.7	3.2	2.0	0.7	1.8	2.5	2.8	0.7	0.6	2.0	1.8	13.5	1.1	0.9	1.9	0.5	2.1	1.0	1.8	1.4	2.1	0.9	0.6	2.4	1.9	1.0	2.1	1.1	1.2	1.0	0.9	2.2	0.9	2.8	3.3	0.4	1.7	5.7	2.7	3.1	1.0	1.2	0.9	0.0	0.5	1.0	0.7	1.1	0.8	0.8	0.5	0.4	0.1	2.2	1.2	0.5	1.2	0.8	0.7	0.0	1.1	0.7	4.8	7.4	7.7	8.0	3.1	37.8	7.6	7.6	4.4	11.2	5.7	5.6	19.5	7.9	3.2	1.5	3.9	11.6	3.1	3.6	0.7	22.2	4.3	4.1	2.8	5.9	1.5	2.0	0.0	0.0	1.4	6.6	1.3	0.0	1.5	3.4	7.0	9.5	4.9	0.0	11.2	6.2	0.4	2.0	7.3	10.2	13.1	0.0	4.7	7.1	2.0	1.1	8.4	5.9	1.2	4.1	1.9	2.2	0.7	1.8	3.3	1.8	1.9	4.0	2.4	4.1	2.5	13.3	1.7	0.2	1.5	16.3	3.0	0.7	0.8	2.4	3.2	0.0	8.1	8.4	3.6	1.4	21.5	2.4	2.6	7.8	3.6	1.3	4.4
